#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Analysis of alcohol use disorders from the Nathan Kline Institute-Rockland Sample: Correlation of brain cortical thickness with neuroticism*
#Text=Background
#Text=Although differences in both neuroanatomical measures and personality traits, in particular neuroticism, have been associated with alcohol use disorders (AUD), whether lifetime AUD diagnosis alters the relationship between neuroticism and neuroanatomical structures remains to be determined.
1-1	0-8	Analysis	_
1-2	9-11	of	_
1-3	12-19	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]
1-4	20-23	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]
1-5	24-33	disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[1]
1-6	34-38	from	_
1-7	39-42	the	_
1-8	43-49	Nathan	_
1-9	50-55	Kline	_
1-10	56-74	Institute-Rockland	_
1-11	75-81	Sample	_
1-12	81-82	:	_
1-13	83-94	Correlation	_
1-14	95-97	of	_
1-15	98-103	brain	_
1-16	104-112	cortical	_
1-17	113-122	thickness	_
1-18	123-127	with	_
1-19	128-139	neuroticism	_
1-20	139-140	*	_
1-21	141-151	Background	_
1-22	152-160	Although	_
1-23	161-172	differences	_
1-24	173-175	in	_
1-25	176-180	both	_
1-26	181-196	neuroanatomical	_
1-27	197-205	measures	_
1-28	206-209	and	_
1-29	210-221	personality	_
1-30	222-228	traits	_
1-31	228-229	,	_
1-32	230-232	in	_
1-33	233-243	particular	_
1-34	244-255	neuroticism	_
1-35	255-256	,	_
1-36	257-261	have	_
1-37	262-266	been	_
1-38	267-277	associated	_
1-39	278-282	with	_
1-40	283-290	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-41	291-294	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-42	295-304	disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-43	305-306	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-44	306-309	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-45	309-310	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-46	310-311	,	_
1-47	312-319	whether	_
1-48	320-328	lifetime	_
1-49	329-332	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-50	333-342	diagnosis	_
1-51	343-349	alters	_
1-52	350-353	the	_
1-53	354-366	relationship	_
1-54	367-374	between	_
1-55	375-386	neuroticism	_
1-56	387-390	and	_
1-57	391-406	neuroanatomical	_
1-58	407-417	structures	_
1-59	418-425	remains	_
1-60	426-428	to	_
1-61	429-431	be	_
1-62	432-442	determined	_
1-63	442-443	.	_

#Text=Methods
#Text=Data from 65 patients with lifetime AUD diagnoses and 65 healthy comparisons (HC) group-matched on age, sex and race were extracted from the Nathan Kline Institute - Rockland Sample data set.
2-1	444-451	Methods	_
2-2	452-456	Data	_
2-3	457-461	from	_
2-4	462-464	65	_
2-5	465-473	patients	_
2-6	474-478	with	_
2-7	479-487	lifetime	_
2-8	488-491	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
2-9	492-501	diagnoses	_
2-10	502-505	and	_
2-11	506-508	65	_
2-12	509-516	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]
2-13	517-528	comparisons	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]
2-14	529-530	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]
2-15	530-532	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]
2-16	532-533	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]
2-17	534-547	group-matched	_
2-18	548-550	on	_
2-19	551-554	age	_
2-20	554-555	,	_
2-21	556-559	sex	_
2-22	560-563	and	_
2-23	564-568	race	_
2-24	569-573	were	_
2-25	574-583	extracted	_
2-26	584-588	from	_
2-27	589-592	the	_
2-28	593-599	Nathan	_
2-29	600-605	Kline	_
2-30	606-615	Institute	_
2-31	616-617	-	_
2-32	618-626	Rockland	_
2-33	627-633	Sample	_
2-34	634-638	data	_
2-35	639-642	set	_
2-36	642-643	.	_

#Text=Each subject completed personality trait measures and underwent MRI scanning.
3-1	644-648	Each	_
3-2	649-656	subject	_
3-3	657-666	completed	_
3-4	667-678	personality	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[4]
3-5	679-684	trait	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[4]
3-6	685-693	measures	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[4]
3-7	694-697	and	_
3-8	698-707	underwent	_
3-9	708-711	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[5]
3-10	712-720	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[5]
3-11	720-721	.	_

#Text=Cortical thickness measures at 68 Desikan-Killiany Atlas regions were obtained using FreeSurfer 5.3.0.
4-1	722-730	Cortical	_
4-2	731-740	thickness	_
4-3	741-749	measures	_
4-4	750-752	at	_
4-5	753-755	68	_
4-6	756-772	Desikan-Killiany	_
4-7	773-778	Atlas	_
4-8	779-786	regions	_
4-9	787-791	were	_
4-10	792-800	obtained	_
4-11	801-806	using	_
4-12	807-817	FreeSurfer	_
4-13	818-823	5.3.0	_
4-14	823-824	.	_

#Text=Regression analyses were performed to identify brain regions at which the neuroticism-cortical thickness relationship was altered by lifetime AUD status.
5-1	825-835	Regression	_
5-2	836-844	analyses	_
5-3	845-849	were	_
5-4	850-859	performed	_
5-5	860-862	to	_
5-6	863-871	identify	_
5-7	872-877	brain	_
5-8	878-885	regions	_
5-9	886-888	at	_
5-10	889-894	which	_
5-11	895-898	the	_
5-12	899-919	neuroticism-cortical	_
5-13	920-929	thickness	_
5-14	930-942	relationship	_
5-15	943-946	was	_
5-16	947-954	altered	_
5-17	955-957	by	_
5-18	958-966	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]
5-19	967-970	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]
5-20	971-977	status	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]
5-21	977-978	.	_

#Text=Results
#Text=As expected, AUDs had higher neuroticism scores than HCs.
6-1	979-986	Results	_
6-2	987-989	As	_
6-3	990-998	expected	_
6-4	998-999	,	_
6-5	1000-1004	AUDs	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
6-6	1005-1008	had	_
6-7	1009-1015	higher	_
6-8	1016-1027	neuroticism	_
6-9	1028-1034	scores	_
6-10	1035-1039	than	_
6-11	1040-1043	HCs	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
6-12	1043-1044	.	_

#Text=Correlations between neuroticism and cortical thickness in the left insula and right fusiform differed significantly across groups.
7-1	1045-1057	Correlations	_
7-2	1058-1065	between	_
7-3	1066-1077	neuroticism	_
7-4	1078-1081	and	_
7-5	1082-1090	cortical	_
7-6	1091-1100	thickness	_
7-7	1101-1103	in	_
7-8	1104-1107	the	_
7-9	1108-1112	left	_
7-10	1113-1119	insula	_
7-11	1120-1123	and	_
7-12	1124-1129	right	_
7-13	1130-1138	fusiform	_
7-14	1139-1147	differed	_
7-15	1148-1161	significantly	_
7-16	1162-1168	across	_
7-17	1169-1175	groups	_
7-18	1175-1176	.	_

#Text=Higher neuroticism score in AUD and the interaction between the insular cortical thickness-neuroticism correlation and AUD status were confirmed in a replication study using the Human Connectome Project data set.
8-1	1177-1183	Higher	_
8-2	1184-1195	neuroticism	_
8-3	1196-1201	score	_
8-4	1202-1204	in	_
8-5	1205-1208	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
8-6	1209-1212	and	_
8-7	1213-1216	the	_
8-8	1217-1228	interaction	_
8-9	1229-1236	between	_
8-10	1237-1240	the	_
8-11	1241-1248	insular	_
8-12	1249-1257	cortical	_
8-13	1258-1279	thickness-neuroticism	_
8-14	1280-1291	correlation	_
8-15	1292-1295	and	_
8-16	1296-1299	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[7]
8-17	1300-1306	status	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[7]
8-18	1307-1311	were	_
8-19	1312-1321	confirmed	_
8-20	1322-1324	in	_
8-21	1325-1326	a	_
8-22	1327-1338	replication	_
8-23	1339-1344	study	_
8-24	1345-1350	using	_
8-25	1351-1354	the	_
8-26	1355-1360	Human	_
8-27	1361-1371	Connectome	_
8-28	1372-1379	Project	_
8-29	1380-1384	data	_
8-30	1385-1388	set	_
8-31	1388-1389	.	_

#Text=Conclusions
#Text=Results confirmed the relationship between neuroticism and AUD and suggests that specific cortical regions, particularly the left insula, represent anatomic substrates underlying this association in AUD.
#Text=1.
9-1	1390-1401	Conclusions	_
9-2	1402-1409	Results	_
9-3	1410-1419	confirmed	_
9-4	1420-1423	the	_
9-5	1424-1436	relationship	_
9-6	1437-1444	between	_
9-7	1445-1456	neuroticism	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale
9-8	1457-1460	and	_
9-9	1461-1464	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
9-10	1465-1468	and	_
9-11	1469-1477	suggests	_
9-12	1478-1482	that	_
9-13	1483-1491	specific	_
9-14	1492-1500	cortical	_
9-15	1501-1508	regions	_
9-16	1508-1509	,	_
9-17	1510-1522	particularly	_
9-18	1523-1526	the	_
9-19	1527-1531	left	_
9-20	1532-1538	insula	_
9-21	1538-1539	,	_
9-22	1540-1549	represent	_
9-23	1550-1558	anatomic	_
9-24	1559-1569	substrates	_
9-25	1570-1580	underlying	_
9-26	1581-1585	this	_
9-27	1586-1597	association	_
9-28	1598-1600	in	_
9-29	1601-1604	AUD	_
9-30	1604-1605	.	_
9-31	1606-1607	1	_
9-32	1607-1608	.	_

#Text=INTRODUCTION
#Text=Alcohol use disorders (AUD), including alcohol abuse and alcohol dependence, continue to be a major and complex public health problem.
10-1	1609-1621	INTRODUCTION	_
10-2	1622-1629	Alcohol	_
10-3	1630-1633	use	_
10-4	1634-1643	disorders	_
10-5	1644-1645	(	_
10-6	1645-1648	AUD	_
10-7	1648-1649	)	_
10-8	1649-1650	,	_
10-9	1651-1660	including	_
10-10	1661-1668	alcohol	_
10-11	1669-1674	abuse	_
10-12	1675-1678	and	_
10-13	1679-1686	alcohol	_
10-14	1687-1697	dependence	_
10-15	1697-1698	,	_
10-16	1699-1707	continue	_
10-17	1708-1710	to	_
10-18	1711-1713	be	_
10-19	1714-1715	a	_
10-20	1716-1721	major	_
10-21	1722-1725	and	_
10-22	1726-1733	complex	_
10-23	1734-1740	public	_
10-24	1741-1747	health	_
10-25	1748-1755	problem	_
10-26	1755-1756	.	_

#Text=The detrimental consequences of AUD include brain damage leading to executive function impairment and memory loss.
11-1	1757-1760	The	_
11-2	1761-1772	detrimental	_
11-3	1773-1785	consequences	_
11-4	1786-1788	of	_
11-5	1789-1792	AUD	_
11-6	1793-1800	include	_
11-7	1801-1806	brain	_
11-8	1807-1813	damage	_
11-9	1814-1821	leading	_
11-10	1822-1824	to	_
11-11	1825-1834	executive	_
11-12	1835-1843	function	_
11-13	1844-1854	impairment	_
11-14	1855-1858	and	_
11-15	1859-1865	memory	_
11-16	1866-1870	loss	_
11-17	1870-1871	.	_

#Text=To reduce deleterious health impacts and the associated economic loss, mechanistic understanding of AUD pathogenesis is required for developing more effective strategies for AUD prevention and treatment.
12-1	1872-1874	To	_
12-2	1875-1881	reduce	_
12-3	1882-1893	deleterious	_
12-4	1894-1900	health	_
12-5	1901-1908	impacts	_
12-6	1909-1912	and	_
12-7	1913-1916	the	_
12-8	1917-1927	associated	_
12-9	1928-1936	economic	_
12-10	1937-1941	loss	_
12-11	1941-1942	,	_
12-12	1943-1954	mechanistic	_
12-13	1955-1968	understanding	_
12-14	1969-1971	of	_
12-15	1972-1975	AUD	_
12-16	1976-1988	pathogenesis	_
12-17	1989-1991	is	_
12-18	1992-2000	required	_
12-19	2001-2004	for	_
12-20	2005-2015	developing	_
12-21	2016-2020	more	_
12-22	2021-2030	effective	_
12-23	2031-2041	strategies	_
12-24	2042-2045	for	_
12-25	2046-2049	AUD	_
12-26	2050-2060	prevention	_
12-27	2061-2064	and	_
12-28	2065-2074	treatment	_
12-29	2074-2075	.	_

#Text=Decades of studies have suggested biological factors and social and interpersonal influences as the major risk factors for the development of AUD.
13-1	2076-2083	Decades	_
13-2	2084-2086	of	_
13-3	2087-2094	studies	_
13-4	2095-2099	have	_
13-5	2100-2109	suggested	_
13-6	2110-2120	biological	_
13-7	2121-2128	factors	_
13-8	2129-2132	and	_
13-9	2133-2139	social	_
13-10	2140-2143	and	_
13-11	2144-2157	interpersonal	_
13-12	2158-2168	influences	_
13-13	2169-2171	as	_
13-14	2172-2175	the	_
13-15	2176-2181	major	_
13-16	2182-2186	risk	_
13-17	2187-2194	factors	_
13-18	2195-2198	for	_
13-19	2199-2202	the	_
13-20	2203-2214	development	_
13-21	2215-2217	of	_
13-22	2218-2221	AUD	_
13-23	2221-2222	.	_

#Text=Among the many risk factors, personality traits have been long recognized as important contributors to the development of AUD.
14-1	2223-2228	Among	_
14-2	2229-2232	the	_
14-3	2233-2237	many	_
14-4	2238-2242	risk	_
14-5	2243-2250	factors	_
14-6	2250-2251	,	_
14-7	2252-2263	personality	_
14-8	2264-2270	traits	_
14-9	2271-2275	have	_
14-10	2276-2280	been	_
14-11	2281-2285	long	_
14-12	2286-2296	recognized	_
14-13	2297-2299	as	_
14-14	2300-2309	important	_
14-15	2310-2322	contributors	_
14-16	2323-2325	to	_
14-17	2326-2329	the	_
14-18	2330-2341	development	_
14-19	2342-2344	of	_
14-20	2345-2348	AUD	_
14-21	2348-2349	.	_

#Text=The Five Factor Model (FFM) is a widely accepted framework that organizes personality traits along five dimensions: openness, conscientiousness, extraversion, agreeableness and neuroticism.
15-1	2350-2353	The	_
15-2	2354-2358	Five	_
15-3	2359-2365	Factor	_
15-4	2366-2371	Model	_
15-5	2372-2373	(	_
15-6	2373-2376	FFM	_
15-7	2376-2377	)	_
15-8	2378-2380	is	_
15-9	2381-2382	a	_
15-10	2383-2389	widely	_
15-11	2390-2398	accepted	_
15-12	2399-2408	framework	_
15-13	2409-2413	that	_
15-14	2414-2423	organizes	_
15-15	2424-2435	personality	_
15-16	2436-2442	traits	_
15-17	2443-2448	along	_
15-18	2449-2453	five	_
15-19	2454-2464	dimensions	_
15-20	2464-2465	:	_
15-21	2466-2474	openness	_
15-22	2474-2475	,	_
15-23	2476-2493	conscientiousness	_
15-24	2493-2494	,	_
15-25	2495-2507	extraversion	_
15-26	2507-2508	,	_
15-27	2509-2522	agreeableness	_
15-28	2523-2526	and	_
15-29	2527-2538	neuroticism	_
15-30	2538-2539	.	_

#Text=Neuroticism, the most frequently examined of these in AUD studies, entails the tendency to experience negative emotions including anger, anxiety, depression and vulnerability.
16-1	2540-2551	Neuroticism	_
16-2	2551-2552	,	_
16-3	2553-2556	the	_
16-4	2557-2561	most	_
16-5	2562-2572	frequently	_
16-6	2573-2581	examined	_
16-7	2582-2584	of	_
16-8	2585-2590	these	_
16-9	2591-2593	in	_
16-10	2594-2597	AUD	_
16-11	2598-2605	studies	_
16-12	2605-2606	,	_
16-13	2607-2614	entails	_
16-14	2615-2618	the	_
16-15	2619-2627	tendency	_
16-16	2628-2630	to	_
16-17	2631-2641	experience	_
16-18	2642-2650	negative	_
16-19	2651-2659	emotions	_
16-20	2660-2669	including	_
16-21	2670-2675	anger	_
16-22	2675-2676	,	_
16-23	2677-2684	anxiety	_
16-24	2684-2685	,	_
16-25	2686-2696	depression	_
16-26	2697-2700	and	_
16-27	2701-2714	vulnerability	_
16-28	2714-2715	.	_

#Text=Neuroticism can be quantified with the standardized NEO Five-Factor Inventory (NEOFFI).
17-1	2716-2727	Neuroticism	_
17-2	2728-2731	can	_
17-3	2732-2734	be	_
17-4	2735-2745	quantified	_
17-5	2746-2750	with	_
17-6	2751-2754	the	_
17-7	2755-2767	standardized	_
17-8	2768-2771	NEO	_
17-9	2772-2783	Five-Factor	_
17-10	2784-2793	Inventory	_
17-11	2794-2795	(	_
17-12	2795-2801	NEOFFI	_
17-13	2801-2802	)	_
17-14	2802-2803	.	_

#Text=Those high in neuroticism are more likely to be impacted by persistent negative feelings.
18-1	2804-2809	Those	_
18-2	2810-2814	high	_
18-3	2815-2817	in	_
18-4	2818-2829	neuroticism	_
18-5	2830-2833	are	_
18-6	2834-2838	more	_
18-7	2839-2845	likely	_
18-8	2846-2848	to	_
18-9	2849-2851	be	_
18-10	2852-2860	impacted	_
18-11	2861-2863	by	_
18-12	2864-2874	persistent	_
18-13	2875-2883	negative	_
18-14	2884-2892	feelings	_
18-15	2892-2893	.	_

#Text=While personality traits, including neuroticism, are considered stable and enduring aspects of individuals with substantial heritability, it has been argued that personality can affect alcohol consumption or shape the development of AUD.
19-1	2894-2899	While	_
19-2	2900-2911	personality	_
19-3	2912-2918	traits	_
19-4	2918-2919	,	_
19-5	2920-2929	including	_
19-6	2930-2941	neuroticism	_
19-7	2941-2942	,	_
19-8	2943-2946	are	_
19-9	2947-2957	considered	_
19-10	2958-2964	stable	_
19-11	2965-2968	and	_
19-12	2969-2977	enduring	_
19-13	2978-2985	aspects	_
19-14	2986-2988	of	_
19-15	2989-3000	individuals	_
19-16	3001-3005	with	_
19-17	3006-3017	substantial	_
19-18	3018-3030	heritability	_
19-19	3030-3031	,	_
19-20	3032-3034	it	_
19-21	3035-3038	has	_
19-22	3039-3043	been	_
19-23	3044-3050	argued	_
19-24	3051-3055	that	_
19-25	3056-3067	personality	_
19-26	3068-3071	can	_
19-27	3072-3078	affect	_
19-28	3079-3086	alcohol	_
19-29	3087-3098	consumption	_
19-30	3099-3101	or	_
19-31	3102-3107	shape	_
19-32	3108-3111	the	_
19-33	3112-3123	development	_
19-34	3124-3126	of	_
19-35	3127-3130	AUD	_
19-36	3130-3131	.	_

#Text=Studies have indicated that neuroticism is positively correlated with AUD or variation in drinking patterns.
20-1	3132-3139	Studies	_
20-2	3140-3144	have	_
20-3	3145-3154	indicated	_
20-4	3155-3159	that	_
20-5	3160-3171	neuroticism	_
20-6	3172-3174	is	_
20-7	3175-3185	positively	_
20-8	3186-3196	correlated	_
20-9	3197-3201	with	_
20-10	3202-3205	AUD	_
20-11	3206-3208	or	_
20-12	3209-3218	variation	_
20-13	3219-3221	in	_
20-14	3222-3230	drinking	_
20-15	3231-3239	patterns	_
20-16	3239-3240	.	_

#Text=Hicks et al. reported the interesting finding that negative emotionality traits at age 11 predict the onset and course (persistence vs. desistence) of AUD and that the course of AUD can affect the rate of personality change.
21-1	3241-3246	Hicks	_
21-2	3247-3249	et	_
21-3	3250-3252	al	_
21-4	3252-3253	.	_
21-5	3254-3262	reported	_
21-6	3263-3266	the	_
21-7	3267-3278	interesting	_
21-8	3279-3286	finding	_
21-9	3287-3291	that	_
21-10	3292-3300	negative	_
21-11	3301-3313	emotionality	_
21-12	3314-3320	traits	_
21-13	3321-3323	at	_
21-14	3324-3327	age	_
21-15	3328-3330	11	_
21-16	3331-3338	predict	_
21-17	3339-3342	the	_
21-18	3343-3348	onset	_
21-19	3349-3352	and	_
21-20	3353-3359	course	_
21-21	3360-3361	(	_
21-22	3361-3372	persistence	_
21-23	3373-3375	vs	_
21-24	3375-3376	.	_
21-25	3377-3387	desistence	_
21-26	3387-3388	)	_
21-27	3389-3391	of	_
21-28	3392-3395	AUD	_
21-29	3396-3399	and	_
21-30	3400-3404	that	_
21-31	3405-3408	the	_
21-32	3409-3415	course	_
21-33	3416-3418	of	_
21-34	3419-3422	AUD	_
21-35	3423-3426	can	_
21-36	3427-3433	affect	_
21-37	3434-3437	the	_
21-38	3438-3442	rate	_
21-39	3443-3445	of	_
21-40	3446-3457	personality	_
21-41	3458-3464	change	_
21-42	3464-3465	.	_

#Text=This finding suggests that neuroticism and AUD can have reciprocal effects during development, indicating a complex relationship between AUD and neuroticism.
22-1	3466-3470	This	_
22-2	3471-3478	finding	_
22-3	3479-3487	suggests	_
22-4	3488-3492	that	_
22-5	3493-3504	neuroticism	_
22-6	3505-3508	and	_
22-7	3509-3512	AUD	_
22-8	3513-3516	can	_
22-9	3517-3521	have	_
22-10	3522-3532	reciprocal	_
22-11	3533-3540	effects	_
22-12	3541-3547	during	_
22-13	3548-3559	development	_
22-14	3559-3560	,	_
22-15	3561-3571	indicating	_
22-16	3572-3573	a	_
22-17	3574-3581	complex	_
22-18	3582-3594	relationship	_
22-19	3595-3602	between	_
22-20	3603-3606	AUD	_
22-21	3607-3610	and	_
22-22	3611-3622	neuroticism	_
22-23	3622-3623	.	_

#Text=A number of studies have focused on the neural correlates of neuroticism and AUD, using various brain imaging technologies such as structural magnetic resonance imaging (sMRI) and functional MRI (fMRI).
23-1	3624-3625	A	_
23-2	3626-3632	number	_
23-3	3633-3635	of	_
23-4	3636-3643	studies	_
23-5	3644-3648	have	_
23-6	3649-3656	focused	_
23-7	3657-3659	on	_
23-8	3660-3663	the	_
23-9	3664-3670	neural	_
23-10	3671-3681	correlates	_
23-11	3682-3684	of	_
23-12	3685-3696	neuroticism	_
23-13	3697-3700	and	_
23-14	3701-3704	AUD	_
23-15	3704-3705	,	_
23-16	3706-3711	using	_
23-17	3712-3719	various	_
23-18	3720-3725	brain	_
23-19	3726-3733	imaging	_
23-20	3734-3746	technologies	_
23-21	3747-3751	such	_
23-22	3752-3754	as	_
23-23	3755-3765	structural	_
23-24	3766-3774	magnetic	_
23-25	3775-3784	resonance	_
23-26	3785-3792	imaging	_
23-27	3793-3794	(	_
23-28	3794-3798	sMRI	_
23-29	3798-3799	)	_
23-30	3800-3803	and	_
23-31	3804-3814	functional	_
23-32	3815-3818	MRI	_
23-33	3819-3820	(	_
23-34	3820-3824	fMRI	_
23-35	3824-3825	)	_
23-36	3825-3826	.	_

#Text=With regard to the brain correlates of neuroticism, several sMRI studies have reported negative correlations of neuroticism with global grey matter volume, thickness of the left orbitofrontal cortex, white matter volume in the superior medial frontal gyrus, volumes in several prefrontal regions and volumes in left medial temporal lobe and in cingulate gyrus.
24-1	3827-3831	With	_
24-2	3832-3838	regard	_
24-3	3839-3841	to	_
24-4	3842-3845	the	_
24-5	3846-3851	brain	_
24-6	3852-3862	correlates	_
24-7	3863-3865	of	_
24-8	3866-3877	neuroticism	_
24-9	3877-3878	,	_
24-10	3879-3886	several	_
24-11	3887-3891	sMRI	_
24-12	3892-3899	studies	_
24-13	3900-3904	have	_
24-14	3905-3913	reported	_
24-15	3914-3922	negative	_
24-16	3923-3935	correlations	_
24-17	3936-3938	of	_
24-18	3939-3950	neuroticism	_
24-19	3951-3955	with	_
24-20	3956-3962	global	_
24-21	3963-3967	grey	_
24-22	3968-3974	matter	_
24-23	3975-3981	volume	_
24-24	3981-3982	,	_
24-25	3983-3992	thickness	_
24-26	3993-3995	of	_
24-27	3996-3999	the	_
24-28	4000-4004	left	_
24-29	4005-4018	orbitofrontal	_
24-30	4019-4025	cortex	_
24-31	4025-4026	,	_
24-32	4027-4032	white	_
24-33	4033-4039	matter	_
24-34	4040-4046	volume	_
24-35	4047-4049	in	_
24-36	4050-4053	the	_
24-37	4054-4062	superior	_
24-38	4063-4069	medial	_
24-39	4070-4077	frontal	_
24-40	4078-4083	gyrus	_
24-41	4083-4084	,	_
24-42	4085-4092	volumes	_
24-43	4093-4095	in	_
24-44	4096-4103	several	_
24-45	4104-4114	prefrontal	_
24-46	4115-4122	regions	_
24-47	4123-4126	and	_
24-48	4127-4134	volumes	_
24-49	4135-4137	in	_
24-50	4138-4142	left	_
24-51	4143-4149	medial	_
24-52	4150-4158	temporal	_
24-53	4159-4163	lobe	_
24-54	4164-4167	and	_
24-55	4168-4170	in	_
24-56	4171-4180	cingulate	_
24-57	4181-4186	gyrus	_
24-58	4186-4187	.	_

#Text=More than a dozen fMRI studies that included cognitive tasks involving emotional conflict or facial stimuli processing have suggested that neuroticism is strongly associated with activity in amygdala and anterior cingulate cortex (ACC) although medial prefrontal cortex, hippocampus and insula are also involved.
25-1	4188-4192	More	_
25-2	4193-4197	than	_
25-3	4198-4199	a	_
25-4	4200-4205	dozen	_
25-5	4206-4210	fMRI	_
25-6	4211-4218	studies	_
25-7	4219-4223	that	_
25-8	4224-4232	included	_
25-9	4233-4242	cognitive	_
25-10	4243-4248	tasks	_
25-11	4249-4258	involving	_
25-12	4259-4268	emotional	_
25-13	4269-4277	conflict	_
25-14	4278-4280	or	_
25-15	4281-4287	facial	_
25-16	4288-4295	stimuli	_
25-17	4296-4306	processing	_
25-18	4307-4311	have	_
25-19	4312-4321	suggested	_
25-20	4322-4326	that	_
25-21	4327-4338	neuroticism	_
25-22	4339-4341	is	_
25-23	4342-4350	strongly	_
25-24	4351-4361	associated	_
25-25	4362-4366	with	_
25-26	4367-4375	activity	_
25-27	4376-4378	in	_
25-28	4379-4387	amygdala	_
25-29	4388-4391	and	_
25-30	4392-4400	anterior	_
25-31	4401-4410	cingulate	_
25-32	4411-4417	cortex	_
25-33	4418-4419	(	_
25-34	4419-4422	ACC	_
25-35	4422-4423	)	_
25-36	4424-4432	although	_
25-37	4433-4439	medial	_
25-38	4440-4450	prefrontal	_
25-39	4451-4457	cortex	_
25-40	4457-4458	,	_
25-41	4459-4470	hippocampus	_
25-42	4471-4474	and	_
25-43	4475-4481	insula	_
25-44	4482-4485	are	_
25-45	4486-4490	also	_
25-46	4491-4499	involved	_
25-47	4499-4500	.	_

#Text=In addition, a recent fMRI study found that right superior parietal cortex activation in the task-independent default mode network was negatively correlated with neuroticism.
26-1	4501-4503	In	_
26-2	4504-4512	addition	_
26-3	4512-4513	,	_
26-4	4514-4515	a	_
26-5	4516-4522	recent	_
26-6	4523-4527	fMRI	_
26-7	4528-4533	study	_
26-8	4534-4539	found	_
26-9	4540-4544	that	_
26-10	4545-4550	right	_
26-11	4551-4559	superior	_
26-12	4560-4568	parietal	_
26-13	4569-4575	cortex	_
26-14	4576-4586	activation	_
26-15	4587-4589	in	_
26-16	4590-4593	the	_
26-17	4594-4610	task-independent	_
26-18	4611-4618	default	_
26-19	4619-4623	mode	_
26-20	4624-4631	network	_
26-21	4632-4635	was	_
26-22	4636-4646	negatively	_
26-23	4647-4657	correlated	_
26-24	4658-4662	with	_
26-25	4663-4674	neuroticism	_
26-26	4674-4675	.	_

#Text=Taken together, the findings from these brain imaging studies suggest that neuroticism is related to certain specific brain regions that are involved in the perception of negative stimuli and/or exert their control over such stimuli.
27-1	4676-4681	Taken	_
27-2	4682-4690	together	_
27-3	4690-4691	,	_
27-4	4692-4695	the	_
27-5	4696-4704	findings	_
27-6	4705-4709	from	_
27-7	4710-4715	these	_
27-8	4716-4721	brain	_
27-9	4722-4729	imaging	_
27-10	4730-4737	studies	_
27-11	4738-4745	suggest	_
27-12	4746-4750	that	_
27-13	4751-4762	neuroticism	_
27-14	4763-4765	is	_
27-15	4766-4773	related	_
27-16	4774-4776	to	_
27-17	4777-4784	certain	_
27-18	4785-4793	specific	_
27-19	4794-4799	brain	_
27-20	4800-4807	regions	_
27-21	4808-4812	that	_
27-22	4813-4816	are	_
27-23	4817-4825	involved	_
27-24	4826-4828	in	_
27-25	4829-4832	the	_
27-26	4833-4843	perception	_
27-27	4844-4846	of	_
27-28	4847-4855	negative	_
27-29	4856-4863	stimuli	_
27-30	4864-4867	and	_
27-31	4867-4868	/	_
27-32	4868-4870	or	_
27-33	4871-4876	exert	_
27-34	4877-4882	their	_
27-35	4883-4890	control	_
27-36	4891-4895	over	_
27-37	4896-4900	such	_
27-38	4901-4908	stimuli	_
27-39	4908-4909	.	_

#Text=Similar brain imaging studies have been performed on AUD, and the observed structural and functional changes in the brain that are strongly associated with the development and/or severity of AUDs have been summarized in several recent reviews or meta-analyses.
28-1	4910-4917	Similar	_
28-2	4918-4923	brain	_
28-3	4924-4931	imaging	_
28-4	4932-4939	studies	_
28-5	4940-4944	have	_
28-6	4945-4949	been	_
28-7	4950-4959	performed	_
28-8	4960-4962	on	_
28-9	4963-4966	AUD	_
28-10	4966-4967	,	_
28-11	4968-4971	and	_
28-12	4972-4975	the	_
28-13	4976-4984	observed	_
28-14	4985-4995	structural	_
28-15	4996-4999	and	_
28-16	5000-5010	functional	_
28-17	5011-5018	changes	_
28-18	5019-5021	in	_
28-19	5022-5025	the	_
28-20	5026-5031	brain	_
28-21	5032-5036	that	_
28-22	5037-5040	are	_
28-23	5041-5049	strongly	_
28-24	5050-5060	associated	_
28-25	5061-5065	with	_
28-26	5066-5069	the	_
28-27	5070-5081	development	_
28-28	5082-5085	and	_
28-29	5085-5086	/	_
28-30	5086-5088	or	_
28-31	5089-5097	severity	_
28-32	5098-5100	of	_
28-33	5101-5105	AUDs	_
28-34	5106-5110	have	_
28-35	5111-5115	been	_
28-36	5116-5126	summarized	_
28-37	5127-5129	in	_
28-38	5130-5137	several	_
28-39	5138-5144	recent	_
28-40	5145-5152	reviews	_
28-41	5153-5155	or	_
28-42	5156-5169	meta-analyses	_
28-43	5169-5170	.	_

#Text=Although the brain structure-functional networks that underlie the development or consequence of AUD remain to be definitively identified, studies have started to shed some light on the structural and functional correlates of AUD.
29-1	5171-5179	Although	_
29-2	5180-5183	the	_
29-3	5184-5189	brain	_
29-4	5190-5210	structure-functional	_
29-5	5211-5219	networks	_
29-6	5220-5224	that	_
29-7	5225-5233	underlie	_
29-8	5234-5237	the	_
29-9	5238-5249	development	_
29-10	5250-5252	or	_
29-11	5253-5264	consequence	_
29-12	5265-5267	of	_
29-13	5268-5271	AUD	_
29-14	5272-5278	remain	_
29-15	5279-5281	to	_
29-16	5282-5284	be	_
29-17	5285-5297	definitively	_
29-18	5298-5308	identified	_
29-19	5308-5309	,	_
29-20	5310-5317	studies	_
29-21	5318-5322	have	_
29-22	5323-5330	started	_
29-23	5331-5333	to	_
29-24	5334-5338	shed	_
29-25	5339-5343	some	_
29-26	5344-5349	light	_
29-27	5350-5352	on	_
29-28	5353-5356	the	_
29-29	5357-5367	structural	_
29-30	5368-5371	and	_
29-31	5372-5382	functional	_
29-32	5383-5393	correlates	_
29-33	5394-5396	of	_
29-34	5397-5400	AUD	_
29-35	5400-5401	.	_

#Text=In general, AUD is associated with structural changes, including reductions in grey matter and white matter volume and cortical thickness in multiple brain regions from the neocortex (in particular the frontal lobes), the limbic system (including hippocampus, amygdala, hypothalamus and anterior cingulate) and the cerebellum.
30-1	5402-5404	In	_
30-2	5405-5412	general	_
30-3	5412-5413	,	_
30-4	5414-5417	AUD	_
30-5	5418-5420	is	_
30-6	5421-5431	associated	_
30-7	5432-5436	with	_
30-8	5437-5447	structural	_
30-9	5448-5455	changes	_
30-10	5455-5456	,	_
30-11	5457-5466	including	_
30-12	5467-5477	reductions	_
30-13	5478-5480	in	_
30-14	5481-5485	grey	_
30-15	5486-5492	matter	_
30-16	5493-5496	and	_
30-17	5497-5502	white	_
30-18	5503-5509	matter	_
30-19	5510-5516	volume	_
30-20	5517-5520	and	_
30-21	5521-5529	cortical	_
30-22	5530-5539	thickness	_
30-23	5540-5542	in	_
30-24	5543-5551	multiple	_
30-25	5552-5557	brain	_
30-26	5558-5565	regions	_
30-27	5566-5570	from	_
30-28	5571-5574	the	_
30-29	5575-5584	neocortex	_
30-30	5585-5586	(	_
30-31	5586-5588	in	_
30-32	5589-5599	particular	_
30-33	5600-5603	the	_
30-34	5604-5611	frontal	_
30-35	5612-5617	lobes	_
30-36	5617-5618	)	_
30-37	5618-5619	,	_
30-38	5620-5623	the	_
30-39	5624-5630	limbic	_
30-40	5631-5637	system	_
30-41	5638-5639	(	_
30-42	5639-5648	including	_
30-43	5649-5660	hippocampus	_
30-44	5660-5661	,	_
30-45	5662-5670	amygdala	_
30-46	5670-5671	,	_
30-47	5672-5684	hypothalamus	_
30-48	5685-5688	and	_
30-49	5689-5697	anterior	_
30-50	5698-5707	cingulate	_
30-51	5707-5708	)	_
30-52	5709-5712	and	_
30-53	5713-5716	the	_
30-54	5717-5727	cerebellum	_
30-55	5727-5728	.	_

#Text=These structural features reflect alterations in various functional domains including personality.
31-1	5729-5734	These	_
31-2	5735-5745	structural	_
31-3	5746-5754	features	_
31-4	5755-5762	reflect	_
31-5	5763-5774	alterations	_
31-6	5775-5777	in	_
31-7	5778-5785	various	_
31-8	5786-5796	functional	_
31-9	5797-5804	domains	_
31-10	5805-5814	including	_
31-11	5815-5826	personality	_
31-12	5826-5827	.	_

#Text=Despite increasing efforts to examine the relationships between AUD and neuroticism and between AUD or neuroticism and neuroanatomy, no study linking AUD, neuroticism and neuroanatomical measures has been reported yet.
32-1	5828-5835	Despite	_
32-2	5836-5846	increasing	_
32-3	5847-5854	efforts	_
32-4	5855-5857	to	_
32-5	5858-5865	examine	_
32-6	5866-5869	the	_
32-7	5870-5883	relationships	_
32-8	5884-5891	between	_
32-9	5892-5895	AUD	_
32-10	5896-5899	and	_
32-11	5900-5911	neuroticism	_
32-12	5912-5915	and	_
32-13	5916-5923	between	_
32-14	5924-5927	AUD	_
32-15	5928-5930	or	_
32-16	5931-5942	neuroticism	_
32-17	5943-5946	and	_
32-18	5947-5959	neuroanatomy	_
32-19	5959-5960	,	_
32-20	5961-5963	no	_
32-21	5964-5969	study	_
32-22	5970-5977	linking	_
32-23	5978-5981	AUD	_
32-24	5981-5982	,	_
32-25	5983-5994	neuroticism	_
32-26	5995-5998	and	_
32-27	5999-6014	neuroanatomical	_
32-28	6015-6023	measures	_
32-29	6024-6027	has	_
32-30	6028-6032	been	_
32-31	6033-6041	reported	_
32-32	6042-6045	yet	_
32-33	6045-6046	.	_

#Text=In this work, we focused on brain cortical thickness, a measure that has been regarded as an indicator of cortical integrity and the most invariant brain size parameter across species.
33-1	6047-6049	In	_
33-2	6050-6054	this	_
33-3	6055-6059	work	_
33-4	6059-6060	,	_
33-5	6061-6063	we	_
33-6	6064-6071	focused	_
33-7	6072-6074	on	_
33-8	6075-6080	brain	_
33-9	6081-6089	cortical	_
33-10	6090-6099	thickness	_
33-11	6099-6100	,	_
33-12	6101-6102	a	_
33-13	6103-6110	measure	_
33-14	6111-6115	that	_
33-15	6116-6119	has	_
33-16	6120-6124	been	_
33-17	6125-6133	regarded	_
33-18	6134-6136	as	_
33-19	6137-6139	an	_
33-20	6140-6149	indicator	_
33-21	6150-6152	of	_
33-22	6153-6161	cortical	_
33-23	6162-6171	integrity	_
33-24	6172-6175	and	_
33-25	6176-6179	the	_
33-26	6180-6184	most	_
33-27	6185-6194	invariant	_
33-28	6195-6200	brain	_
33-29	6201-6205	size	_
33-30	6206-6215	parameter	_
33-31	6216-6222	across	_
33-32	6223-6230	species	_
33-33	6230-6231	.	_

#Text=Specifically, we attempted to gain initial insights into the possible correlation of brain cortical thickness phenotypes with neuroticism scores and AUD diagnostic status, using the community-based Nathan Kline Institute-Rockland Sample (NKI-RS).
34-1	6232-6244	Specifically	_
34-2	6244-6245	,	_
34-3	6246-6248	we	_
34-4	6249-6258	attempted	_
34-5	6259-6261	to	_
34-6	6262-6266	gain	_
34-7	6267-6274	initial	_
34-8	6275-6283	insights	_
34-9	6284-6288	into	_
34-10	6289-6292	the	_
34-11	6293-6301	possible	_
34-12	6302-6313	correlation	_
34-13	6314-6316	of	_
34-14	6317-6322	brain	_
34-15	6323-6331	cortical	_
34-16	6332-6341	thickness	_
34-17	6342-6352	phenotypes	_
34-18	6353-6357	with	_
34-19	6358-6369	neuroticism	_
34-20	6370-6376	scores	_
34-21	6377-6380	and	_
34-22	6381-6384	AUD	_
34-23	6385-6395	diagnostic	_
34-24	6396-6402	status	_
34-25	6402-6403	,	_
34-26	6404-6409	using	_
34-27	6410-6413	the	_
34-28	6414-6429	community-based	_
34-29	6430-6436	Nathan	_
34-30	6437-6442	Kline	_
34-31	6443-6461	Institute-Rockland	_
34-32	6462-6468	Sample	_
34-33	6469-6470	(	_
34-34	6470-6476	NKI-RS	_
34-35	6476-6477	)	_
34-36	6477-6478	.	_

#Text=In the NKI-RS, volunteers from Rockland County, New York, are deeply phenotyped with advanced neuroimaging and DNA samples available to the research community, with the goal of accelerating the pace of discovery science in psychiatry.
35-1	6479-6481	In	_
35-2	6482-6485	the	_
35-3	6486-6492	NKI-RS	_
35-4	6492-6493	,	_
35-5	6494-6504	volunteers	_
35-6	6505-6509	from	_
35-7	6510-6518	Rockland	_
35-8	6519-6525	County	_
35-9	6525-6526	,	_
35-10	6527-6530	New	_
35-11	6531-6535	York	_
35-12	6535-6536	,	_
35-13	6537-6540	are	_
35-14	6541-6547	deeply	_
35-15	6548-6558	phenotyped	_
35-16	6559-6563	with	_
35-17	6564-6572	advanced	_
35-18	6573-6585	neuroimaging	_
35-19	6586-6589	and	_
35-20	6590-6593	DNA	_
35-21	6594-6601	samples	_
35-22	6602-6611	available	_
35-23	6612-6614	to	_
35-24	6615-6618	the	_
35-25	6619-6627	research	_
35-26	6628-6637	community	_
35-27	6637-6638	,	_
35-28	6639-6643	with	_
35-29	6644-6647	the	_
35-30	6648-6652	goal	_
35-31	6653-6655	of	_
35-32	6656-6668	accelerating	_
35-33	6669-6672	the	_
35-34	6673-6677	pace	_
35-35	6678-6680	of	_
35-36	6681-6690	discovery	_
35-37	6691-6698	science	_
35-38	6699-6701	in	_
35-39	6702-6712	psychiatry	_
35-40	6712-6713	.	_

#Text=As of September, 2015, behavioral measurements and structural imaging data were available for 494 subjects.
36-1	6714-6716	As	_
36-2	6717-6719	of	_
36-3	6720-6729	September	_
36-4	6729-6730	,	_
36-5	6731-6735	2015	_
36-6	6735-6736	,	_
36-7	6737-6747	behavioral	_
36-8	6748-6760	measurements	_
36-9	6761-6764	and	_
36-10	6765-6775	structural	_
36-11	6776-6783	imaging	_
36-12	6784-6788	data	_
36-13	6789-6793	were	_
36-14	6794-6803	available	_
36-15	6804-6807	for	_
36-16	6808-6811	494	_
36-17	6812-6820	subjects	_
36-18	6820-6821	.	_

#Text=After screening, we had 65 individuals with a lifetime history of AUD.
37-1	6822-6827	After	_
37-2	6828-6837	screening	_
37-3	6837-6838	,	_
37-4	6839-6841	we	_
37-5	6842-6845	had	_
37-6	6846-6848	65	_
37-7	6849-6860	individuals	_
37-8	6861-6865	with	_
37-9	6866-6867	a	_
37-10	6868-6876	lifetime	_
37-11	6877-6884	history	_
37-12	6885-6887	of	_
37-13	6888-6891	AUD	_
37-14	6891-6892	.	_

#Text=Sixty-five healthy comparisons (HC) were selected to match the cases on age, sex, and race as closely as possible.
38-1	6893-6903	Sixty-five	_
38-2	6904-6911	healthy	_
38-3	6912-6923	comparisons	_
38-4	6924-6925	(	_
38-5	6925-6927	HC	_
38-6	6927-6928	)	_
38-7	6929-6933	were	_
38-8	6934-6942	selected	_
38-9	6943-6945	to	_
38-10	6946-6951	match	_
38-11	6952-6955	the	_
38-12	6956-6961	cases	_
38-13	6962-6964	on	_
38-14	6965-6968	age	_
38-15	6968-6969	,	_
38-16	6970-6973	sex	_
38-17	6973-6974	,	_
38-18	6975-6978	and	_
38-19	6979-6983	race	_
38-20	6984-6986	as	_
38-21	6987-6994	closely	_
38-22	6995-6997	as	_
38-23	6998-7006	possible	_
38-24	7006-7007	.	_

#Text=To confirm the replicability of our results, we used data from the Human Connectome Project.
#Text=2.
39-1	7008-7010	To	_
39-2	7011-7018	confirm	_
39-3	7019-7022	the	_
39-4	7023-7036	replicability	_
39-5	7037-7039	of	_
39-6	7040-7043	our	_
39-7	7044-7051	results	_
39-8	7051-7052	,	_
39-9	7053-7055	we	_
39-10	7056-7060	used	_
39-11	7061-7065	data	_
39-12	7066-7070	from	_
39-13	7071-7074	the	_
39-14	7075-7080	Human	_
39-15	7081-7091	Connectome	_
39-16	7092-7099	Project	_
39-17	7099-7100	.	_
39-18	7101-7102	2	_
39-19	7102-7103	.	_

#Text=MATERIALS AND METHODS
#Text=2.1.
40-1	7104-7113	MATERIALS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]
40-2	7114-7117	AND	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]
40-3	7118-7125	METHODS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]
40-4	7126-7129	2.1	_
40-5	7129-7130	.	_

#Text=Participants
#Text=Participants were drawn from the first eight releases of the NKI-RS.
41-1	7131-7143	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-2	7144-7156	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-3	7157-7161	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-4	7162-7167	drawn	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-5	7168-7172	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-6	7173-7176	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-7	7177-7182	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-8	7183-7188	eight	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-9	7189-7197	releases	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-10	7198-7200	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-11	7201-7204	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-12	7205-7211	NKI-RS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]
41-13	7211-7212	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]

#Text=As part of a larger battery of measures, each participant completed the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID).
42-1	7213-7215	As	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-2	7216-7220	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-3	7221-7223	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-4	7224-7225	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-5	7226-7232	larger	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-6	7233-7240	battery	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-7	7241-7243	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-8	7244-7252	measures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-9	7252-7253	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-10	7254-7258	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-11	7259-7270	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-12	7271-7280	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-13	7281-7284	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-14	7285-7295	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-15	7296-7304	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-16	7305-7314	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-17	7315-7318	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-18	7319-7328	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-19	7329-7333	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-20	7334-7335	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-21	7336-7345	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[11]
42-22	7346-7347	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-23	7347-7351	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-24	7351-7352	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
42-25	7352-7353	.	_

#Text=Study staff provided a diagnostic summary for each participant based on semi-structured interviews.
43-1	7354-7359	Study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-2	7360-7365	staff	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-3	7366-7374	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-4	7375-7376	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-5	7377-7387	diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-6	7388-7395	summary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-7	7396-7399	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-8	7400-7404	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-9	7405-7416	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-10	7417-7422	based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-11	7423-7425	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-12	7426-7441	semi-structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-13	7442-7452	interviews	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]
43-14	7452-7453	.	_

#Text=Among 494 subjects with publicly available behavioral measurements and structural image data as of September 2015, those who met any of the following criteria were excluded: 1) age below 18 years; 2) diagnosis of other psychiatric disorders without AUD; 3) a diagnosis of epilepsy and/or a history of seizures; 4) subjects who ever lost consciousness due to head injury; 5) missing data on age, sex, race, age at drinking onset, neuroticism, and/or brain structural measure; and 6) subjects with AUD diagnosis history but reporting no lifetime alcohol consumption.
44-1	7454-7459	Among	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-2	7460-7463	494	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-3	7464-7472	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-4	7473-7477	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-5	7478-7486	publicly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-6	7487-7496	available	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-7	7497-7507	behavioral	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-8	7508-7520	measurements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-9	7521-7524	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-10	7525-7535	structural	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-11	7536-7541	image	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-12	7542-7546	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-13	7547-7549	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-14	7550-7552	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-15	7553-7562	September	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-16	7563-7567	2015	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-17	7567-7568	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-18	7569-7574	those	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-19	7575-7578	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-20	7579-7582	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-21	7583-7586	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-22	7587-7589	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-23	7590-7593	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-24	7594-7603	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-25	7604-7612	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-26	7613-7617	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-27	7618-7626	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-28	7626-7627	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-29	7628-7629	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-30	7629-7630	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-31	7631-7634	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-32	7635-7640	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-33	7641-7643	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-34	7644-7649	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-35	7649-7650	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-36	7651-7652	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-37	7652-7653	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-38	7654-7663	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-39	7664-7666	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-40	7667-7672	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-41	7673-7684	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-42	7685-7694	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-43	7695-7702	without	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-44	7703-7706	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[14]
44-45	7706-7707	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-46	7708-7709	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-47	7709-7710	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-48	7711-7712	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-49	7713-7722	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-50	7723-7725	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-51	7726-7734	epilepsy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-52	7735-7738	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-53	7738-7739	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-54	7739-7741	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-55	7742-7743	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-56	7744-7751	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-57	7752-7754	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-58	7755-7763	seizures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-59	7763-7764	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-60	7765-7766	4	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-61	7766-7767	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-62	7768-7776	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-63	7777-7780	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-64	7781-7785	ever	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-65	7786-7790	lost	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-66	7791-7804	consciousness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-67	7805-7808	due	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-68	7809-7811	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-69	7812-7816	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-70	7817-7823	injury	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-71	7823-7824	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-72	7825-7826	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-73	7826-7827	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-74	7828-7835	missing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-75	7836-7840	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-76	7841-7843	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-77	7844-7847	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-78	7847-7848	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-79	7849-7852	sex	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-80	7852-7853	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-81	7854-7858	race	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-82	7858-7859	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-83	7860-7863	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-84	7864-7866	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-85	7867-7875	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-86	7876-7881	onset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-87	7881-7882	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-88	7883-7894	neuroticism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-89	7894-7895	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-90	7896-7899	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-91	7899-7900	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-92	7900-7902	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-93	7903-7908	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-94	7909-7919	structural	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-95	7920-7927	measure	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-96	7927-7928	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-97	7929-7932	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-98	7933-7934	6	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-99	7934-7935	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-100	7936-7944	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-101	7945-7949	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-102	7950-7953	AUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-103	7954-7963	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-104	7964-7971	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-105	7972-7975	but	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-106	7976-7985	reporting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-107	7986-7988	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-108	7989-7997	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-109	7998-8005	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-110	8006-8017	consumption	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
44-111	8017-8018	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]

#Text=Also exclusionary for healthy comparisons were 7) substance (including alcohol, cannabis, opioid, cocaine et al.) involvement scores greater than 3; and 8) inconsistency regarding substance use between self-report and lab results.
45-1	8019-8023	Also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-2	8024-8036	exclusionary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-3	8037-8040	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-4	8041-8048	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-5	8049-8060	comparisons	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-6	8061-8065	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-7	8066-8067	7	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-8	8067-8068	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-9	8069-8078	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-10	8079-8080	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-11	8080-8089	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-12	8090-8097	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-13	8097-8098	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-14	8099-8107	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-15	8107-8108	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-16	8109-8115	opioid	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-17	8115-8116	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-18	8117-8124	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-19	8125-8127	et	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-20	8128-8130	al	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-21	8130-8131	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-22	8131-8132	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-23	8133-8144	involvement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-24	8145-8151	scores	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-25	8152-8159	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-26	8160-8164	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-27	8165-8166	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
45-28	8166-8167	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-29	8168-8171	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-30	8172-8173	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-31	8173-8174	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-32	8175-8188	inconsistency	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-33	8189-8198	regarding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-34	8199-8208	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-35	8209-8212	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-36	8213-8220	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-37	8221-8232	self-report	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-38	8233-8236	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-39	8237-8240	lab	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-40	8241-8248	results	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
45-41	8248-8249	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]

#Text=This screen resulted in a total of 172 subjects.
46-1	8250-8254	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-2	8255-8261	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-3	8262-8270	resulted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-4	8271-8273	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-5	8274-8275	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-6	8276-8281	total	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-7	8282-8284	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-8	8285-8288	172	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-9	8289-8297	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
46-10	8297-8298	.	_

#Text=From these, 65 patients with AUD comprised our disease group, and 65 subjects with no Axis I diagnosis, group-matched on age, sex and race, were selected as HC.
#Text=2.2.
47-1	8299-8303	From	_
47-2	8304-8309	these	_
47-3	8309-8310	,	_
47-4	8311-8313	65	_
47-5	8314-8322	patients	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[18]
47-6	8323-8327	with	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[18]
47-7	8328-8331	AUD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[18]
47-8	8332-8341	comprised	_
47-9	8342-8345	our	_
47-10	8346-8353	disease	_
47-11	8354-8359	group	_
47-12	8359-8360	,	_
47-13	8361-8364	and	_
47-14	8365-8367	65	_
47-15	8368-8376	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-16	8377-8381	with	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-17	8382-8384	no	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-18	8385-8389	Axis	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-19	8390-8391	I	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-20	8392-8401	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-21	8401-8402	,	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-22	8403-8416	group-matched	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-23	8417-8419	on	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-24	8420-8423	age	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-25	8423-8424	,	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-26	8425-8428	sex	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-27	8429-8432	and	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-28	8433-8437	race	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-29	8437-8438	,	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-30	8439-8443	were	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-31	8444-8452	selected	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-32	8453-8455	as	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-33	8456-8458	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[19]
47-34	8458-8459	.	_
47-35	8460-8463	2.2	_
47-36	8463-8464	.	_

#Text=MRI image pre-processing and data processing
#Text=T1-weighted structural imaging was obtained using a magnetization prepared, rapid-acquisition gradient-echo (MPRAGE) sequence with 1 mm isotropic resolution (TR=1900 ms).
48-1	8465-8468	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
48-2	8469-8474	image	_
48-3	8475-8489	pre-processing	_
48-4	8490-8493	and	_
48-5	8494-8498	data	_
48-6	8499-8509	processing	_
48-7	8510-8512	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]
48-8	8512-8513	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]
48-9	8513-8521	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]
48-10	8522-8532	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]
48-11	8533-8540	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]
48-12	8541-8544	was	_
48-13	8545-8553	obtained	_
48-14	8554-8559	using	_
48-15	8560-8561	a	_
48-16	8562-8575	magnetization	_
48-17	8576-8584	prepared	_
48-18	8584-8585	,	_
48-19	8586-8603	rapid-acquisition	_
48-20	8604-8617	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[21]
48-21	8618-8619	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[21]
48-22	8619-8625	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[21]
48-23	8625-8626	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[21]
48-24	8627-8635	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[21]
48-25	8636-8640	with	_
48-26	8641-8642	1	_
48-27	8643-8645	mm	_
48-28	8646-8655	isotropic	_
48-29	8656-8666	resolution	_
48-30	8667-8668	(	_
48-31	8668-8670	TR	_
48-32	8670-8671	=	_
48-33	8671-8675	1900	_
48-34	8676-8678	ms	_
48-35	8678-8679	)	_
48-36	8679-8680	.	_

#Text=The structural images were preprocessed using the recon-all pipeline from FreeSurfer version 5.3.0, which is an extensively used robust pipeline optimized for 1 mm isotropic data.
49-1	8681-8684	The	_
49-2	8685-8695	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[22]
49-3	8696-8702	images	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[22]
49-4	8703-8707	were	_
49-5	8708-8720	preprocessed	_
49-6	8721-8726	using	_
49-7	8727-8730	the	_
49-8	8731-8740	recon-all	_
49-9	8741-8749	pipeline	_
49-10	8750-8754	from	_
49-11	8755-8765	FreeSurfer	_
49-12	8766-8773	version	_
49-13	8774-8779	5.3.0	_
49-14	8779-8780	,	_
49-15	8781-8786	which	_
49-16	8787-8789	is	_
49-17	8790-8792	an	_
49-18	8793-8804	extensively	_
49-19	8805-8809	used	_
49-20	8810-8816	robust	_
49-21	8817-8825	pipeline	_
49-22	8826-8835	optimized	_
49-23	8836-8839	for	_
49-24	8840-8841	1	_
49-25	8842-8844	mm	_
49-26	8845-8854	isotropic	_
49-27	8855-8859	data	_
49-28	8859-8860	.	_

#Text=Mean cortical thicknesses of 68 gyral regions based on the Desikan-Killiany atlas were extracted for each participant.
50-1	8861-8865	Mean	_
50-2	8866-8874	cortical	_
50-3	8875-8886	thicknesses	_
50-4	8887-8889	of	_
50-5	8890-8892	68	_
50-6	8893-8898	gyral	_
50-7	8899-8906	regions	_
50-8	8907-8912	based	_
50-9	8913-8915	on	_
50-10	8916-8919	the	_
50-11	8920-8936	Desikan-Killiany	_
50-12	8937-8942	atlas	_
50-13	8943-8947	were	_
50-14	8948-8957	extracted	_
50-15	8958-8961	for	_
50-16	8962-8966	each	_
50-17	8967-8978	participant	_
50-18	8978-8979	.	_

#Text=Quality control of cortical measurements followed the steps outlined in the ENIGMA protocol (http://enigma.ini.usc.edu/protocols/imaging-protocols/).
51-1	8980-8987	Quality	_
51-2	8988-8995	control	_
51-3	8996-8998	of	_
51-4	8999-9007	cortical	_
51-5	9008-9020	measurements	_
51-6	9021-9029	followed	_
51-7	9030-9033	the	_
51-8	9034-9039	steps	_
51-9	9040-9048	outlined	_
51-10	9049-9051	in	_
51-11	9052-9055	the	_
51-12	9056-9062	ENIGMA	_
51-13	9063-9071	protocol	_
51-14	9072-9073	(	_
51-15	9073-9077	http	_
51-16	9077-9078	:	_
51-17	9078-9079	/	_
51-18	9079-9080	/	_
51-19	9080-9098	enigma.ini.usc.edu	_
51-20	9098-9099	/	_
51-21	9099-9108	protocols	_
51-22	9108-9109	/	_
51-23	9109-9126	imaging-protocols	_
51-24	9126-9127	/	_
51-25	9127-9128	)	_
51-26	9128-9129	.	_

#Text=Briefly, subjects with outlying cortical thickness were identified and visually checked to make sure that they were properly segmented.
52-1	9130-9137	Briefly	_
52-2	9137-9138	,	_
52-3	9139-9147	subjects	_
52-4	9148-9152	with	_
52-5	9153-9161	outlying	_
52-6	9162-9170	cortical	_
52-7	9171-9180	thickness	_
52-8	9181-9185	were	_
52-9	9186-9196	identified	_
52-10	9197-9200	and	_
52-11	9201-9209	visually	_
52-12	9210-9217	checked	_
52-13	9218-9220	to	_
52-14	9221-9225	make	_
52-15	9226-9230	sure	_
52-16	9231-9235	that	_
52-17	9236-9240	they	_
52-18	9241-9245	were	_
52-19	9246-9254	properly	_
52-20	9255-9264	segmented	_
52-21	9264-9265	.	_

#Text=In addition, we visually inspected the snapshots of cortical surface segmentations from both internal slices and external surfaces of the brain to make sure that cortical regions were properly segmented and labeled.
#Text=2.3.
53-1	9266-9268	In	_
53-2	9269-9277	addition	_
53-3	9277-9278	,	_
53-4	9279-9281	we	_
53-5	9282-9290	visually	_
53-6	9291-9300	inspected	_
53-7	9301-9304	the	_
53-8	9305-9314	snapshots	_
53-9	9315-9317	of	_
53-10	9318-9326	cortical	_
53-11	9327-9334	surface	_
53-12	9335-9348	segmentations	_
53-13	9349-9353	from	_
53-14	9354-9358	both	_
53-15	9359-9367	internal	_
53-16	9368-9374	slices	_
53-17	9375-9378	and	_
53-18	9379-9387	external	_
53-19	9388-9396	surfaces	_
53-20	9397-9399	of	_
53-21	9400-9403	the	_
53-22	9404-9409	brain	_
53-23	9410-9412	to	_
53-24	9413-9417	make	_
53-25	9418-9422	sure	_
53-26	9423-9427	that	_
53-27	9428-9436	cortical	_
53-28	9437-9444	regions	_
53-29	9445-9449	were	_
53-30	9450-9458	properly	_
53-31	9459-9468	segmented	_
53-32	9469-9472	and	_
53-33	9473-9480	labeled	_
53-34	9480-9481	.	_
53-35	9482-9485	2.3	_
53-36	9485-9486	.	_

#Text=Personality trait assessments and covariates
#Text=Scores for neuroticism and other personality traits were calculated based on 60 items from the NEO Five-Factor Inventory (NEO-FFI).
54-1	9487-9498	Personality	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[23]
54-2	9499-9504	trait	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[23]
54-3	9505-9516	assessments	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[23]
54-4	9517-9520	and	_
54-5	9521-9531	covariates	_
54-6	9532-9538	Scores	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-7	9539-9542	for	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-8	9543-9554	neuroticism	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-9	9555-9558	and	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-10	9559-9564	other	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-11	9565-9576	personality	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-12	9577-9583	traits	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[24]
54-13	9584-9588	were	_
54-14	9589-9599	calculated	_
54-15	9600-9605	based	_
54-16	9606-9608	on	_
54-17	9609-9611	60	_
54-18	9612-9617	items	_
54-19	9618-9622	from	_
54-20	9623-9626	the	_
54-21	9627-9630	NEO	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-22	9631-9642	Five-Factor	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-23	9643-9652	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-24	9653-9654	(	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-25	9654-9661	NEO-FFI	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-26	9661-9662	)	http://maven.renci.org/NeuroBridge/neurobridge#PersonalityRatingScale[25]
54-27	9662-9663	.	_

#Text=All analyses controlled for the covariates of age, sex, race (i.e., Caucasian or not), full scale intelligence based on Wechsler abbreviated scale of intelligence quotient (IQ), past childhood traumatic event status, smoking and marijuana use status, and age at drinking onset.
55-1	9664-9667	All	_
55-2	9668-9676	analyses	_
55-3	9677-9687	controlled	_
55-4	9688-9691	for	_
55-5	9692-9695	the	_
55-6	9696-9706	covariates	_
55-7	9707-9709	of	_
55-8	9710-9713	age	_
55-9	9713-9714	,	_
55-10	9715-9718	sex	_
55-11	9718-9719	,	_
55-12	9720-9724	race	_
55-13	9725-9726	(	_
55-14	9726-9729	i.e	_
55-15	9729-9730	.	_
55-16	9730-9731	,	_
55-17	9732-9741	Caucasian	_
55-18	9742-9744	or	_
55-19	9745-9748	not	_
55-20	9748-9749	)	_
55-21	9749-9750	,	_
55-22	9751-9755	full	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-23	9756-9761	scale	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-24	9762-9774	intelligence	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-25	9775-9780	based	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-26	9781-9783	on	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-27	9784-9792	Wechsler	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-28	9793-9804	abbreviated	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-29	9805-9810	scale	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-30	9811-9813	of	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-31	9814-9826	intelligence	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-32	9827-9835	quotient	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-33	9836-9837	(	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-34	9837-9839	IQ	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-35	9839-9840	)	http://www.case.edu/ProvCaRe/provcare#NeurocognitiveTest[26]
55-36	9840-9841	,	_
55-37	9842-9846	past	_
55-38	9847-9856	childhood	_
55-39	9857-9866	traumatic	_
55-40	9867-9872	event	_
55-41	9873-9879	status	_
55-42	9879-9880	,	_
55-43	9881-9888	smoking	_
55-44	9889-9892	and	_
55-45	9893-9902	marijuana	_
55-46	9903-9906	use	_
55-47	9907-9913	status	_
55-48	9913-9914	,	_
55-49	9915-9918	and	_
55-50	9919-9922	age	_
55-51	9923-9925	at	_
55-52	9926-9934	drinking	_
55-53	9935-9940	onset	_
55-54	9940-9941	.	_

#Text=Hollingshead four-factor index of socioeconomic status (SES) and laterality index from Edinburgh handedness questionnaire (handedness) were also considered as possible confounders.
56-1	9942-9954	Hollingshead	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-2	9955-9966	four-factor	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-3	9967-9972	index	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-4	9973-9975	of	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-5	9976-9989	socioeconomic	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-6	9990-9996	status	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-7	9997-9998	(	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-8	9998-10001	SES	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-9	10001-10002	)	http://maven.renci.org/NeuroBridge/neurobridge#SocioEconomicStatus[27]
56-10	10003-10006	and	_
56-11	10007-10017	laterality	_
56-12	10018-10023	index	_
56-13	10024-10028	from	_
56-14	10029-10038	Edinburgh	_
56-15	10039-10049	handedness	_
56-16	10050-10063	questionnaire	_
56-17	10064-10065	(	_
56-18	10065-10075	handedness	_
56-19	10075-10076	)	_
56-20	10077-10081	were	_
56-21	10082-10086	also	_
56-22	10087-10097	considered	_
56-23	10098-10100	as	_
56-24	10101-10109	possible	_
56-25	10110-10121	confounders	_
56-26	10121-10122	.	_

#Text=However, their inclusion did not alter the pattern of results and degraded prediction accuracy.
57-1	10123-10130	However	_
57-2	10130-10131	,	_
57-3	10132-10137	their	_
57-4	10138-10147	inclusion	_
57-5	10148-10151	did	_
57-6	10152-10155	not	_
57-7	10156-10161	alter	_
57-8	10162-10165	the	_
57-9	10166-10173	pattern	_
57-10	10174-10176	of	_
57-11	10177-10184	results	_
57-12	10185-10188	and	_
57-13	10189-10197	degraded	_
57-14	10198-10208	prediction	_
57-15	10209-10217	accuracy	_
57-16	10217-10218	.	_

#Text=Accordingly, they were not included in analyses
#Text=2.4.
58-1	10219-10230	Accordingly	_
58-2	10230-10231	,	_
58-3	10232-10236	they	_
58-4	10237-10241	were	_
58-5	10242-10245	not	_
58-6	10246-10254	included	_
58-7	10255-10257	in	_
58-8	10258-10266	analyses	_
58-9	10267-10270	2.4	_
58-10	10270-10271	.	_

#Text=Statistical analyses
#Text=Two sample t-tests and chi-square tests were used to test for differences in continuous and categorical covariates between participants with lifetime AUD diagnosis and healthy comparisons.
59-1	10272-10283	Statistical	_
59-2	10284-10292	analyses	_
59-3	10293-10296	Two	_
59-4	10297-10303	sample	_
59-5	10304-10311	t-tests	_
59-6	10312-10315	and	_
59-7	10316-10326	chi-square	_
59-8	10327-10332	tests	_
59-9	10333-10337	were	_
59-10	10338-10342	used	_
59-11	10343-10345	to	_
59-12	10346-10350	test	_
59-13	10351-10354	for	_
59-14	10355-10366	differences	_
59-15	10367-10369	in	_
59-16	10370-10380	continuous	_
59-17	10381-10384	and	_
59-18	10385-10396	categorical	_
59-19	10397-10407	covariates	_
59-20	10408-10415	between	_
59-21	10416-10428	participants	_
59-22	10429-10433	with	_
59-23	10434-10442	lifetime	_
59-24	10443-10446	AUD	_
59-25	10447-10456	diagnosis	_
59-26	10457-10460	and	_
59-27	10461-10468	healthy	_
59-28	10469-10480	comparisons	_
59-29	10480-10481	.	_

#Text=Multiple linear regression analyses were used to estimate group differences in personality traits.
60-1	10482-10490	Multiple	_
60-2	10491-10497	linear	_
60-3	10498-10508	regression	_
60-4	10509-10517	analyses	_
60-5	10518-10522	were	_
60-6	10523-10527	used	_
60-7	10528-10530	to	_
60-8	10531-10539	estimate	_
60-9	10540-10545	group	_
60-10	10546-10557	differences	_
60-11	10558-10560	in	_
60-12	10561-10572	personality	_
60-13	10573-10579	traits	_
60-14	10579-10580	.	_

#Text=Personality traits from the NEO five-factor model were our primary behavioral measures.
61-1	10581-10592	Personality	_
61-2	10593-10599	traits	_
61-3	10600-10604	from	_
61-4	10605-10608	the	_
61-5	10609-10612	NEO	_
61-6	10613-10624	five-factor	_
61-7	10625-10630	model	_
61-8	10631-10635	were	_
61-9	10636-10639	our	_
61-10	10640-10647	primary	_
61-11	10648-10658	behavioral	_
61-12	10659-10667	measures	_
61-13	10667-10668	.	_

#Text=In the subsequent analysis of brain-behavior relationship we focused only on neuroticism, as this was the only measure showing a significant group difference.
62-1	10669-10671	In	_
62-2	10672-10675	the	_
62-3	10676-10686	subsequent	_
62-4	10687-10695	analysis	_
62-5	10696-10698	of	_
62-6	10699-10713	brain-behavior	_
62-7	10714-10726	relationship	_
62-8	10727-10729	we	_
62-9	10730-10737	focused	_
62-10	10738-10742	only	_
62-11	10743-10745	on	_
62-12	10746-10757	neuroticism	_
62-13	10757-10758	,	_
62-14	10759-10761	as	_
62-15	10762-10766	this	_
62-16	10767-10770	was	_
62-17	10771-10774	the	_
62-18	10775-10779	only	_
62-19	10780-10787	measure	_
62-20	10788-10795	showing	_
62-21	10796-10797	a	_
62-22	10798-10809	significant	_
62-23	10810-10815	group	_
62-24	10816-10826	difference	_
62-25	10826-10827	.	_

#Text=To identify brain regions where a lifetime history of AUD moderated the relationship between neuroticism and cortical thickness, a two-stage procedure, namely screening and formal model testing, was used.
63-1	10828-10830	To	_
63-2	10831-10839	identify	_
63-3	10840-10845	brain	_
63-4	10846-10853	regions	_
63-5	10854-10859	where	_
63-6	10860-10861	a	_
63-7	10862-10870	lifetime	_
63-8	10871-10878	history	_
63-9	10879-10881	of	_
63-10	10882-10885	AUD	_
63-11	10886-10895	moderated	_
63-12	10896-10899	the	_
63-13	10900-10912	relationship	_
63-14	10913-10920	between	_
63-15	10921-10932	neuroticism	_
63-16	10933-10936	and	_
63-17	10937-10945	cortical	_
63-18	10946-10955	thickness	_
63-19	10955-10956	,	_
63-20	10957-10958	a	_
63-21	10959-10968	two-stage	_
63-22	10969-10978	procedure	_
63-23	10978-10979	,	_
63-24	10980-10986	namely	_
63-25	10987-10996	screening	_
63-26	10997-11000	and	_
63-27	11001-11007	formal	_
63-28	11008-11013	model	_
63-29	11014-11021	testing	_
63-30	11021-11022	,	_
63-31	11023-11026	was	_
63-32	11027-11031	used	_
63-33	11031-11032	.	_

#Text=Rational for the use of this two-stage procedure can be found in Supplementary Material S2 1 .
64-1	11033-11041	Rational	_
64-2	11042-11045	for	_
64-3	11046-11049	the	_
64-4	11050-11053	use	_
64-5	11054-11056	of	_
64-6	11057-11061	this	_
64-7	11062-11071	two-stage	_
64-8	11072-11081	procedure	_
64-9	11082-11085	can	_
64-10	11086-11088	be	_
64-11	11089-11094	found	_
64-12	11095-11097	in	_
64-13	11098-11111	Supplementary	_
64-14	11112-11120	Material	_
64-15	11121-11123	S2	_
64-16	11124-11125	1	_
64-17	11126-11127	.	_

#Text=We assumed that only few brain regions were relevant.
65-1	11128-11130	We	_
65-2	11131-11138	assumed	_
65-3	11139-11143	that	_
65-4	11144-11148	only	_
65-5	11149-11152	few	_
65-6	11153-11158	brain	_
65-7	11159-11166	regions	_
65-8	11167-11171	were	_
65-9	11172-11180	relevant	_
65-10	11180-11181	.	_

#Text=In screening stage, the main goal is to identifying a subset of potentially relevant brain regions.
66-1	11182-11184	In	_
66-2	11185-11194	screening	_
66-3	11195-11200	stage	_
66-4	11200-11201	,	_
66-5	11202-11205	the	_
66-6	11206-11210	main	_
66-7	11211-11215	goal	_
66-8	11216-11218	is	_
66-9	11219-11221	to	_
66-10	11222-11233	identifying	_
66-11	11234-11235	a	_
66-12	11236-11242	subset	_
66-13	11243-11245	of	_
66-14	11246-11257	potentially	_
66-15	11258-11266	relevant	_
66-16	11267-11272	brain	_
66-17	11273-11280	regions	_
66-18	11280-11281	.	_

#Text=The L2Boosting algorithm was used to select a subset of potentially relevant brain regions.
67-1	11282-11285	The	_
67-2	11286-11296	L2Boosting	_
67-3	11297-11306	algorithm	_
67-4	11307-11310	was	_
67-5	11311-11315	used	_
67-6	11316-11318	to	_
67-7	11319-11325	select	_
67-8	11326-11327	a	_
67-9	11328-11334	subset	_
67-10	11335-11337	of	_
67-11	11338-11349	potentially	_
67-12	11350-11358	relevant	_
67-13	11359-11364	brain	_
67-14	11365-11372	regions	_
67-15	11372-11373	.	_

#Text=Specifically, a linear model with neuroticism as response variable was fitted by least squares method.
68-1	11374-11386	Specifically	_
68-2	11386-11387	,	_
68-3	11388-11389	a	_
68-4	11390-11396	linear	_
68-5	11397-11402	model	_
68-6	11403-11407	with	_
68-7	11408-11419	neuroticism	_
68-8	11420-11422	as	_
68-9	11423-11431	response	_
68-10	11432-11440	variable	_
68-11	11441-11444	was	_
68-12	11445-11451	fitted	_
68-13	11452-11454	by	_
68-14	11455-11460	least	_
68-15	11461-11468	squares	_
68-16	11469-11475	method	_
68-17	11475-11476	.	_

#Text=Predictors in the linear model include cortical thickness in 68 regions, their interactions with AUD status, and a set of confounding variables.
69-1	11477-11487	Predictors	_
69-2	11488-11490	in	_
69-3	11491-11494	the	_
69-4	11495-11501	linear	_
69-5	11502-11507	model	_
69-6	11508-11515	include	_
69-7	11516-11524	cortical	_
69-8	11525-11534	thickness	_
69-9	11535-11537	in	_
69-10	11538-11540	68	_
69-11	11541-11548	regions	_
69-12	11548-11549	,	_
69-13	11550-11555	their	_
69-14	11556-11568	interactions	_
69-15	11569-11573	with	_
69-16	11574-11577	AUD	_
69-17	11578-11584	status	_
69-18	11584-11585	,	_
69-19	11586-11589	and	_
69-20	11590-11591	a	_
69-21	11592-11595	set	_
69-22	11596-11598	of	_
69-23	11599-11610	confounding	_
69-24	11611-11620	variables	_
69-25	11620-11621	.	_

#Text=Next, L2Boosting iteratively fit the linear model to current least square residuals.
70-1	11622-11626	Next	_
70-2	11626-11627	,	_
70-3	11628-11638	L2Boosting	_
70-4	11639-11650	iteratively	_
70-5	11651-11654	fit	_
70-6	11655-11658	the	_
70-7	11659-11665	linear	_
70-8	11666-11671	model	_
70-9	11672-11674	to	_
70-10	11675-11682	current	_
70-11	11683-11688	least	_
70-12	11689-11695	square	_
70-13	11696-11705	residuals	_
70-14	11705-11706	.	_

#Text=The final boosting estimator was constructed via a linear combination of multiple estimates.
71-1	11707-11710	The	_
71-2	11711-11716	final	_
71-3	11717-11725	boosting	_
71-4	11726-11735	estimator	_
71-5	11736-11739	was	_
71-6	11740-11751	constructed	_
71-7	11752-11755	via	_
71-8	11756-11757	a	_
71-9	11758-11764	linear	_
71-10	11765-11776	combination	_
71-11	11777-11779	of	_
71-12	11780-11788	multiple	_
71-13	11789-11798	estimates	_
71-14	11798-11799	.	_

#Text=To avoid overfitting, the Akaike Information Criterion stopping rule was employed to stop boosting at a suitable number of iterations.
72-1	11800-11802	To	_
72-2	11803-11808	avoid	_
72-3	11809-11820	overfitting	_
72-4	11820-11821	,	_
72-5	11822-11825	the	_
72-6	11826-11832	Akaike	_
72-7	11833-11844	Information	_
72-8	11845-11854	Criterion	_
72-9	11855-11863	stopping	_
72-10	11864-11868	rule	_
72-11	11869-11872	was	_
72-12	11873-11881	employed	_
72-13	11882-11884	to	_
72-14	11885-11889	stop	_
72-15	11890-11898	boosting	_
72-16	11899-11901	at	_
72-17	11902-11903	a	_
72-18	11904-11912	suitable	_
72-19	11913-11919	number	_
72-20	11920-11922	of	_
72-21	11923-11933	iterations	_
72-22	11933-11934	.	_

#Text=Analyses of brain-behavior relationships were focused only on the regions selected by the L2Boosting algorithm.
73-1	11935-11943	Analyses	_
73-2	11944-11946	of	_
73-3	11947-11961	brain-behavior	_
73-4	11962-11975	relationships	_
73-5	11976-11980	were	_
73-6	11981-11988	focused	_
73-7	11989-11993	only	_
73-8	11994-11996	on	_
73-9	11997-12000	the	_
73-10	12001-12008	regions	_
73-11	12009-12017	selected	_
73-12	12018-12020	by	_
73-13	12021-12024	the	_
73-14	12025-12035	L2Boosting	_
73-15	12036-12045	algorithm	_
73-16	12045-12046	.	_

#Text=In model testing stage, linear regression models, with each selected brain region as an outcome measure, were used to test whether there was a significant group by neuroticism effect.
74-1	12047-12049	In	_
74-2	12050-12055	model	_
74-3	12056-12063	testing	_
74-4	12064-12069	stage	_
74-5	12069-12070	,	_
74-6	12071-12077	linear	_
74-7	12078-12088	regression	_
74-8	12089-12095	models	_
74-9	12095-12096	,	_
74-10	12097-12101	with	_
74-11	12102-12106	each	_
74-12	12107-12115	selected	_
74-13	12116-12121	brain	_
74-14	12122-12128	region	_
74-15	12129-12131	as	_
74-16	12132-12134	an	_
74-17	12135-12142	outcome	_
74-18	12143-12150	measure	_
74-19	12150-12151	,	_
74-20	12152-12156	were	_
74-21	12157-12161	used	_
74-22	12162-12164	to	_
74-23	12165-12169	test	_
74-24	12170-12177	whether	_
74-25	12178-12183	there	_
74-26	12184-12187	was	_
74-27	12188-12189	a	_
74-28	12190-12201	significant	_
74-29	12202-12207	group	_
74-30	12208-12210	by	_
74-31	12211-12222	neuroticism	_
74-32	12223-12229	effect	_
74-33	12229-12230	.	_

#Text=All tests are two-sided at false discovery rate (FDR) adjusted significance level of 0.05.
75-1	12231-12234	All	_
75-2	12235-12240	tests	_
75-3	12241-12244	are	_
75-4	12245-12254	two-sided	_
75-5	12255-12257	at	_
75-6	12258-12263	false	_
75-7	12264-12273	discovery	_
75-8	12274-12278	rate	_
75-9	12279-12280	(	_
75-10	12280-12283	FDR	_
75-11	12283-12284	)	_
75-12	12285-12293	adjusted	_
75-13	12294-12306	significance	_
75-14	12307-12312	level	_
75-15	12313-12315	of	_
75-16	12316-12320	0.05	_
75-17	12320-12321	.	_

#Text=Multiple comparisons were adjusted for behavioral measures and brain-behavior relationships, respectively.
76-1	12322-12330	Multiple	_
76-2	12331-12342	comparisons	_
76-3	12343-12347	were	_
76-4	12348-12356	adjusted	_
76-5	12357-12360	for	_
76-6	12361-12371	behavioral	_
76-7	12372-12380	measures	_
76-8	12381-12384	and	_
76-9	12385-12399	brain-behavior	_
76-10	12400-12413	relationships	_
76-11	12413-12414	,	_
76-12	12415-12427	respectively	_
76-13	12427-12428	.	_

#Text=Finally, vertex-based analysis was performed to localize significant findings.
77-1	12429-12436	Finally	_
77-2	12436-12437	,	_
77-3	12438-12450	vertex-based	_
77-4	12451-12459	analysis	_
77-5	12460-12463	was	_
77-6	12464-12473	performed	_
77-7	12474-12476	to	_
77-8	12477-12485	localize	_
77-9	12486-12497	significant	_
77-10	12498-12506	findings	_
77-11	12506-12507	.	_

#Text=Specifically, we pre-smoothed the cortical thickness data by full width half maximum of 10 mm onto the surface fsaverage6 for each subject.
78-1	12508-12520	Specifically	_
78-2	12520-12521	,	_
78-3	12522-12524	we	_
78-4	12525-12537	pre-smoothed	_
78-5	12538-12541	the	_
78-6	12542-12550	cortical	_
78-7	12551-12560	thickness	_
78-8	12561-12565	data	_
78-9	12566-12568	by	_
78-10	12569-12573	full	_
78-11	12574-12579	width	_
78-12	12580-12584	half	_
78-13	12585-12592	maximum	_
78-14	12593-12595	of	_
78-15	12596-12598	10	_
78-16	12599-12601	mm	_
78-17	12602-12606	onto	_
78-18	12607-12610	the	_
78-19	12611-12618	surface	_
78-20	12619-12629	fsaverage6	_
78-21	12630-12633	for	_
78-22	12634-12638	each	_
78-23	12639-12646	subject	_
78-24	12646-12647	.	_

#Text=Multiple linear models were used to test the interaction effects of group and neuroticism on the cortical thickness at each vertex on the above three regions.
79-1	12648-12656	Multiple	_
79-2	12657-12663	linear	_
79-3	12664-12670	models	_
79-4	12671-12675	were	_
79-5	12676-12680	used	_
79-6	12681-12683	to	_
79-7	12684-12688	test	_
79-8	12689-12692	the	_
79-9	12693-12704	interaction	_
79-10	12705-12712	effects	_
79-11	12713-12715	of	_
79-12	12716-12721	group	_
79-13	12722-12725	and	_
79-14	12726-12737	neuroticism	_
79-15	12738-12740	on	_
79-16	12741-12744	the	_
79-17	12745-12753	cortical	_
79-18	12754-12763	thickness	_
79-19	12764-12766	at	_
79-20	12767-12771	each	_
79-21	12772-12778	vertex	_
79-22	12779-12781	on	_
79-23	12782-12785	the	_
79-24	12786-12791	above	_
79-25	12792-12797	three	_
79-26	12798-12805	regions	_
79-27	12805-12806	.	_

#Text=Analyses were performed using R version 3.4.0 (The R Project for Statistical Computing).
#Text=3.
80-1	12807-12815	Analyses	_
80-2	12816-12820	were	_
80-3	12821-12830	performed	_
80-4	12831-12836	using	_
80-5	12837-12838	R	_
80-6	12839-12846	version	_
80-7	12847-12852	3.4.0	_
80-8	12853-12854	(	_
80-9	12854-12857	The	_
80-10	12858-12859	R	_
80-11	12860-12867	Project	_
80-12	12868-12871	for	_
80-13	12872-12883	Statistical	_
80-14	12884-12893	Computing	_
80-15	12893-12894	)	_
80-16	12894-12895	.	_
80-17	12896-12897	3	_
80-18	12897-12898	.	_

#Text=RESULTS
#Text=3.1.
81-1	12899-12906	RESULTS	_
81-2	12907-12910	3.1	_
81-3	12910-12911	.	_

#Text=Sample characteristics
#Text=The HC and AUD subjects did not differ in age, sex, race, IQ, handedness, SES, or age at drinking onset.
82-1	12912-12918	Sample	_
82-2	12919-12934	characteristics	_
82-3	12935-12938	The	_
82-4	12939-12941	HC	_
82-5	12942-12945	and	_
82-6	12946-12949	AUD	_
82-7	12950-12958	subjects	_
82-8	12959-12962	did	_
82-9	12963-12966	not	_
82-10	12967-12973	differ	_
82-11	12974-12976	in	_
82-12	12977-12980	age	_
82-13	12980-12981	,	_
82-14	12982-12985	sex	_
82-15	12985-12986	,	_
82-16	12987-12991	race	_
82-17	12991-12992	,	_
82-18	12993-12995	IQ	_
82-19	12995-12996	,	_
82-20	12997-13007	handedness	_
82-21	13007-13008	,	_
82-22	13009-13012	SES	_
82-23	13012-13013	,	_
82-24	13014-13016	or	_
82-25	13017-13020	age	_
82-26	13021-13023	at	_
82-27	13024-13032	drinking	_
82-28	13033-13038	onset	_
82-29	13038-13039	.	_

#Text=More AUD subjects reported having experienced childhood traumatic events (78.5%) as opposed to 52.3% for HC subjects.
83-1	13040-13044	More	_
83-2	13045-13048	AUD	_
83-3	13049-13057	subjects	_
83-4	13058-13066	reported	_
83-5	13067-13073	having	_
83-6	13074-13085	experienced	_
83-7	13086-13095	childhood	_
83-8	13096-13105	traumatic	_
83-9	13106-13112	events	_
83-10	13113-13114	(	_
83-11	13114-13119	78.5%	_
83-12	13119-13120	)	_
83-13	13121-13123	as	_
83-14	13124-13131	opposed	_
83-15	13132-13134	to	_
83-16	13135-13140	52.3%	_
83-17	13141-13144	for	_
83-18	13145-13147	HC	_
83-19	13148-13156	subjects	_
83-20	13156-13157	.	_

#Text=There was a significant difference in tobacco and marijuana use status.
84-1	13158-13163	There	_
84-2	13164-13167	was	_
84-3	13168-13169	a	_
84-4	13170-13181	significant	_
84-5	13182-13192	difference	_
84-6	13193-13195	in	_
84-7	13196-13203	tobacco	_
84-8	13204-13207	and	_
84-9	13208-13217	marijuana	_
84-10	13218-13221	use	_
84-11	13222-13228	status	_
84-12	13228-13229	.	_

#Text=More AUD subjects reported to be current (35.4%) and past (44.6%) tobacco user as opposed to 16.9% and 29.2% for HC subjects.
85-1	13230-13234	More	_
85-2	13235-13238	AUD	_
85-3	13239-13247	subjects	_
85-4	13248-13256	reported	_
85-5	13257-13259	to	_
85-6	13260-13262	be	_
85-7	13263-13270	current	_
85-8	13271-13272	(	_
85-9	13272-13277	35.4%	_
85-10	13277-13278	)	_
85-11	13279-13282	and	_
85-12	13283-13287	past	_
85-13	13288-13289	(	_
85-14	13289-13294	44.6%	_
85-15	13294-13295	)	_
85-16	13296-13303	tobacco	_
85-17	13304-13308	user	_
85-18	13309-13311	as	_
85-19	13312-13319	opposed	_
85-20	13320-13322	to	_
85-21	13323-13328	16.9%	_
85-22	13329-13332	and	_
85-23	13333-13338	29.2%	_
85-24	13339-13342	for	_
85-25	13343-13345	HC	_
85-26	13346-13354	subjects	_
85-27	13354-13355	.	_

#Text=The prevalence of current and past marijuana user was higher in AUD subjects (29.2% and 52.3%, respectively) than in HCs (10.8% and 36.9%).
86-1	13356-13359	The	_
86-2	13360-13370	prevalence	_
86-3	13371-13373	of	_
86-4	13374-13381	current	_
86-5	13382-13385	and	_
86-6	13386-13390	past	_
86-7	13391-13400	marijuana	_
86-8	13401-13405	user	_
86-9	13406-13409	was	_
86-10	13410-13416	higher	_
86-11	13417-13419	in	_
86-12	13420-13423	AUD	_
86-13	13424-13432	subjects	_
86-14	13433-13434	(	_
86-15	13434-13439	29.2%	_
86-16	13440-13443	and	_
86-17	13444-13449	52.3%	_
86-18	13449-13450	,	_
86-19	13451-13463	respectively	_
86-20	13463-13464	)	_
86-21	13465-13469	than	_
86-22	13470-13472	in	_
86-23	13473-13476	HCs	_
86-24	13477-13478	(	_
86-25	13478-13483	10.8%	_
86-26	13484-13487	and	_
86-27	13488-13493	36.9%	_
86-28	13493-13494	)	_
86-29	13494-13495	.	_

#Text=Only 20.0 % and 18.5% AUD subjects, compared to 53.9% and 52.3% in HC subjects, reported they had never smoked and never used marijuana, respectively (Table 1).
87-1	13496-13500	Only	_
87-2	13501-13505	20.0	_
87-3	13506-13507	%	_
87-4	13508-13511	and	_
87-5	13512-13517	18.5%	_
87-6	13518-13521	AUD	_
87-7	13522-13530	subjects	_
87-8	13530-13531	,	_
87-9	13532-13540	compared	_
87-10	13541-13543	to	_
87-11	13544-13549	53.9%	_
87-12	13550-13553	and	_
87-13	13554-13559	52.3%	_
87-14	13560-13562	in	_
87-15	13563-13565	HC	_
87-16	13566-13574	subjects	_
87-17	13574-13575	,	_
87-18	13576-13584	reported	_
87-19	13585-13589	they	_
87-20	13590-13593	had	_
87-21	13594-13599	never	_
87-22	13600-13606	smoked	_
87-23	13607-13610	and	_
87-24	13611-13616	never	_
87-25	13617-13621	used	_
87-26	13622-13631	marijuana	_
87-27	13631-13632	,	_
87-28	13633-13645	respectively	_
87-29	13646-13647	(	_
87-30	13647-13652	Table	_
87-31	13653-13654	1	_
87-32	13654-13655	)	_
87-33	13655-13656	.	_

#Text=There were no significant group differences in estimated total intracranial volume or mean cortical thickness in either hemisphere.
#Text=3.2.
88-1	13657-13662	There	_
88-2	13663-13667	were	_
88-3	13668-13670	no	_
88-4	13671-13682	significant	_
88-5	13683-13688	group	_
88-6	13689-13700	differences	_
88-7	13701-13703	in	_
88-8	13704-13713	estimated	_
88-9	13714-13719	total	_
88-10	13720-13732	intracranial	_
88-11	13733-13739	volume	_
88-12	13740-13742	or	_
88-13	13743-13747	mean	_
88-14	13748-13756	cortical	_
88-15	13757-13766	thickness	_
88-16	13767-13769	in	_
88-17	13770-13776	either	_
88-18	13777-13787	hemisphere	_
88-19	13787-13788	.	_
88-20	13789-13792	3.2	_
88-21	13792-13793	.	_

#Text=AUD subjects had higher neuroticism scores
#Text=Multiple linear regression models were used to test group differences in NEO-FFI personality traits (Table 2).
89-1	13794-13797	AUD	_
89-2	13798-13806	subjects	_
89-3	13807-13810	had	_
89-4	13811-13817	higher	_
89-5	13818-13829	neuroticism	_
89-6	13830-13836	scores	_
89-7	13837-13845	Multiple	_
89-8	13846-13852	linear	_
89-9	13853-13863	regression	_
89-10	13864-13870	models	_
89-11	13871-13875	were	_
89-12	13876-13880	used	_
89-13	13881-13883	to	_
89-14	13884-13888	test	_
89-15	13889-13894	group	_
89-16	13895-13906	differences	_
89-17	13907-13909	in	_
89-18	13910-13917	NEO-FFI	_
89-19	13918-13929	personality	_
89-20	13930-13936	traits	_
89-21	13937-13938	(	_
89-22	13938-13943	Table	_
89-23	13944-13945	2	_
89-24	13945-13946	)	_
89-25	13946-13947	.	_

#Text=Neuroticism was the only trait differing significantly between groups after multiple comparison adjustments.
90-1	13948-13959	Neuroticism	_
90-2	13960-13963	was	_
90-3	13964-13967	the	_
90-4	13968-13972	only	_
90-5	13973-13978	trait	_
90-6	13979-13988	differing	_
90-7	13989-14002	significantly	_
90-8	14003-14010	between	_
90-9	14011-14017	groups	_
90-10	14018-14023	after	_
90-11	14024-14032	multiple	_
90-12	14033-14043	comparison	_
90-13	14044-14055	adjustments	_
90-14	14055-14056	.	_

#Text=Specifically, controlling for age, sex and race, AUDs had significantly higher neuroticism scores than HCs (q=0.043; q-values represent FDR adjusted p-values).
91-1	14057-14069	Specifically	_
91-2	14069-14070	,	_
91-3	14071-14082	controlling	_
91-4	14083-14086	for	_
91-5	14087-14090	age	_
91-6	14090-14091	,	_
91-7	14092-14095	sex	_
91-8	14096-14099	and	_
91-9	14100-14104	race	_
91-10	14104-14105	,	_
91-11	14106-14110	AUDs	_
91-12	14111-14114	had	_
91-13	14115-14128	significantly	_
91-14	14129-14135	higher	_
91-15	14136-14147	neuroticism	_
91-16	14148-14154	scores	_
91-17	14155-14159	than	_
91-18	14160-14163	HCs	_
91-19	14164-14165	(	_
91-20	14165-14166	q	_
91-21	14166-14167	=	_
91-22	14167-14172	0.043	_
91-23	14172-14173	;	_
91-24	14174-14182	q-values	_
91-25	14183-14192	represent	_
91-26	14193-14196	FDR	_
91-27	14197-14205	adjusted	_
91-28	14206-14214	p-values	_
91-29	14214-14215	)	_
91-30	14215-14216	.	_

#Text=Group status alone explained 4.3% of the variation in neuroticism scores.
92-1	14217-14222	Group	_
92-2	14223-14229	status	_
92-3	14230-14235	alone	_
92-4	14236-14245	explained	_
92-5	14246-14250	4.3%	_
92-6	14251-14253	of	_
92-7	14254-14257	the	_
92-8	14258-14267	variation	_
92-9	14268-14270	in	_
92-10	14271-14282	neuroticism	_
92-11	14283-14289	scores	_
92-12	14289-14290	.	_

#Text=The estimated mean neuroticism score in AUDs was 3.5 points higher than in HCs.
93-1	14291-14294	The	_
93-2	14295-14304	estimated	_
93-3	14305-14309	mean	_
93-4	14310-14321	neuroticism	_
93-5	14322-14327	score	_
93-6	14328-14330	in	_
93-7	14331-14335	AUDs	_
93-8	14336-14339	was	_
93-9	14340-14343	3.5	_
93-10	14344-14350	points	_
93-11	14351-14357	higher	_
93-12	14358-14362	than	_
93-13	14363-14365	in	_
93-14	14366-14369	HCs	_
93-15	14369-14370	.	_

#Text=The finding of elevated neuroticism score in AUDs was consistent with prior reports.
#Text=3.3.
94-1	14371-14374	The	_
94-2	14375-14382	finding	_
94-3	14383-14385	of	_
94-4	14386-14394	elevated	_
94-5	14395-14406	neuroticism	_
94-6	14407-14412	score	_
94-7	14413-14415	in	_
94-8	14416-14420	AUDs	_
94-9	14421-14424	was	_
94-10	14425-14435	consistent	_
94-11	14436-14440	with	_
94-12	14441-14446	prior	_
94-13	14447-14454	reports	_
94-14	14454-14455	.	_
94-15	14456-14459	3.3	_
94-16	14459-14460	.	_

#Text=Lifetime AUD diagnosis alters correlations between cortical thickness and neuroticism
#Text=A two-step procedure was used to assess whether a lifetime history of AUD altered the relationship between neuroticism and cortical thickness in certain brain regions.
95-1	14461-14469	Lifetime	_
95-2	14470-14473	AUD	_
95-3	14474-14483	diagnosis	_
95-4	14484-14490	alters	_
95-5	14491-14503	correlations	_
95-6	14504-14511	between	_
95-7	14512-14520	cortical	_
95-8	14521-14530	thickness	_
95-9	14531-14534	and	_
95-10	14535-14546	neuroticism	_
95-11	14547-14548	A	_
95-12	14549-14557	two-step	_
95-13	14558-14567	procedure	_
95-14	14568-14571	was	_
95-15	14572-14576	used	_
95-16	14577-14579	to	_
95-17	14580-14586	assess	_
95-18	14587-14594	whether	_
95-19	14595-14596	a	_
95-20	14597-14605	lifetime	_
95-21	14606-14613	history	_
95-22	14614-14616	of	_
95-23	14617-14620	AUD	_
95-24	14621-14628	altered	_
95-25	14629-14632	the	_
95-26	14633-14645	relationship	_
95-27	14646-14653	between	_
95-28	14654-14665	neuroticism	_
95-29	14666-14669	and	_
95-30	14670-14678	cortical	_
95-31	14679-14688	thickness	_
95-32	14689-14691	in	_
95-33	14692-14699	certain	_
95-34	14700-14705	brain	_
95-35	14706-14713	regions	_
95-36	14713-14714	.	_

#Text=In Step 1, three brain regions, i.e., left insula, postcentral gyrus and right fusiform, were selected by L2Boosting, indicating lifetime AUD history might alter the association between neuroticism and cortical thickness at these brain regions.
96-1	14715-14717	In	_
96-2	14718-14722	Step	_
96-3	14723-14724	1	_
96-4	14724-14725	,	_
96-5	14726-14731	three	_
96-6	14732-14737	brain	_
96-7	14738-14745	regions	_
96-8	14745-14746	,	_
96-9	14747-14750	i.e	_
96-10	14750-14751	.	_
96-11	14751-14752	,	_
96-12	14753-14757	left	_
96-13	14758-14764	insula	_
96-14	14764-14765	,	_
96-15	14766-14777	postcentral	_
96-16	14778-14783	gyrus	_
96-17	14784-14787	and	_
96-18	14788-14793	right	_
96-19	14794-14802	fusiform	_
96-20	14802-14803	,	_
96-21	14804-14808	were	_
96-22	14809-14817	selected	_
96-23	14818-14820	by	_
96-24	14821-14831	L2Boosting	_
96-25	14831-14832	,	_
96-26	14833-14843	indicating	_
96-27	14844-14852	lifetime	_
96-28	14853-14856	AUD	_
96-29	14857-14864	history	_
96-30	14865-14870	might	_
96-31	14871-14876	alter	_
96-32	14877-14880	the	_
96-33	14881-14892	association	_
96-34	14893-14900	between	_
96-35	14901-14912	neuroticism	_
96-36	14913-14916	and	_
96-37	14917-14925	cortical	_
96-38	14926-14935	thickness	_
96-39	14936-14938	at	_
96-40	14939-14944	these	_
96-41	14945-14950	brain	_
96-42	14951-14958	regions	_
96-43	14958-14959	.	_

#Text=In Step 2, multiple linear models were used to assess the relationship.
97-1	14960-14962	In	_
97-2	14963-14967	Step	_
97-3	14968-14969	2	_
97-4	14969-14970	,	_
97-5	14971-14979	multiple	_
97-6	14980-14986	linear	_
97-7	14987-14993	models	_
97-8	14994-14998	were	_
97-9	14999-15003	used	_
97-10	15004-15006	to	_
97-11	15007-15013	assess	_
97-12	15014-15017	the	_
97-13	15018-15030	relationship	_
97-14	15030-15031	.	_

#Text=Regression analyses showed that lifetime AUD diagnosis altered the relationship between neuroticism and cortical thickness at left insula (q=0.019) and right fusiform (q=0.011).
98-1	15032-15042	Regression	_
98-2	15043-15051	analyses	_
98-3	15052-15058	showed	_
98-4	15059-15063	that	_
98-5	15064-15072	lifetime	_
98-6	15073-15076	AUD	_
98-7	15077-15086	diagnosis	_
98-8	15087-15094	altered	_
98-9	15095-15098	the	_
98-10	15099-15111	relationship	_
98-11	15112-15119	between	_
98-12	15120-15131	neuroticism	_
98-13	15132-15135	and	_
98-14	15136-15144	cortical	_
98-15	15145-15154	thickness	_
98-16	15155-15157	at	_
98-17	15158-15162	left	_
98-18	15163-15169	insula	_
98-19	15170-15171	(	_
98-20	15171-15172	q	_
98-21	15172-15173	=	_
98-22	15173-15178	0.019	_
98-23	15178-15179	)	_
98-24	15180-15183	and	_
98-25	15184-15189	right	_
98-26	15190-15198	fusiform	_
98-27	15199-15200	(	_
98-28	15200-15201	q	_
98-29	15201-15202	=	_
98-30	15202-15207	0.011	_
98-31	15207-15208	)	_
98-32	15208-15209	.	_

#Text=We failed to detect a significant diagnosis by neuroticism interaction at left postcentral gyrus (q=0.918).
99-1	15210-15212	We	_
99-2	15213-15219	failed	_
99-3	15220-15222	to	_
99-4	15223-15229	detect	_
99-5	15230-15231	a	_
99-6	15232-15243	significant	_
99-7	15244-15253	diagnosis	_
99-8	15254-15256	by	_
99-9	15257-15268	neuroticism	_
99-10	15269-15280	interaction	_
99-11	15281-15283	at	_
99-12	15284-15288	left	_
99-13	15289-15300	postcentral	_
99-14	15301-15306	gyrus	_
99-15	15307-15308	(	_
99-16	15308-15309	q	_
99-17	15309-15310	=	_
99-18	15310-15315	0.918	_
99-19	15315-15316	)	_
99-20	15316-15317	.	_

#Text=Subsequent subgroup analysis revealed that in HCs a positive but non-significant correlation between neuroticism and cortical thickness was observed in the left insula (β=0.002, P=0.465) and right fusiform (β=0.005, P=0.146).
100-1	15318-15328	Subsequent	_
100-2	15329-15337	subgroup	_
100-3	15338-15346	analysis	_
100-4	15347-15355	revealed	_
100-5	15356-15360	that	_
100-6	15361-15363	in	_
100-7	15364-15367	HCs	_
100-8	15368-15369	a	_
100-9	15370-15378	positive	_
100-10	15379-15382	but	_
100-11	15383-15398	non-significant	_
100-12	15399-15410	correlation	_
100-13	15411-15418	between	_
100-14	15419-15430	neuroticism	_
100-15	15431-15434	and	_
100-16	15435-15443	cortical	_
100-17	15444-15453	thickness	_
100-18	15454-15457	was	_
100-19	15458-15466	observed	_
100-20	15467-15469	in	_
100-21	15470-15473	the	_
100-22	15474-15478	left	_
100-23	15479-15485	insula	_
100-24	15486-15487	(	_
100-25	15487-15488	β	_
100-26	15488-15489	=	_
100-27	15489-15494	0.002	_
100-28	15494-15495	,	_
100-29	15496-15497	P	_
100-30	15497-15498	=	_
100-31	15498-15503	0.465	_
100-32	15503-15504	)	_
100-33	15505-15508	and	_
100-34	15509-15514	right	_
100-35	15515-15523	fusiform	_
100-36	15524-15525	(	_
100-37	15525-15526	β	_
100-38	15526-15527	=	_
100-39	15527-15532	0.005	_
100-40	15532-15533	,	_
100-41	15534-15535	P	_
100-42	15535-15536	=	_
100-43	15536-15541	0.146	_
100-44	15541-15542	)	_
100-45	15542-15543	.	_

#Text=However, in AUDs the cortical thickness of both regions showed a significant inverse correlation with neuroticism in the left insula (β=-0.005, P=0.040) and right fusiform (β=-0.007, P=0.008), respectively (Fig. 1).
101-1	15544-15551	However	_
101-2	15551-15552	,	_
101-3	15553-15555	in	_
101-4	15556-15560	AUDs	_
101-5	15561-15564	the	_
101-6	15565-15573	cortical	_
101-7	15574-15583	thickness	_
101-8	15584-15586	of	_
101-9	15587-15591	both	_
101-10	15592-15599	regions	_
101-11	15600-15606	showed	_
101-12	15607-15608	a	_
101-13	15609-15620	significant	_
101-14	15621-15628	inverse	_
101-15	15629-15640	correlation	_
101-16	15641-15645	with	_
101-17	15646-15657	neuroticism	_
101-18	15658-15660	in	_
101-19	15661-15664	the	_
101-20	15665-15669	left	_
101-21	15670-15676	insula	_
101-22	15677-15678	(	_
101-23	15678-15679	β	_
101-24	15679-15680	=	_
101-25	15680-15681	-	_
101-26	15681-15686	0.005	_
101-27	15686-15687	,	_
101-28	15688-15689	P	_
101-29	15689-15690	=	_
101-30	15690-15695	0.040	_
101-31	15695-15696	)	_
101-32	15697-15700	and	_
101-33	15701-15706	right	_
101-34	15707-15715	fusiform	_
101-35	15716-15717	(	_
101-36	15717-15718	β	_
101-37	15718-15719	=	_
101-38	15719-15720	-	_
101-39	15720-15725	0.007	_
101-40	15725-15726	,	_
101-41	15727-15728	P	_
101-42	15728-15729	=	_
101-43	15729-15734	0.008	_
101-44	15734-15735	)	_
101-45	15735-15736	,	_
101-46	15737-15749	respectively	_
101-47	15750-15751	(	_
101-48	15751-15754	Fig	_
101-49	15754-15755	.	_
101-50	15756-15757	1	_
101-51	15757-15758	)	_
101-52	15758-15759	.	_

#Text=These results indicate that AUD diagnosis affected the correlations between cortical thickness and neuroticism.
102-1	15760-15765	These	_
102-2	15766-15773	results	_
102-3	15774-15782	indicate	_
102-4	15783-15787	that	_
102-5	15788-15791	AUD	_
102-6	15792-15801	diagnosis	_
102-7	15802-15810	affected	_
102-8	15811-15814	the	_
102-9	15815-15827	correlations	_
102-10	15828-15835	between	_
102-11	15836-15844	cortical	_
102-12	15845-15854	thickness	_
102-13	15855-15858	and	_
102-14	15859-15870	neuroticism	_
102-15	15870-15871	.	_

#Text=To facilitate interpretation, secondary vertex-based analysis was performed to localize findings.
103-1	15872-15874	To	_
103-2	15875-15885	facilitate	_
103-3	15886-15900	interpretation	_
103-4	15900-15901	,	_
103-5	15902-15911	secondary	_
103-6	15912-15924	vertex-based	_
103-7	15925-15933	analysis	_
103-8	15934-15937	was	_
103-9	15938-15947	performed	_
103-10	15948-15950	to	_
103-11	15951-15959	localize	_
103-12	15960-15968	findings	_
103-13	15968-15969	.	_

#Text=Multiple linear models were used to assess the interaction effects of group and neuroticism on cortical thickness at each vertex for the three implicated regions.
104-1	15970-15978	Multiple	_
104-2	15979-15985	linear	_
104-3	15986-15992	models	_
104-4	15993-15997	were	_
104-5	15998-16002	used	_
104-6	16003-16005	to	_
104-7	16006-16012	assess	_
104-8	16013-16016	the	_
104-9	16017-16028	interaction	_
104-10	16029-16036	effects	_
104-11	16037-16039	of	_
104-12	16040-16045	group	_
104-13	16046-16049	and	_
104-14	16050-16061	neuroticism	_
104-15	16062-16064	on	_
104-16	16065-16073	cortical	_
104-17	16074-16083	thickness	_
104-18	16084-16086	at	_
104-19	16087-16091	each	_
104-20	16092-16098	vertex	_
104-21	16099-16102	for	_
104-22	16103-16106	the	_
104-23	16107-16112	three	_
104-24	16113-16123	implicated	_
104-25	16124-16131	regions	_
104-26	16131-16132	.	_

#Text=As shown in Fig. 3, significant vertices were located mainly in left anterior and posterior insula, and the lateral and medial aspects of the right fusiform gyrus.
105-1	16133-16135	As	_
105-2	16136-16141	shown	_
105-3	16142-16144	in	_
105-4	16145-16148	Fig	_
105-5	16148-16149	.	_
105-6	16150-16151	3	_
105-7	16151-16152	,	_
105-8	16153-16164	significant	_
105-9	16165-16173	vertices	_
105-10	16174-16178	were	_
105-11	16179-16186	located	_
105-12	16187-16193	mainly	_
105-13	16194-16196	in	_
105-14	16197-16201	left	_
105-15	16202-16210	anterior	_
105-16	16211-16214	and	_
105-17	16215-16224	posterior	_
105-18	16225-16231	insula	_
105-19	16231-16232	,	_
105-20	16233-16236	and	_
105-21	16237-16240	the	_
105-22	16241-16248	lateral	_
105-23	16249-16252	and	_
105-24	16253-16259	medial	_
105-25	16260-16267	aspects	_
105-26	16268-16270	of	_
105-27	16271-16274	the	_
105-28	16275-16280	right	_
105-29	16281-16289	fusiform	_
105-30	16290-16295	gyrus	_
105-31	16295-16296	.	_

#Text=These explicatory results are displayed at p-value of 0.05 without multiple comparison adjustment.
#Text=3.4.
106-1	16297-16302	These	_
106-2	16303-16314	explicatory	_
106-3	16315-16322	results	_
106-4	16323-16326	are	_
106-5	16327-16336	displayed	_
106-6	16337-16339	at	_
106-7	16340-16347	p-value	_
106-8	16348-16350	of	_
106-9	16351-16355	0.05	_
106-10	16356-16363	without	_
106-11	16364-16372	multiple	_
106-12	16373-16383	comparison	_
106-13	16384-16394	adjustment	_
106-14	16394-16395	.	_
106-15	16396-16399	3.4	_
106-16	16399-16400	.	_

#Text=Validation using the Human Connectome Project
#Text=To determine the replicability of our findings, we examined AUD samples from the HCP data set.
107-1	16401-16411	Validation	_
107-2	16412-16417	using	_
107-3	16418-16421	the	_
107-4	16422-16427	Human	_
107-5	16428-16438	Connectome	_
107-6	16439-16446	Project	_
107-7	16447-16449	To	_
107-8	16450-16459	determine	_
107-9	16460-16463	the	_
107-10	16464-16477	replicability	_
107-11	16478-16480	of	_
107-12	16481-16484	our	_
107-13	16485-16493	findings	_
107-14	16493-16494	,	_
107-15	16495-16497	we	_
107-16	16498-16506	examined	_
107-17	16507-16510	AUD	_
107-18	16511-16518	samples	_
107-19	16519-16523	from	_
107-20	16524-16527	the	_
107-21	16528-16531	HCP	_
107-22	16532-16536	data	_
107-23	16537-16540	set	_
107-24	16540-16541	.	_

#Text=Using similar criteria (Supplementary Material S12), we selected 107 AUD subjects and 107 HC.
108-1	16542-16547	Using	_
108-2	16548-16555	similar	_
108-3	16556-16564	criteria	_
108-4	16565-16566	(	_
108-5	16566-16579	Supplementary	_
108-6	16580-16588	Material	_
108-7	16589-16592	S12	_
108-8	16592-16593	)	_
108-9	16593-16594	,	_
108-10	16595-16597	we	_
108-11	16598-16606	selected	_
108-12	16607-16610	107	_
108-13	16611-16614	AUD	_
108-14	16615-16623	subjects	_
108-15	16624-16627	and	_
108-16	16628-16631	107	_
108-17	16632-16634	HC	_
108-18	16634-16635	.	_

#Text=As in the NKI-RS data set, controlling for age, gender, race, smoking and marijuana use status, age at drinking onset, and age-adjusted picture vocabulary score as a proxy for IQ, we found that a high neuroticism score was associated with AUD (β=-3.06, P=0.03) (Fig. 2A).
109-1	16636-16638	As	_
109-2	16639-16641	in	_
109-3	16642-16645	the	_
109-4	16646-16652	NKI-RS	_
109-5	16653-16657	data	_
109-6	16658-16661	set	_
109-7	16661-16662	,	_
109-8	16663-16674	controlling	_
109-9	16675-16678	for	_
109-10	16679-16682	age	_
109-11	16682-16683	,	_
109-12	16684-16690	gender	_
109-13	16690-16691	,	_
109-14	16692-16696	race	_
109-15	16696-16697	,	_
109-16	16698-16705	smoking	_
109-17	16706-16709	and	_
109-18	16710-16719	marijuana	_
109-19	16720-16723	use	_
109-20	16724-16730	status	_
109-21	16730-16731	,	_
109-22	16732-16735	age	_
109-23	16736-16738	at	_
109-24	16739-16747	drinking	_
109-25	16748-16753	onset	_
109-26	16753-16754	,	_
109-27	16755-16758	and	_
109-28	16759-16771	age-adjusted	_
109-29	16772-16779	picture	_
109-30	16780-16790	vocabulary	_
109-31	16791-16796	score	_
109-32	16797-16799	as	_
109-33	16800-16801	a	_
109-34	16802-16807	proxy	_
109-35	16808-16811	for	_
109-36	16812-16814	IQ	_
109-37	16814-16815	,	_
109-38	16816-16818	we	_
109-39	16819-16824	found	_
109-40	16825-16829	that	_
109-41	16830-16831	a	_
109-42	16832-16836	high	_
109-43	16837-16848	neuroticism	_
109-44	16849-16854	score	_
109-45	16855-16858	was	_
109-46	16859-16869	associated	_
109-47	16870-16874	with	_
109-48	16875-16878	AUD	_
109-49	16879-16880	(	_
109-50	16880-16881	β	_
109-51	16881-16882	=	_
109-52	16882-16883	-	_
109-53	16883-16887	3.06	_
109-54	16887-16888	,	_
109-55	16889-16890	P	_
109-56	16890-16891	=	_
109-57	16891-16895	0.03	_
109-58	16895-16896	)	_
109-59	16897-16898	(	_
109-60	16898-16901	Fig	_
109-61	16901-16902	.	_
109-62	16903-16905	2A	_
109-63	16905-16906	)	_
109-64	16906-16907	.	_

#Text=With regard to the brain regions in which lifetime AUD history was associated with distinct cortical thickness and neuroticism correlations in NKI-RS, the result for the left insula (P=0.003) was unequivocally significant (Fig. 2B).
110-1	16908-16912	With	_
110-2	16913-16919	regard	_
110-3	16920-16922	to	_
110-4	16923-16926	the	_
110-5	16927-16932	brain	_
110-6	16933-16940	regions	_
110-7	16941-16943	in	_
110-8	16944-16949	which	_
110-9	16950-16958	lifetime	_
110-10	16959-16962	AUD	_
110-11	16963-16970	history	_
110-12	16971-16974	was	_
110-13	16975-16985	associated	_
110-14	16986-16990	with	_
110-15	16991-16999	distinct	_
110-16	17000-17008	cortical	_
110-17	17009-17018	thickness	_
110-18	17019-17022	and	_
110-19	17023-17034	neuroticism	_
110-20	17035-17047	correlations	_
110-21	17048-17050	in	_
110-22	17051-17057	NKI-RS	_
110-23	17057-17058	,	_
110-24	17059-17062	the	_
110-25	17063-17069	result	_
110-26	17070-17073	for	_
110-27	17074-17077	the	_
110-28	17078-17082	left	_
110-29	17083-17089	insula	_
110-30	17090-17091	(	_
110-31	17091-17092	P	_
110-32	17092-17093	=	_
110-33	17093-17098	0.003	_
110-34	17098-17099	)	_
110-35	17100-17103	was	_
110-36	17104-17117	unequivocally	_
110-37	17118-17129	significant	_
110-38	17130-17131	(	_
110-39	17131-17134	Fig	_
110-40	17134-17135	.	_
110-41	17136-17138	2B	_
110-42	17138-17139	)	_
110-43	17139-17140	.	_

#Text=Similar to the finding for the NKI-RS data (Fig. 1A), subgroup analysis revealed the correlation between neuroticism and cortical thickness at the left insula was significant in AUD (β=−0.005, P=0.002) but not in HC (β=0.002, P=0.258).
111-1	17141-17148	Similar	_
111-2	17149-17151	to	_
111-3	17152-17155	the	_
111-4	17156-17163	finding	_
111-5	17164-17167	for	_
111-6	17168-17171	the	_
111-7	17172-17178	NKI-RS	_
111-8	17179-17183	data	_
111-9	17184-17185	(	_
111-10	17185-17188	Fig	_
111-11	17188-17189	.	_
111-12	17190-17192	1A	_
111-13	17192-17193	)	_
111-14	17193-17194	,	_
111-15	17195-17203	subgroup	_
111-16	17204-17212	analysis	_
111-17	17213-17221	revealed	_
111-18	17222-17225	the	_
111-19	17226-17237	correlation	_
111-20	17238-17245	between	_
111-21	17246-17257	neuroticism	_
111-22	17258-17261	and	_
111-23	17262-17270	cortical	_
111-24	17271-17280	thickness	_
111-25	17281-17283	at	_
111-26	17284-17287	the	_
111-27	17288-17292	left	_
111-28	17293-17299	insula	_
111-29	17300-17303	was	_
111-30	17304-17315	significant	_
111-31	17316-17318	in	_
111-32	17319-17322	AUD	_
111-33	17323-17324	(	_
111-34	17324-17325	β	_
111-35	17325-17326	=	_
111-36	17326-17327	−	_
111-37	17327-17332	0.005	_
111-38	17332-17333	,	_
111-39	17334-17335	P	_
111-40	17335-17336	=	_
111-41	17336-17341	0.002	_
111-42	17341-17342	)	_
111-43	17343-17346	but	_
111-44	17347-17350	not	_
111-45	17351-17353	in	_
111-46	17354-17356	HC	_
111-47	17357-17358	(	_
111-48	17358-17359	β	_
111-49	17359-17360	=	_
111-50	17360-17365	0.002	_
111-51	17365-17366	,	_
111-52	17367-17368	P	_
111-53	17368-17369	=	_
111-54	17369-17374	0.258	_
111-55	17374-17375	)	_
111-56	17375-17376	.	_

#Text=The result for fusiform gyrus was also significant (P=0.041), though subgroup analysis did not show significant correlations between cortical thickness and neuroticism in AUDs (β=−0.002, P=0.275) and HCs (β=0.003, P=0.073).
112-1	17377-17380	The	_
112-2	17381-17387	result	_
112-3	17388-17391	for	_
112-4	17392-17400	fusiform	_
112-5	17401-17406	gyrus	_
112-6	17407-17410	was	_
112-7	17411-17415	also	_
112-8	17416-17427	significant	_
112-9	17428-17429	(	_
112-10	17429-17430	P	_
112-11	17430-17431	=	_
112-12	17431-17436	0.041	_
112-13	17436-17437	)	_
112-14	17437-17438	,	_
112-15	17439-17445	though	_
112-16	17446-17454	subgroup	_
112-17	17455-17463	analysis	_
112-18	17464-17467	did	_
112-19	17468-17471	not	_
112-20	17472-17476	show	_
112-21	17477-17488	significant	_
112-22	17489-17501	correlations	_
112-23	17502-17509	between	_
112-24	17510-17518	cortical	_
112-25	17519-17528	thickness	_
112-26	17529-17532	and	_
112-27	17533-17544	neuroticism	_
112-28	17545-17547	in	_
112-29	17548-17552	AUDs	_
112-30	17553-17554	(	_
112-31	17554-17555	β	_
112-32	17555-17556	=	_
112-33	17556-17557	−	_
112-34	17557-17562	0.002	_
112-35	17562-17563	,	_
112-36	17564-17565	P	_
112-37	17565-17566	=	_
112-38	17566-17571	0.275	_
112-39	17571-17572	)	_
112-40	17573-17576	and	_
112-41	17577-17580	HCs	_
112-42	17581-17582	(	_
112-43	17582-17583	β	_
112-44	17583-17584	=	_
112-45	17584-17589	0.003	_
112-46	17589-17590	,	_
112-47	17591-17592	P	_
112-48	17592-17593	=	_
112-49	17593-17598	0.073	_
112-50	17598-17599	)	_
112-51	17599-17600	.	_

#Text=Due to the dense nature of HCP data and computational limitations, vertex level explicatory analyses were not performed for the HCP data.
#Text=4.
113-1	17601-17604	Due	_
113-2	17605-17607	to	_
113-3	17608-17611	the	_
113-4	17612-17617	dense	_
113-5	17618-17624	nature	_
113-6	17625-17627	of	_
113-7	17628-17631	HCP	_
113-8	17632-17636	data	_
113-9	17637-17640	and	_
113-10	17641-17654	computational	_
113-11	17655-17666	limitations	_
113-12	17666-17667	,	_
113-13	17668-17674	vertex	_
113-14	17675-17680	level	_
113-15	17681-17692	explicatory	_
113-16	17693-17701	analyses	_
113-17	17702-17706	were	_
113-18	17707-17710	not	_
113-19	17711-17720	performed	_
113-20	17721-17724	for	_
113-21	17725-17728	the	_
113-22	17729-17732	HCP	_
113-23	17733-17737	data	_
113-24	17737-17738	.	_
113-25	17739-17740	4	_
113-26	17740-17741	.	_

#Text=DISCUSSION
#Text=We confirmed that individuals with lifetime AUDs had higher neuroticism scores than healthy comparisons in both NKI-RS and HCP data sets; we did not confirm associations of other personality traits, such as extraversion or consciousness, with AUDs.
114-1	17742-17752	DISCUSSION	_
114-2	17753-17755	We	_
114-3	17756-17765	confirmed	_
114-4	17766-17770	that	_
114-5	17771-17782	individuals	_
114-6	17783-17787	with	_
114-7	17788-17796	lifetime	_
114-8	17797-17801	AUDs	_
114-9	17802-17805	had	_
114-10	17806-17812	higher	_
114-11	17813-17824	neuroticism	_
114-12	17825-17831	scores	_
114-13	17832-17836	than	_
114-14	17837-17844	healthy	_
114-15	17845-17856	comparisons	_
114-16	17857-17859	in	_
114-17	17860-17864	both	_
114-18	17865-17871	NKI-RS	_
114-19	17872-17875	and	_
114-20	17876-17879	HCP	_
114-21	17880-17884	data	_
114-22	17885-17889	sets	_
114-23	17889-17890	;	_
114-24	17891-17893	we	_
114-25	17894-17897	did	_
114-26	17898-17901	not	_
114-27	17902-17909	confirm	_
114-28	17910-17922	associations	_
114-29	17923-17925	of	_
114-30	17926-17931	other	_
114-31	17932-17943	personality	_
114-32	17944-17950	traits	_
114-33	17950-17951	,	_
114-34	17952-17956	such	_
114-35	17957-17959	as	_
114-36	17960-17972	extraversion	_
114-37	17973-17975	or	_
114-38	17976-17989	consciousness	_
114-39	17989-17990	,	_
114-40	17991-17995	with	_
114-41	17996-18000	AUDs	_
114-42	18000-18001	.	_

#Text=This could be partly due to our using community-based samples in which more than 95% of participants with AUDs had a past rather than a current AUD diagnosis, with less extreme behavior measures than found in treatment-seeking AUD subjects.
115-1	18002-18006	This	_
115-2	18007-18012	could	_
115-3	18013-18015	be	_
115-4	18016-18022	partly	_
115-5	18023-18026	due	_
115-6	18027-18029	to	_
115-7	18030-18033	our	_
115-8	18034-18039	using	_
115-9	18040-18055	community-based	_
115-10	18056-18063	samples	_
115-11	18064-18066	in	_
115-12	18067-18072	which	_
115-13	18073-18077	more	_
115-14	18078-18082	than	_
115-15	18083-18086	95%	_
115-16	18087-18089	of	_
115-17	18090-18102	participants	_
115-18	18103-18107	with	_
115-19	18108-18112	AUDs	_
115-20	18113-18116	had	_
115-21	18117-18118	a	_
115-22	18119-18123	past	_
115-23	18124-18130	rather	_
115-24	18131-18135	than	_
115-25	18136-18137	a	_
115-26	18138-18145	current	_
115-27	18146-18149	AUD	_
115-28	18150-18159	diagnosis	_
115-29	18159-18160	,	_
115-30	18161-18165	with	_
115-31	18166-18170	less	_
115-32	18171-18178	extreme	_
115-33	18179-18187	behavior	_
115-34	18188-18196	measures	_
115-35	18197-18201	than	_
115-36	18202-18207	found	_
115-37	18208-18210	in	_
115-38	18211-18228	treatment-seeking	_
115-39	18229-18232	AUD	_
115-40	18233-18241	subjects	_
115-41	18241-18242	.	_

#Text=This suggests the link between neuroticism and AUD may be more enduring than other personality traits.
116-1	18243-18247	This	_
116-2	18248-18256	suggests	_
116-3	18257-18260	the	_
116-4	18261-18265	link	_
116-5	18266-18273	between	_
116-6	18274-18285	neuroticism	_
116-7	18286-18289	and	_
116-8	18290-18293	AUD	_
116-9	18294-18297	may	_
116-10	18298-18300	be	_
116-11	18301-18305	more	_
116-12	18306-18314	enduring	_
116-13	18315-18319	than	_
116-14	18320-18325	other	_
116-15	18326-18337	personality	_
116-16	18338-18344	traits	_
116-17	18344-18345	.	_

#Text=The impact of AUD status on the relationship between neuroticism and cortical thickness has not previously been reported.
117-1	18346-18349	The	_
117-2	18350-18356	impact	_
117-3	18357-18359	of	_
117-4	18360-18363	AUD	_
117-5	18364-18370	status	_
117-6	18371-18373	on	_
117-7	18374-18377	the	_
117-8	18378-18390	relationship	_
117-9	18391-18398	between	_
117-10	18399-18410	neuroticism	_
117-11	18411-18414	and	_
117-12	18415-18423	cortical	_
117-13	18424-18433	thickness	_
117-14	18434-18437	has	_
117-15	18438-18441	not	_
117-16	18442-18452	previously	_
117-17	18453-18457	been	_
117-18	18458-18466	reported	_
117-19	18466-18467	.	_

#Text=In the NKI-RS, we found a significant negative correlation between neuroticism and cortical thickness in the left insula and right fusiform in participants with lifetime AUD diagnosis.
118-1	18468-18470	In	_
118-2	18471-18474	the	_
118-3	18475-18481	NKI-RS	_
118-4	18481-18482	,	_
118-5	18483-18485	we	_
118-6	18486-18491	found	_
118-7	18492-18493	a	_
118-8	18494-18505	significant	_
118-9	18506-18514	negative	_
118-10	18515-18526	correlation	_
118-11	18527-18534	between	_
118-12	18535-18546	neuroticism	_
118-13	18547-18550	and	_
118-14	18551-18559	cortical	_
118-15	18560-18569	thickness	_
118-16	18570-18572	in	_
118-17	18573-18576	the	_
118-18	18577-18581	left	_
118-19	18582-18588	insula	_
118-20	18589-18592	and	_
118-21	18593-18598	right	_
118-22	18599-18607	fusiform	_
118-23	18608-18610	in	_
118-24	18611-18623	participants	_
118-25	18624-18628	with	_
118-26	18629-18637	lifetime	_
118-27	18638-18641	AUD	_
118-28	18642-18651	diagnosis	_
118-29	18651-18652	.	_

#Text=By contrast, this relationship was not observed in HCs.
119-1	18653-18655	By	_
119-2	18656-18664	contrast	_
119-3	18664-18665	,	_
119-4	18666-18670	this	_
119-5	18671-18683	relationship	_
119-6	18684-18687	was	_
119-7	18688-18691	not	_
119-8	18692-18700	observed	_
119-9	18701-18703	in	_
119-10	18704-18707	HCs	_
119-11	18707-18708	.	_

#Text=The lack of correlation between cortical thickness of the left insula and right fusiform in HC is consistent with prior studies in healthy samples.
120-1	18709-18712	The	_
120-2	18713-18717	lack	_
120-3	18718-18720	of	_
120-4	18721-18732	correlation	_
120-5	18733-18740	between	_
120-6	18741-18749	cortical	_
120-7	18750-18759	thickness	_
120-8	18760-18762	of	_
120-9	18763-18766	the	_
120-10	18767-18771	left	_
120-11	18772-18778	insula	_
120-12	18779-18782	and	_
120-13	18783-18788	right	_
120-14	18789-18797	fusiform	_
120-15	18798-18800	in	_
120-16	18801-18803	HC	_
120-17	18804-18806	is	_
120-18	18807-18817	consistent	_
120-19	18818-18822	with	_
120-20	18823-18828	prior	_
120-21	18829-18836	studies	_
120-22	18837-18839	in	_
120-23	18840-18847	healthy	_
120-24	18848-18855	samples	_
120-25	18855-18856	.	_

#Text=Our novel finding that lifetime AUD diagnosis impacts the correlation between neuroticism and cortical thickness at specific brain regions is a step towards dissecting the complex relationship between brain structure, AUD and neuroticism.
121-1	18857-18860	Our	_
121-2	18861-18866	novel	_
121-3	18867-18874	finding	_
121-4	18875-18879	that	_
121-5	18880-18888	lifetime	_
121-6	18889-18892	AUD	_
121-7	18893-18902	diagnosis	_
121-8	18903-18910	impacts	_
121-9	18911-18914	the	_
121-10	18915-18926	correlation	_
121-11	18927-18934	between	_
121-12	18935-18946	neuroticism	_
121-13	18947-18950	and	_
121-14	18951-18959	cortical	_
121-15	18960-18969	thickness	_
121-16	18970-18972	at	_
121-17	18973-18981	specific	_
121-18	18982-18987	brain	_
121-19	18988-18995	regions	_
121-20	18996-18998	is	_
121-21	18999-19000	a	_
121-22	19001-19005	step	_
121-23	19006-19013	towards	_
121-24	19014-19024	dissecting	_
121-25	19025-19028	the	_
121-26	19029-19036	complex	_
121-27	19037-19049	relationship	_
121-28	19050-19057	between	_
121-29	19058-19063	brain	_
121-30	19064-19073	structure	_
121-31	19073-19074	,	_
121-32	19075-19078	AUD	_
121-33	19079-19082	and	_
121-34	19083-19094	neuroticism	_
121-35	19094-19095	.	_

#Text=It also supports the utility of community-based samples for identifying biological and psychological risk factors impacting AUD.
122-1	19096-19098	It	_
122-2	19099-19103	also	_
122-3	19104-19112	supports	_
122-4	19113-19116	the	_
122-5	19117-19124	utility	_
122-6	19125-19127	of	_
122-7	19128-19143	community-based	_
122-8	19144-19151	samples	_
122-9	19152-19155	for	_
122-10	19156-19167	identifying	_
122-11	19168-19178	biological	_
122-12	19179-19182	and	_
122-13	19183-19196	psychological	_
122-14	19197-19201	risk	_
122-15	19202-19209	factors	_
122-16	19210-19219	impacting	_
122-17	19220-19223	AUD	_
122-18	19223-19224	.	_

#Text=The most compellingly replicable result was our observation of negative correlations between left insular cortical thickness and neuroticism in AUD subjects in both the NKI-RS and the HCP data sets, suggesting that left insular cortical thickness could be a reliable brain endophenotype linking AUD and neuroticism.
123-1	19225-19228	The	_
123-2	19229-19233	most	_
123-3	19234-19246	compellingly	_
123-4	19247-19257	replicable	_
123-5	19258-19264	result	_
123-6	19265-19268	was	_
123-7	19269-19272	our	_
123-8	19273-19284	observation	_
123-9	19285-19287	of	_
123-10	19288-19296	negative	_
123-11	19297-19309	correlations	_
123-12	19310-19317	between	_
123-13	19318-19322	left	_
123-14	19323-19330	insular	_
123-15	19331-19339	cortical	_
123-16	19340-19349	thickness	_
123-17	19350-19353	and	_
123-18	19354-19365	neuroticism	_
123-19	19366-19368	in	_
123-20	19369-19372	AUD	_
123-21	19373-19381	subjects	_
123-22	19382-19384	in	_
123-23	19385-19389	both	_
123-24	19390-19393	the	_
123-25	19394-19400	NKI-RS	_
123-26	19401-19404	and	_
123-27	19405-19408	the	_
123-28	19409-19412	HCP	_
123-29	19413-19417	data	_
123-30	19418-19422	sets	_
123-31	19422-19423	,	_
123-32	19424-19434	suggesting	_
123-33	19435-19439	that	_
123-34	19440-19444	left	_
123-35	19445-19452	insular	_
123-36	19453-19461	cortical	_
123-37	19462-19471	thickness	_
123-38	19472-19477	could	_
123-39	19478-19480	be	_
123-40	19481-19482	a	_
123-41	19483-19491	reliable	_
123-42	19492-19497	brain	_
123-43	19498-19511	endophenotype	_
123-44	19512-19519	linking	_
123-45	19520-19523	AUD	_
123-46	19524-19527	and	_
123-47	19528-19539	neuroticism	_
123-48	19539-19540	.	_

#Text=The insula is involved in multiple processes including perception, motor control, self-consciousness, cognitive functioning, and emotional regulation, and it has been particularly linked to addictive behaviors.
124-1	19541-19544	The	_
124-2	19545-19551	insula	_
124-3	19552-19554	is	_
124-4	19555-19563	involved	_
124-5	19564-19566	in	_
124-6	19567-19575	multiple	_
124-7	19576-19585	processes	_
124-8	19586-19595	including	_
124-9	19596-19606	perception	_
124-10	19606-19607	,	_
124-11	19608-19613	motor	_
124-12	19614-19621	control	_
124-13	19621-19622	,	_
124-14	19623-19641	self-consciousness	_
124-15	19641-19642	,	_
124-16	19643-19652	cognitive	_
124-17	19653-19664	functioning	_
124-18	19664-19665	,	_
124-19	19666-19669	and	_
124-20	19670-19679	emotional	_
124-21	19680-19690	regulation	_
124-22	19690-19691	,	_
124-23	19692-19695	and	_
124-24	19696-19698	it	_
124-25	19699-19702	has	_
124-26	19703-19707	been	_
124-27	19708-19720	particularly	_
124-28	19721-19727	linked	_
124-29	19728-19730	to	_
124-30	19731-19740	addictive	_
124-31	19741-19750	behaviors	_
124-32	19750-19751	.	_

#Text=Our vertex-based analysis revealed that the correlation between neuroticism and cortical thickness was predominantly affected by AUD status in both anterior and posterior subdivisions of the left insula.
125-1	19752-19755	Our	_
125-2	19756-19768	vertex-based	_
125-3	19769-19777	analysis	_
125-4	19778-19786	revealed	_
125-5	19787-19791	that	_
125-6	19792-19795	the	_
125-7	19796-19807	correlation	_
125-8	19808-19815	between	_
125-9	19816-19827	neuroticism	_
125-10	19828-19831	and	_
125-11	19832-19840	cortical	_
125-12	19841-19850	thickness	_
125-13	19851-19854	was	_
125-14	19855-19868	predominantly	_
125-15	19869-19877	affected	_
125-16	19878-19880	by	_
125-17	19881-19884	AUD	_
125-18	19885-19891	status	_
125-19	19892-19894	in	_
125-20	19895-19899	both	_
125-21	19900-19908	anterior	_
125-22	19909-19912	and	_
125-23	19913-19922	posterior	_
125-24	19923-19935	subdivisions	_
125-25	19936-19938	of	_
125-26	19939-19942	the	_
125-27	19943-19947	left	_
125-28	19948-19954	insula	_
125-29	19954-19955	.	_

#Text=The literature on structure-functional relationships in the insula is conflicted.
126-1	19956-19959	The	_
126-2	19960-19970	literature	_
126-3	19971-19973	on	_
126-4	19974-19994	structure-functional	_
126-5	19995-20008	relationships	_
126-6	20009-20011	in	_
126-7	20012-20015	the	_
126-8	20016-20022	insula	_
126-9	20023-20025	is	_
126-10	20026-20036	conflicted	_
126-11	20036-20037	.	_

#Text=Bilateral insula damage was associated with loss of addictive craving, but reduction in insular cortical thickness has also been reported in cocaine addiction and in alcohol dependent subjects.
127-1	20038-20047	Bilateral	_
127-2	20048-20054	insula	_
127-3	20055-20061	damage	_
127-4	20062-20065	was	_
127-5	20066-20076	associated	_
127-6	20077-20081	with	_
127-7	20082-20086	loss	_
127-8	20087-20089	of	_
127-9	20090-20099	addictive	_
127-10	20100-20107	craving	_
127-11	20107-20108	,	_
127-12	20109-20112	but	_
127-13	20113-20122	reduction	_
127-14	20123-20125	in	_
127-15	20126-20133	insular	_
127-16	20134-20142	cortical	_
127-17	20143-20152	thickness	_
127-18	20153-20156	has	_
127-19	20157-20161	also	_
127-20	20162-20166	been	_
127-21	20167-20175	reported	_
127-22	20176-20178	in	_
127-23	20179-20186	cocaine	_
127-24	20187-20196	addiction	_
127-25	20197-20200	and	_
127-26	20201-20203	in	_
127-27	20204-20211	alcohol	_
127-28	20212-20221	dependent	_
127-29	20222-20230	subjects	_
127-30	20230-20231	.	_

#Text=In addition, substance users have been found to show reduced posterior insula activity during risky choice tasks, as well as increased insula activity in response to drug-related cues.
128-1	20232-20234	In	_
128-2	20235-20243	addition	_
128-3	20243-20244	,	_
128-4	20245-20254	substance	_
128-5	20255-20260	users	_
128-6	20261-20265	have	_
128-7	20266-20270	been	_
128-8	20271-20276	found	_
128-9	20277-20279	to	_
128-10	20280-20284	show	_
128-11	20285-20292	reduced	_
128-12	20293-20302	posterior	_
128-13	20303-20309	insula	_
128-14	20310-20318	activity	_
128-15	20319-20325	during	_
128-16	20326-20331	risky	_
128-17	20332-20338	choice	_
128-18	20339-20344	tasks	_
128-19	20344-20345	,	_
128-20	20346-20348	as	_
128-21	20349-20353	well	_
128-22	20354-20356	as	_
128-23	20357-20366	increased	_
128-24	20367-20373	insula	_
128-25	20374-20382	activity	_
128-26	20383-20385	in	_
128-27	20386-20394	response	_
128-28	20395-20397	to	_
128-29	20398-20410	drug-related	_
128-30	20411-20415	cues	_
128-31	20415-20416	.	_

#Text=In the same vein, severity of alcohol addiction has been positively associated with cue-induced insula activity.
129-1	20417-20419	In	_
129-2	20420-20423	the	_
129-3	20424-20428	same	_
129-4	20429-20433	vein	_
129-5	20433-20434	,	_
129-6	20435-20443	severity	_
129-7	20444-20446	of	_
129-8	20447-20454	alcohol	_
129-9	20455-20464	addiction	_
129-10	20465-20468	has	_
129-11	20469-20473	been	_
129-12	20474-20484	positively	_
129-13	20485-20495	associated	_
129-14	20496-20500	with	_
129-15	20501-20512	cue-induced	_
129-16	20513-20519	insula	_
129-17	20520-20528	activity	_
129-18	20528-20529	.	_

#Text=In cocaine addiction, insula involvement has been understood on the basis of interconnections with the dorsolateral prefrontal cortex in normative functioning of the reward system.
130-1	20530-20532	In	_
130-2	20533-20540	cocaine	_
130-3	20541-20550	addiction	_
130-4	20550-20551	,	_
130-5	20552-20558	insula	_
130-6	20559-20570	involvement	_
130-7	20571-20574	has	_
130-8	20575-20579	been	_
130-9	20580-20590	understood	_
130-10	20591-20593	on	_
130-11	20594-20597	the	_
130-12	20598-20603	basis	_
130-13	20604-20606	of	_
130-14	20607-20623	interconnections	_
130-15	20624-20628	with	_
130-16	20629-20632	the	_
130-17	20633-20645	dorsolateral	_
130-18	20646-20656	prefrontal	_
130-19	20657-20663	cortex	_
130-20	20664-20666	in	_
130-21	20667-20676	normative	_
130-22	20677-20688	functioning	_
130-23	20689-20691	of	_
130-24	20692-20695	the	_
130-25	20696-20702	reward	_
130-26	20703-20709	system	_
130-27	20709-20710	.	_

#Text=Furthermore, the strong emotional states produced by substance abuse have been proposed to enhance insula connectivity, which in turn leads to strong associations between drugs of abuse and emotional states in drug abusing subjects.
131-1	20711-20722	Furthermore	_
131-2	20722-20723	,	_
131-3	20724-20727	the	_
131-4	20728-20734	strong	_
131-5	20735-20744	emotional	_
131-6	20745-20751	states	_
131-7	20752-20760	produced	_
131-8	20761-20763	by	_
131-9	20764-20773	substance	_
131-10	20774-20779	abuse	_
131-11	20780-20784	have	_
131-12	20785-20789	been	_
131-13	20790-20798	proposed	_
131-14	20799-20801	to	_
131-15	20802-20809	enhance	_
131-16	20810-20816	insula	_
131-17	20817-20829	connectivity	_
131-18	20829-20830	,	_
131-19	20831-20836	which	_
131-20	20837-20839	in	_
131-21	20840-20844	turn	_
131-22	20845-20850	leads	_
131-23	20851-20853	to	_
131-24	20854-20860	strong	_
131-25	20861-20873	associations	_
131-26	20874-20881	between	_
131-27	20882-20887	drugs	_
131-28	20888-20890	of	_
131-29	20891-20896	abuse	_
131-30	20897-20900	and	_
131-31	20901-20910	emotional	_
131-32	20911-20917	states	_
131-33	20918-20920	in	_
131-34	20921-20925	drug	_
131-35	20926-20933	abusing	_
131-36	20934-20942	subjects	_
131-37	20942-20943	.	_

#Text=Interestingly, several studies have indicated that activation in the anterior subdivision of the left insula is negatively correlated with emotional control-related neuroticism.
132-1	20944-20957	Interestingly	_
132-2	20957-20958	,	_
132-3	20959-20966	several	_
132-4	20967-20974	studies	_
132-5	20975-20979	have	_
132-6	20980-20989	indicated	_
132-7	20990-20994	that	_
132-8	20995-21005	activation	_
132-9	21006-21008	in	_
132-10	21009-21012	the	_
132-11	21013-21021	anterior	_
132-12	21022-21033	subdivision	_
132-13	21034-21036	of	_
132-14	21037-21040	the	_
132-15	21041-21045	left	_
132-16	21046-21052	insula	_
132-17	21053-21055	is	_
132-18	21056-21066	negatively	_
132-19	21067-21077	correlated	_
132-20	21078-21082	with	_
132-21	21083-21092	emotional	_
132-22	21093-21108	control-related	_
132-23	21109-21120	neuroticism	_
132-24	21120-21121	.	_

#Text=We speculate that the insula-neuroticism correlation we observed in AUD may reflect the same relationship.
133-1	21122-21124	We	_
133-2	21125-21134	speculate	_
133-3	21135-21139	that	_
133-4	21140-21143	the	_
133-5	21144-21162	insula-neuroticism	_
133-6	21163-21174	correlation	_
133-7	21175-21177	we	_
133-8	21178-21186	observed	_
133-9	21187-21189	in	_
133-10	21190-21193	AUD	_
133-11	21194-21197	may	_
133-12	21198-21205	reflect	_
133-13	21206-21209	the	_
133-14	21210-21214	same	_
133-15	21215-21227	relationship	_
133-16	21227-21228	.	_

#Text=Our finding that AUD impacted the correlation between neuroticism and cortical thickness in the anterior and posterior insula supports the tentative suggestion that this effect may involve pain perception in participants with AUDs.
134-1	21229-21232	Our	_
134-2	21233-21240	finding	_
134-3	21241-21245	that	_
134-4	21246-21249	AUD	_
134-5	21250-21258	impacted	_
134-6	21259-21262	the	_
134-7	21263-21274	correlation	_
134-8	21275-21282	between	_
134-9	21283-21294	neuroticism	_
134-10	21295-21298	and	_
134-11	21299-21307	cortical	_
134-12	21308-21317	thickness	_
134-13	21318-21320	in	_
134-14	21321-21324	the	_
134-15	21325-21333	anterior	_
134-16	21334-21337	and	_
134-17	21338-21347	posterior	_
134-18	21348-21354	insula	_
134-19	21355-21363	supports	_
134-20	21364-21367	the	_
134-21	21368-21377	tentative	_
134-22	21378-21388	suggestion	_
134-23	21389-21393	that	_
134-24	21394-21398	this	_
134-25	21399-21405	effect	_
134-26	21406-21409	may	_
134-27	21410-21417	involve	_
134-28	21418-21422	pain	_
134-29	21423-21433	perception	_
134-30	21434-21436	in	_
134-31	21437-21449	participants	_
134-32	21450-21454	with	_
134-33	21455-21459	AUDs	_
134-34	21459-21460	.	_

#Text=Our vertex-based analysis result pinpointing both anterior and posterior subdivisions of the insula is consistent with the involvement of both these subdivisions in pain perception.
135-1	21461-21464	Our	_
135-2	21465-21477	vertex-based	_
135-3	21478-21486	analysis	_
135-4	21487-21493	result	_
135-5	21494-21505	pinpointing	_
135-6	21506-21510	both	_
135-7	21511-21519	anterior	_
135-8	21520-21523	and	_
135-9	21524-21533	posterior	_
135-10	21534-21546	subdivisions	_
135-11	21547-21549	of	_
135-12	21550-21553	the	_
135-13	21554-21560	insula	_
135-14	21561-21563	is	_
135-15	21564-21574	consistent	_
135-16	21575-21579	with	_
135-17	21580-21583	the	_
135-18	21584-21595	involvement	_
135-19	21596-21598	of	_
135-20	21599-21603	both	_
135-21	21604-21609	these	_
135-22	21610-21622	subdivisions	_
135-23	21623-21625	in	_
135-24	21626-21630	pain	_
135-25	21631-21641	perception	_
135-26	21641-21642	.	_

#Text=Pain sensations evoked from various painful stimuli are relayed to dorsal posterior insula via the spinothalamocortical pathway and then integrated in the anterior subdivision.
136-1	21643-21647	Pain	_
136-2	21648-21658	sensations	_
136-3	21659-21665	evoked	_
136-4	21666-21670	from	_
136-5	21671-21678	various	_
136-6	21679-21686	painful	_
136-7	21687-21694	stimuli	_
136-8	21695-21698	are	_
136-9	21699-21706	relayed	_
136-10	21707-21709	to	_
136-11	21710-21716	dorsal	_
136-12	21717-21726	posterior	_
136-13	21727-21733	insula	_
136-14	21734-21737	via	_
136-15	21738-21741	the	_
136-16	21742-21762	spinothalamocortical	_
136-17	21763-21770	pathway	_
136-18	21771-21774	and	_
136-19	21775-21779	then	_
136-20	21780-21790	integrated	_
136-21	21791-21793	in	_
136-22	21794-21797	the	_
136-23	21798-21806	anterior	_
136-24	21807-21818	subdivision	_
136-25	21818-21819	.	_

#Text=AUD has been increasingly viewed as a chronic pain disorder based on accumulating pathophysiological observation and brain imaging evidence.
137-1	21820-21823	AUD	_
137-2	21824-21827	has	_
137-3	21828-21832	been	_
137-4	21833-21845	increasingly	_
137-5	21846-21852	viewed	_
137-6	21853-21855	as	_
137-7	21856-21857	a	_
137-8	21858-21865	chronic	_
137-9	21866-21870	pain	_
137-10	21871-21879	disorder	_
137-11	21880-21885	based	_
137-12	21886-21888	on	_
137-13	21889-21901	accumulating	_
137-14	21902-21920	pathophysiological	_
137-15	21921-21932	observation	_
137-16	21933-21936	and	_
137-17	21937-21942	brain	_
137-18	21943-21950	imaging	_
137-19	21951-21959	evidence	_
137-20	21959-21960	.	_

#Text=Alcohol administration is believed to trigger an initial rewarding and pain alleviating response, although excessive alcohol intoxication and withdrawal episodes can dysregulate brain stress and reward circuits.
138-1	21961-21968	Alcohol	_
138-2	21969-21983	administration	_
138-3	21984-21986	is	_
138-4	21987-21995	believed	_
138-5	21996-21998	to	_
138-6	21999-22006	trigger	_
138-7	22007-22009	an	_
138-8	22010-22017	initial	_
138-9	22018-22027	rewarding	_
138-10	22028-22031	and	_
138-11	22032-22036	pain	_
138-12	22037-22048	alleviating	_
138-13	22049-22057	response	_
138-14	22057-22058	,	_
138-15	22059-22067	although	_
138-16	22068-22077	excessive	_
138-17	22078-22085	alcohol	_
138-18	22086-22098	intoxication	_
138-19	22099-22102	and	_
138-20	22103-22113	withdrawal	_
138-21	22114-22122	episodes	_
138-22	22123-22126	can	_
138-23	22127-22138	dysregulate	_
138-24	22139-22144	brain	_
138-25	22145-22151	stress	_
138-26	22152-22155	and	_
138-27	22156-22162	reward	_
138-28	22163-22171	circuits	_
138-29	22171-22172	.	_

#Text=Such repeated episodes can lead to a persistent negative affective state that in turn motivates excessive alcohol consumption to restore the normal emotional state.
139-1	22173-22177	Such	_
139-2	22178-22186	repeated	_
139-3	22187-22195	episodes	_
139-4	22196-22199	can	_
139-5	22200-22204	lead	_
139-6	22205-22207	to	_
139-7	22208-22209	a	_
139-8	22210-22220	persistent	_
139-9	22221-22229	negative	_
139-10	22230-22239	affective	_
139-11	22240-22245	state	_
139-12	22246-22250	that	_
139-13	22251-22253	in	_
139-14	22254-22258	turn	_
139-15	22259-22268	motivates	_
139-16	22269-22278	excessive	_
139-17	22279-22286	alcohol	_
139-18	22287-22298	consumption	_
139-19	22299-22301	to	_
139-20	22302-22309	restore	_
139-21	22310-22313	the	_
139-22	22314-22320	normal	_
139-23	22321-22330	emotional	_
139-24	22331-22336	state	_
139-25	22336-22337	.	_

#Text=Neuroticism score, which was higher in participants with AUDs than in HCs, has been reported to be negatively related to pain tolerance.
140-1	22338-22349	Neuroticism	_
140-2	22350-22355	score	_
140-3	22355-22356	,	_
140-4	22357-22362	which	_
140-5	22363-22366	was	_
140-6	22367-22373	higher	_
140-7	22374-22376	in	_
140-8	22377-22389	participants	_
140-9	22390-22394	with	_
140-10	22395-22399	AUDs	_
140-11	22400-22404	than	_
140-12	22405-22407	in	_
140-13	22408-22411	HCs	_
140-14	22411-22412	,	_
140-15	22413-22416	has	_
140-16	22417-22421	been	_
140-17	22422-22430	reported	_
140-18	22431-22433	to	_
140-19	22434-22436	be	_
140-20	22437-22447	negatively	_
140-21	22448-22455	related	_
140-22	22456-22458	to	_
140-23	22459-22463	pain	_
140-24	22464-22473	tolerance	_
140-25	22473-22474	.	_

#Text=The insula’s fundamental role in human pain perception is further supported by its being the most consistently activated region in response to abnormal and induced pain.
141-1	22475-22478	The	_
141-2	22479-22485	insula	_
141-3	22485-22486	’	_
141-4	22486-22487	s	_
141-5	22488-22499	fundamental	_
141-6	22500-22504	role	_
141-7	22505-22507	in	_
141-8	22508-22513	human	_
141-9	22514-22518	pain	_
141-10	22519-22529	perception	_
141-11	22530-22532	is	_
141-12	22533-22540	further	_
141-13	22541-22550	supported	_
141-14	22551-22553	by	_
141-15	22554-22557	its	_
141-16	22558-22563	being	_
141-17	22564-22567	the	_
141-18	22568-22572	most	_
141-19	22573-22585	consistently	_
141-20	22586-22595	activated	_
141-21	22596-22602	region	_
141-22	22603-22605	in	_
141-23	22606-22614	response	_
141-24	22615-22617	to	_
141-25	22618-22626	abnormal	_
141-26	22627-22630	and	_
141-27	22631-22638	induced	_
141-28	22639-22643	pain	_
141-29	22643-22644	.	_

#Text=Finally, the insula is also activated in subjects with alcohol dependence during reward anticipation.
142-1	22645-22652	Finally	_
142-2	22652-22653	,	_
142-3	22654-22657	the	_
142-4	22658-22664	insula	_
142-5	22665-22667	is	_
142-6	22668-22672	also	_
142-7	22673-22682	activated	_
142-8	22683-22685	in	_
142-9	22686-22694	subjects	_
142-10	22695-22699	with	_
142-11	22700-22707	alcohol	_
142-12	22708-22718	dependence	_
142-13	22719-22725	during	_
142-14	22726-22732	reward	_
142-15	22733-22745	anticipation	_
142-16	22745-22746	.	_

#Text=Therefore, our observation in two independent data sets that the insula cortical thickness-neuroticism correlation differs in participants with AUD versus HCs may also be explained by the intriguing, albeit untested, hypothesis that insula cortex dysfunction, indexed by structural differences, may mediate the impact of alcohol consumption on affective pain states, consequently contributing to the development of AUDs.
143-1	22747-22756	Therefore	_
143-2	22756-22757	,	_
143-3	22758-22761	our	_
143-4	22762-22773	observation	_
143-5	22774-22776	in	_
143-6	22777-22780	two	_
143-7	22781-22792	independent	_
143-8	22793-22797	data	_
143-9	22798-22802	sets	_
143-10	22803-22807	that	_
143-11	22808-22811	the	_
143-12	22812-22818	insula	_
143-13	22819-22827	cortical	_
143-14	22828-22849	thickness-neuroticism	_
143-15	22850-22861	correlation	_
143-16	22862-22869	differs	_
143-17	22870-22872	in	_
143-18	22873-22885	participants	_
143-19	22886-22890	with	_
143-20	22891-22894	AUD	_
143-21	22895-22901	versus	_
143-22	22902-22905	HCs	_
143-23	22906-22909	may	_
143-24	22910-22914	also	_
143-25	22915-22917	be	_
143-26	22918-22927	explained	_
143-27	22928-22930	by	_
143-28	22931-22934	the	_
143-29	22935-22945	intriguing	_
143-30	22945-22946	,	_
143-31	22947-22953	albeit	_
143-32	22954-22962	untested	_
143-33	22962-22963	,	_
143-34	22964-22974	hypothesis	_
143-35	22975-22979	that	_
143-36	22980-22986	insula	_
143-37	22987-22993	cortex	_
143-38	22994-23005	dysfunction	_
143-39	23005-23006	,	_
143-40	23007-23014	indexed	_
143-41	23015-23017	by	_
143-42	23018-23028	structural	_
143-43	23029-23040	differences	_
143-44	23040-23041	,	_
143-45	23042-23045	may	_
143-46	23046-23053	mediate	_
143-47	23054-23057	the	_
143-48	23058-23064	impact	_
143-49	23065-23067	of	_
143-50	23068-23075	alcohol	_
143-51	23076-23087	consumption	_
143-52	23088-23090	on	_
143-53	23091-23100	affective	_
143-54	23101-23105	pain	_
143-55	23106-23112	states	_
143-56	23112-23113	,	_
143-57	23114-23126	consequently	_
143-58	23127-23139	contributing	_
143-59	23140-23142	to	_
143-60	23143-23146	the	_
143-61	23147-23158	development	_
143-62	23159-23161	of	_
143-63	23162-23166	AUDs	_
143-64	23166-23167	.	_

#Text=Clearly, understanding the potential role of the insula in addiction requires further investigation.
144-1	23168-23175	Clearly	_
144-2	23175-23176	,	_
144-3	23177-23190	understanding	_
144-4	23191-23194	the	_
144-5	23195-23204	potential	_
144-6	23205-23209	role	_
144-7	23210-23212	of	_
144-8	23213-23216	the	_
144-9	23217-23223	insula	_
144-10	23224-23226	in	_
144-11	23227-23236	addiction	_
144-12	23237-23245	requires	_
144-13	23246-23253	further	_
144-14	23254-23267	investigation	_
144-15	23267-23268	.	_

#Text=The study which reported the association between insular activity and AUD also showed associations of AUD with cue-induced activity in fusiform gyrus, among others.
145-1	23269-23272	The	_
145-2	23273-23278	study	_
145-3	23279-23284	which	_
145-4	23285-23293	reported	_
145-5	23294-23297	the	_
145-6	23298-23309	association	_
145-7	23310-23317	between	_
145-8	23318-23325	insular	_
145-9	23326-23334	activity	_
145-10	23335-23338	and	_
145-11	23339-23342	AUD	_
145-12	23343-23347	also	_
145-13	23348-23354	showed	_
145-14	23355-23367	associations	_
145-15	23368-23370	of	_
145-16	23371-23374	AUD	_
145-17	23375-23379	with	_
145-18	23380-23391	cue-induced	_
145-19	23392-23400	activity	_
145-20	23401-23403	in	_
145-21	23404-23412	fusiform	_
145-22	23413-23418	gyrus	_
145-23	23418-23419	,	_
145-24	23420-23425	among	_
145-25	23426-23432	others	_
145-26	23432-23433	.	_

#Text=In the NKI-RS dataset, we also found a significant negative correlation between right fusiform cortical thickness and neuroticism in AUDs.
146-1	23434-23436	In	_
146-2	23437-23440	the	_
146-3	23441-23447	NKI-RS	_
146-4	23448-23455	dataset	_
146-5	23455-23456	,	_
146-6	23457-23459	we	_
146-7	23460-23464	also	_
146-8	23465-23470	found	_
146-9	23471-23472	a	_
146-10	23473-23484	significant	_
146-11	23485-23493	negative	_
146-12	23494-23505	correlation	_
146-13	23506-23513	between	_
146-14	23514-23519	right	_
146-15	23520-23528	fusiform	_
146-16	23529-23537	cortical	_
146-17	23538-23547	thickness	_
146-18	23548-23551	and	_
146-19	23552-23563	neuroticism	_
146-20	23564-23566	in	_
146-21	23567-23571	AUDs	_
146-22	23571-23572	.	_

#Text=This correlation was non-significantly positive in HCs.
147-1	23573-23577	This	_
147-2	23578-23589	correlation	_
147-3	23590-23593	was	_
147-4	23594-23611	non-significantly	_
147-5	23612-23620	positive	_
147-6	23621-23623	in	_
147-7	23624-23627	HCs	_
147-8	23627-23628	.	_

#Text=The relationship between AUD history and the correlation between neuroticism and right fusiform cortical thickness replicated in the HCP (P =0.041).
148-1	23629-23632	The	_
148-2	23633-23645	relationship	_
148-3	23646-23653	between	_
148-4	23654-23657	AUD	_
148-5	23658-23665	history	_
148-6	23666-23669	and	_
148-7	23670-23673	the	_
148-8	23674-23685	correlation	_
148-9	23686-23693	between	_
148-10	23694-23705	neuroticism	_
148-11	23706-23709	and	_
148-12	23710-23715	right	_
148-13	23716-23724	fusiform	_
148-14	23725-23733	cortical	_
148-15	23734-23743	thickness	_
148-16	23744-23754	replicated	_
148-17	23755-23757	in	_
148-18	23758-23761	the	_
148-19	23762-23765	HCP	_
148-20	23766-23767	(	_
148-21	23767-23768	P	_
148-22	23769-23770	=	_
148-23	23770-23775	0.041	_
148-24	23775-23776	)	_
148-25	23776-23777	.	_

#Text=However, exploratory subgroup analyses did not replicate strictly.
149-1	23778-23785	However	_
149-2	23785-23786	,	_
149-3	23787-23798	exploratory	_
149-4	23799-23807	subgroup	_
149-5	23808-23816	analyses	_
149-6	23817-23820	did	_
149-7	23821-23824	not	_
149-8	23825-23834	replicate	_
149-9	23835-23843	strictly	_
149-10	23843-23844	.	_

#Text=The significant negative neuroticism-right fusiform gyrus correlation in AUDs (P =0.008) in NKI-RS data was not significant (P =0.275) in HCP data.
150-1	23845-23848	The	_
150-2	23849-23860	significant	_
150-3	23861-23869	negative	_
150-4	23870-23887	neuroticism-right	_
150-5	23888-23896	fusiform	_
150-6	23897-23902	gyrus	_
150-7	23903-23914	correlation	_
150-8	23915-23917	in	_
150-9	23918-23922	AUDs	_
150-10	23923-23924	(	_
150-11	23924-23925	P	_
150-12	23926-23927	=	_
150-13	23927-23932	0.008	_
150-14	23932-23933	)	_
150-15	23934-23936	in	_
150-16	23937-23943	NKI-RS	_
150-17	23944-23948	data	_
150-18	23949-23952	was	_
150-19	23953-23956	not	_
150-20	23957-23968	significant	_
150-21	23969-23970	(	_
150-22	23970-23971	P	_
150-23	23972-23973	=	_
150-24	23973-23978	0.275	_
150-25	23978-23979	)	_
150-26	23980-23982	in	_
150-27	23983-23986	HCP	_
150-28	23987-23991	data	_
150-29	23991-23992	.	_

#Text=We interpret this result as broadly but not completely convergent with our NKI-RS finding.
151-1	23993-23995	We	_
151-2	23996-24005	interpret	_
151-3	24006-24010	this	_
151-4	24011-24017	result	_
151-5	24018-24020	as	_
151-6	24021-24028	broadly	_
151-7	24029-24032	but	_
151-8	24033-24036	not	_
151-9	24037-24047	completely	_
151-10	24048-24058	convergent	_
151-11	24059-24063	with	_
151-12	24064-24067	our	_
151-13	24068-24074	NKI-RS	_
151-14	24075-24082	finding	_
151-15	24082-24083	.	_

#Text=Despite the lack of complete replication, prior results implicate the right fusiform in AUD or emotional control.
152-1	24084-24091	Despite	_
152-2	24092-24095	the	_
152-3	24096-24100	lack	_
152-4	24101-24103	of	_
152-5	24104-24112	complete	_
152-6	24113-24124	replication	_
152-7	24124-24125	,	_
152-8	24126-24131	prior	_
152-9	24132-24139	results	_
152-10	24140-24149	implicate	_
152-11	24150-24153	the	_
152-12	24154-24159	right	_
152-13	24160-24168	fusiform	_
152-14	24169-24171	in	_
152-15	24172-24175	AUD	_
152-16	24176-24178	or	_
152-17	24179-24188	emotional	_
152-18	24189-24196	control	_
152-19	24196-24197	.	_

#Text=Right fusiform cortical thickness was recently found to be negatively correlated with lifetime alcohol use in adolescent alcohol users.
153-1	24198-24203	Right	_
153-2	24204-24212	fusiform	_
153-3	24213-24221	cortical	_
153-4	24222-24231	thickness	_
153-5	24232-24235	was	_
153-6	24236-24244	recently	_
153-7	24245-24250	found	_
153-8	24251-24253	to	_
153-9	24254-24256	be	_
153-10	24257-24267	negatively	_
153-11	24268-24278	correlated	_
153-12	24279-24283	with	_
153-13	24284-24292	lifetime	_
153-14	24293-24300	alcohol	_
153-15	24301-24304	use	_
153-16	24305-24307	in	_
153-17	24308-24318	adolescent	_
153-18	24319-24326	alcohol	_
153-19	24327-24332	users	_
153-20	24332-24333	.	_

#Text=Similarly, in subjects with AUD, significant activation in bilateral fusiform gyri correlated with the level of craving to alcohol cues (; Park et al., 2007).
154-1	24334-24343	Similarly	_
154-2	24343-24344	,	_
154-3	24345-24347	in	_
154-4	24348-24356	subjects	_
154-5	24357-24361	with	_
154-6	24362-24365	AUD	_
154-7	24365-24366	,	_
154-8	24367-24378	significant	_
154-9	24379-24389	activation	_
154-10	24390-24392	in	_
154-11	24393-24402	bilateral	_
154-12	24403-24411	fusiform	_
154-13	24412-24416	gyri	_
154-14	24417-24427	correlated	_
154-15	24428-24432	with	_
154-16	24433-24436	the	_
154-17	24437-24442	level	_
154-18	24443-24445	of	_
154-19	24446-24453	craving	_
154-20	24454-24456	to	_
154-21	24457-24464	alcohol	_
154-22	24465-24469	cues	_
154-23	24470-24471	(	_
154-24	24471-24472	;	_
154-25	24473-24477	Park	_
154-26	24478-24480	et	_
154-27	24481-24483	al	_
154-28	24483-24484	.	_
154-29	24484-24485	,	_
154-30	24486-24490	2007	_
154-31	24490-24491	)	_
154-32	24491-24492	.	_

#Text=In addition, the fusiform gyrus has been linked to neural pathways involved in face recognition and responding to emotional faces.
155-1	24493-24495	In	_
155-2	24496-24504	addition	_
155-3	24504-24505	,	_
155-4	24506-24509	the	_
155-5	24510-24518	fusiform	_
155-6	24519-24524	gyrus	_
155-7	24525-24528	has	_
155-8	24529-24533	been	_
155-9	24534-24540	linked	_
155-10	24541-24543	to	_
155-11	24544-24550	neural	_
155-12	24551-24559	pathways	_
155-13	24560-24568	involved	_
155-14	24569-24571	in	_
155-15	24572-24576	face	_
155-16	24577-24588	recognition	_
155-17	24589-24592	and	_
155-18	24593-24603	responding	_
155-19	24604-24606	to	_
155-20	24607-24616	emotional	_
155-21	24617-24622	faces	_
155-22	24622-24623	.	_

#Text=A negative correlation between activation in the right fusiform gyrus and neuroticism during anticipation of visceral pain has also been reported.
156-1	24624-24625	A	_
156-2	24626-24634	negative	_
156-3	24635-24646	correlation	_
156-4	24647-24654	between	_
156-5	24655-24665	activation	_
156-6	24666-24668	in	_
156-7	24669-24672	the	_
156-8	24673-24678	right	_
156-9	24679-24687	fusiform	_
156-10	24688-24693	gyrus	_
156-11	24694-24697	and	_
156-12	24698-24709	neuroticism	_
156-13	24710-24716	during	_
156-14	24717-24729	anticipation	_
156-15	24730-24732	of	_
156-16	24733-24741	visceral	_
156-17	24742-24746	pain	_
156-18	24747-24750	has	_
156-19	24751-24755	also	_
156-20	24756-24760	been	_
156-21	24761-24769	reported	_
156-22	24769-24770	.	_

#Text=Our study has several limitations.
157-1	24771-24774	Our	_
157-2	24775-24780	study	_
157-3	24781-24784	has	_
157-4	24785-24792	several	_
157-5	24793-24804	limitations	_
157-6	24804-24805	.	_

#Text=First, the sample sizes from the NKI-RS (130 subjects) and HCP (214 subjects) datasets are relatively small.
158-1	24806-24811	First	_
158-2	24811-24812	,	_
158-3	24813-24816	the	_
158-4	24817-24823	sample	_
158-5	24824-24829	sizes	_
158-6	24830-24834	from	_
158-7	24835-24838	the	_
158-8	24839-24845	NKI-RS	_
158-9	24846-24847	(	_
158-10	24847-24850	130	_
158-11	24851-24859	subjects	_
158-12	24859-24860	)	_
158-13	24861-24864	and	_
158-14	24865-24868	HCP	_
158-15	24869-24870	(	_
158-16	24870-24873	214	_
158-17	24874-24882	subjects	_
158-18	24882-24883	)	_
158-19	24884-24892	datasets	_
158-20	24893-24896	are	_
158-21	24897-24907	relatively	_
158-22	24908-24913	small	_
158-23	24913-24914	.	_

#Text=These resulted from our matched case-control design, which we adopted to reduce possible confounding.
159-1	24915-24920	These	_
159-2	24921-24929	resulted	_
159-3	24930-24934	from	_
159-4	24935-24938	our	_
159-5	24939-24946	matched	_
159-6	24947-24959	case-control	_
159-7	24960-24966	design	_
159-8	24966-24967	,	_
159-9	24968-24973	which	_
159-10	24974-24976	we	_
159-11	24977-24984	adopted	_
159-12	24985-24987	to	_
159-13	24988-24994	reduce	_
159-14	24995-25003	possible	_
159-15	25004-25015	confounding	_
159-16	25015-25016	.	_

#Text=Second, about 50% of participants with histories of AUDs were comorbid with at least one other psychiatric disorder.
160-1	25017-25023	Second	_
160-2	25023-25024	,	_
160-3	25025-25030	about	_
160-4	25031-25034	50%	_
160-5	25035-25037	of	_
160-6	25038-25050	participants	_
160-7	25051-25055	with	_
160-8	25056-25065	histories	_
160-9	25066-25068	of	_
160-10	25069-25073	AUDs	_
160-11	25074-25078	were	_
160-12	25079-25087	comorbid	_
160-13	25088-25092	with	_
160-14	25093-25095	at	_
160-15	25096-25101	least	_
160-16	25102-25105	one	_
160-17	25106-25111	other	_
160-18	25112-25123	psychiatric	_
160-19	25124-25132	disorder	_
160-20	25132-25133	.	_

#Text=Specifically, 26.2%, 10.8%, 9.2% and 6.1% subjects comorbid with 1, 2, 3, and more than 3 other disorders, respectively (Table 1).
161-1	25134-25146	Specifically	_
161-2	25146-25147	,	_
161-3	25148-25153	26.2%	_
161-4	25153-25154	,	_
161-5	25155-25160	10.8%	_
161-6	25160-25161	,	_
161-7	25162-25166	9.2%	_
161-8	25167-25170	and	_
161-9	25171-25175	6.1%	_
161-10	25176-25184	subjects	_
161-11	25185-25193	comorbid	_
161-12	25194-25198	with	_
161-13	25199-25200	1	_
161-14	25200-25201	,	_
161-15	25202-25203	2	_
161-16	25203-25204	,	_
161-17	25205-25206	3	_
161-18	25206-25207	,	_
161-19	25208-25211	and	_
161-20	25212-25216	more	_
161-21	25217-25221	than	_
161-22	25222-25223	3	_
161-23	25224-25229	other	_
161-24	25230-25239	disorders	_
161-25	25239-25240	,	_
161-26	25241-25253	respectively	_
161-27	25254-25255	(	_
161-28	25255-25260	Table	_
161-29	25261-25262	1	_
161-30	25262-25263	)	_
161-31	25263-25264	.	_

#Text=The top three comorbidities were cannabis use disorder (23.1%), major depressive disorder (21.5%), and cocaine use disorder (12.3%).
162-1	25265-25268	The	_
162-2	25269-25272	top	_
162-3	25273-25278	three	_
162-4	25279-25292	comorbidities	_
162-5	25293-25297	were	_
162-6	25298-25306	cannabis	_
162-7	25307-25310	use	_
162-8	25311-25319	disorder	_
162-9	25320-25321	(	_
162-10	25321-25326	23.1%	_
162-11	25326-25327	)	_
162-12	25327-25328	,	_
162-13	25329-25334	major	_
162-14	25335-25345	depressive	_
162-15	25346-25354	disorder	_
162-16	25355-25356	(	_
162-17	25356-25361	21.5%	_
162-18	25361-25362	)	_
162-19	25362-25363	,	_
162-20	25364-25367	and	_
162-21	25368-25375	cocaine	_
162-22	25376-25379	use	_
162-23	25380-25388	disorder	_
162-24	25389-25390	(	_
162-25	25390-25395	12.3%	_
162-26	25395-25396	)	_
162-27	25396-25397	.	_

#Text=Exploratory analysis, using AUD subjects without other comorbid disorders, revealed that the neuroticism-cortical thickness correlation remained to be negative in both brain regions.
163-1	25398-25409	Exploratory	_
163-2	25410-25418	analysis	_
163-3	25418-25419	,	_
163-4	25420-25425	using	_
163-5	25426-25429	AUD	_
163-6	25430-25438	subjects	_
163-7	25439-25446	without	_
163-8	25447-25452	other	_
163-9	25453-25461	comorbid	_
163-10	25462-25471	disorders	_
163-11	25471-25472	,	_
163-12	25473-25481	revealed	_
163-13	25482-25486	that	_
163-14	25487-25490	the	_
163-15	25491-25511	neuroticism-cortical	_
163-16	25512-25521	thickness	_
163-17	25522-25533	correlation	_
163-18	25534-25542	remained	_
163-19	25543-25545	to	_
163-20	25546-25548	be	_
163-21	25549-25557	negative	_
163-22	25558-25560	in	_
163-23	25561-25565	both	_
163-24	25566-25571	brain	_
163-25	25572-25579	regions	_
163-26	25579-25580	.	_

#Text=However, the relationship was not statistically significant.
164-1	25581-25588	However	_
164-2	25588-25589	,	_
164-3	25590-25593	the	_
164-4	25594-25606	relationship	_
164-5	25607-25610	was	_
164-6	25611-25614	not	_
164-7	25615-25628	statistically	_
164-8	25629-25640	significant	_
164-9	25640-25641	.	_

#Text=Therefore, the effect of comorbid psychiatric disorders on the cortical thickness-neuroticism relationship warrants further investigation in a larger study.
165-1	25642-25651	Therefore	_
165-2	25651-25652	,	_
165-3	25653-25656	the	_
165-4	25657-25663	effect	_
165-5	25664-25666	of	_
165-6	25667-25675	comorbid	_
165-7	25676-25687	psychiatric	_
165-8	25688-25697	disorders	_
165-9	25698-25700	on	_
165-10	25701-25704	the	_
165-11	25705-25713	cortical	_
165-12	25714-25735	thickness-neuroticism	_
165-13	25736-25748	relationship	_
165-14	25749-25757	warrants	_
165-15	25758-25765	further	_
165-16	25766-25779	investigation	_
165-17	25780-25782	in	_
165-18	25783-25784	a	_
165-19	25785-25791	larger	_
165-20	25792-25797	study	_
165-21	25797-25798	.	_

#Text=Third, the insula cortex finding was replicated in an independent data set, but the subgroup analysis of fusiform result did not strictly replicate.
166-1	25799-25804	Third	_
166-2	25804-25805	,	_
166-3	25806-25809	the	_
166-4	25810-25816	insula	_
166-5	25817-25823	cortex	_
166-6	25824-25831	finding	_
166-7	25832-25835	was	_
166-8	25836-25846	replicated	_
166-9	25847-25849	in	_
166-10	25850-25852	an	_
166-11	25853-25864	independent	_
166-12	25865-25869	data	_
166-13	25870-25873	set	_
166-14	25873-25874	,	_
166-15	25875-25878	but	_
166-16	25879-25882	the	_
166-17	25883-25891	subgroup	_
166-18	25892-25900	analysis	_
166-19	25901-25903	of	_
166-20	25904-25912	fusiform	_
166-21	25913-25919	result	_
166-22	25920-25923	did	_
166-23	25924-25927	not	_
166-24	25928-25936	strictly	_
166-25	25937-25946	replicate	_
166-26	25946-25947	.	_

#Text=Thus, the complex relationship among cortical thickness, neuroticism, and AUD status in the fusiform must be interpreted as preliminary.
167-1	25948-25952	Thus	_
167-2	25952-25953	,	_
167-3	25954-25957	the	_
167-4	25958-25965	complex	_
167-5	25966-25978	relationship	_
167-6	25979-25984	among	_
167-7	25985-25993	cortical	_
167-8	25994-26003	thickness	_
167-9	26003-26004	,	_
167-10	26005-26016	neuroticism	_
167-11	26016-26017	,	_
167-12	26018-26021	and	_
167-13	26022-26025	AUD	_
167-14	26026-26032	status	_
167-15	26033-26035	in	_
167-16	26036-26039	the	_
167-17	26040-26048	fusiform	_
167-18	26049-26053	must	_
167-19	26054-26056	be	_
167-20	26057-26068	interpreted	_
167-21	26069-26071	as	_
167-22	26072-26083	preliminary	_
167-23	26083-26084	.	_

#Text=Fourth, our findings do not address cause-effect relationships.
168-1	26085-26091	Fourth	_
168-2	26091-26092	,	_
168-3	26093-26096	our	_
168-4	26097-26105	findings	_
168-5	26106-26108	do	_
168-6	26109-26112	not	_
168-7	26113-26120	address	_
168-8	26121-26133	cause-effect	_
168-9	26134-26147	relationships	_
168-10	26147-26148	.	_

#Text=Clearly, well-controlled longitudinal studies are needed to delineate the potential causative factors involved in neuroticism and AUD development.
169-1	26149-26156	Clearly	_
169-2	26156-26157	,	_
169-3	26158-26173	well-controlled	_
169-4	26174-26186	longitudinal	_
169-5	26187-26194	studies	_
169-6	26195-26198	are	_
169-7	26199-26205	needed	_
169-8	26206-26208	to	_
169-9	26209-26218	delineate	_
169-10	26219-26222	the	_
169-11	26223-26232	potential	_
169-12	26233-26242	causative	_
169-13	26243-26250	factors	_
169-14	26251-26259	involved	_
169-15	26260-26262	in	_
169-16	26263-26274	neuroticism	_
169-17	26275-26278	and	_
169-18	26279-26282	AUD	_
169-19	26283-26294	development	_
169-20	26294-26295	.	_

#Text=In conclusion, as a first step towards the dissection of the complex relationship among AUD, neuroticism and brain structure, we used a novel machine learning tool to analyze data from two community-based samples.
170-1	26296-26298	In	_
170-2	26299-26309	conclusion	_
170-3	26309-26310	,	_
170-4	26311-26313	as	_
170-5	26314-26315	a	_
170-6	26316-26321	first	_
170-7	26322-26326	step	_
170-8	26327-26334	towards	_
170-9	26335-26338	the	_
170-10	26339-26349	dissection	_
170-11	26350-26352	of	_
170-12	26353-26356	the	_
170-13	26357-26364	complex	_
170-14	26365-26377	relationship	_
170-15	26378-26383	among	_
170-16	26384-26387	AUD	_
170-17	26387-26388	,	_
170-18	26389-26400	neuroticism	_
170-19	26401-26404	and	_
170-20	26405-26410	brain	_
170-21	26411-26420	structure	_
170-22	26420-26421	,	_
170-23	26422-26424	we	_
170-24	26425-26429	used	_
170-25	26430-26431	a	_
170-26	26432-26437	novel	_
170-27	26438-26445	machine	_
170-28	26446-26454	learning	_
170-29	26455-26459	tool	_
170-30	26460-26462	to	_
170-31	26463-26470	analyze	_
170-32	26471-26475	data	_
170-33	26476-26480	from	_
170-34	26481-26484	two	_
170-35	26485-26500	community-based	_
170-36	26501-26508	samples	_
170-37	26508-26509	.	_

#Text=Our results suggest that neuroticism is related to AUD status, which affects the correlation of neuroticism with cortical thickness in the left posterior insula and right fusiform gyrus in both NKI-RS and HCP data sets.
171-1	26510-26513	Our	_
171-2	26514-26521	results	_
171-3	26522-26529	suggest	_
171-4	26530-26534	that	_
171-5	26535-26546	neuroticism	_
171-6	26547-26549	is	_
171-7	26550-26557	related	_
171-8	26558-26560	to	_
171-9	26561-26564	AUD	_
171-10	26565-26571	status	_
171-11	26571-26572	,	_
171-12	26573-26578	which	_
171-13	26579-26586	affects	_
171-14	26587-26590	the	_
171-15	26591-26602	correlation	_
171-16	26603-26605	of	_
171-17	26606-26617	neuroticism	_
171-18	26618-26622	with	_
171-19	26623-26631	cortical	_
171-20	26632-26641	thickness	_
171-21	26642-26644	in	_
171-22	26645-26648	the	_
171-23	26649-26653	left	_
171-24	26654-26663	posterior	_
171-25	26664-26670	insula	_
171-26	26671-26674	and	_
171-27	26675-26680	right	_
171-28	26681-26689	fusiform	_
171-29	26690-26695	gyrus	_
171-30	26696-26698	in	_
171-31	26699-26703	both	_
171-32	26704-26710	NKI-RS	_
171-33	26711-26714	and	_
171-34	26715-26718	HCP	_
171-35	26719-26723	data	_
171-36	26724-26728	sets	_
171-37	26728-26729	.	_

#Text=Future work on the dissection of the mechanisms underlying AUD-neuroticism interactions will provide further insights into the relationship between specific brain loci, AUD and neuroticism, which may contribute to the development of more effective strategies for preventing and treating AUD.
172-1	26730-26736	Future	_
172-2	26737-26741	work	_
172-3	26742-26744	on	_
172-4	26745-26748	the	_
172-5	26749-26759	dissection	_
172-6	26760-26762	of	_
172-7	26763-26766	the	_
172-8	26767-26777	mechanisms	_
172-9	26778-26788	underlying	_
172-10	26789-26804	AUD-neuroticism	_
172-11	26805-26817	interactions	_
172-12	26818-26822	will	_
172-13	26823-26830	provide	_
172-14	26831-26838	further	_
172-15	26839-26847	insights	_
172-16	26848-26852	into	_
172-17	26853-26856	the	_
172-18	26857-26869	relationship	_
172-19	26870-26877	between	_
172-20	26878-26886	specific	_
172-21	26887-26892	brain	_
172-22	26893-26897	loci	_
172-23	26897-26898	,	_
172-24	26899-26902	AUD	_
172-25	26903-26906	and	_
172-26	26907-26918	neuroticism	_
172-27	26918-26919	,	_
172-28	26920-26925	which	_
172-29	26926-26929	may	_
172-30	26930-26940	contribute	_
172-31	26941-26943	to	_
172-32	26944-26947	the	_
172-33	26948-26959	development	_
172-34	26960-26962	of	_
172-35	26963-26967	more	_
172-36	26968-26977	effective	_
172-37	26978-26988	strategies	_
172-38	26989-26992	for	_
172-39	26993-27003	preventing	_
172-40	27004-27007	and	_
172-41	27008-27016	treating	_
172-42	27017-27020	AUD	_
172-43	27020-27021	.	_

#Text=Supplementary Material
#Text=Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org and by entering doi:...
173-1	27022-27035	Supplementary	_
173-2	27036-27044	Material	_
173-3	27045-27058	Supplementary	_
173-4	27059-27067	material	_
173-5	27068-27071	can	_
173-6	27072-27074	be	_
173-7	27075-27080	found	_
173-8	27081-27083	by	_
173-9	27084-27093	accessing	_
173-10	27094-27097	the	_
173-11	27098-27104	online	_
173-12	27105-27112	version	_
173-13	27113-27115	of	_
173-14	27116-27120	this	_
173-15	27121-27126	paper	_
173-16	27127-27129	at	_
173-17	27130-27134	http	_
173-18	27134-27135	:	_
173-19	27135-27136	/	_
173-20	27136-27137	/	_
173-21	27137-27147	dx.doi.org	_
173-22	27148-27151	and	_
173-23	27152-27154	by	_
173-24	27155-27163	entering	_
173-25	27164-27167	doi	_
173-26	27167-27168	:	_
173-27	27168-27169	.	_
173-28	27169-27170	.	_
173-29	27170-27171	.	_

#Text=Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org and by entering doi:...
174-1	27172-27185	Supplementary	_
174-2	27186-27194	material	_
174-3	27195-27198	can	_
174-4	27199-27201	be	_
174-5	27202-27207	found	_
174-6	27208-27210	by	_
174-7	27211-27220	accessing	_
174-8	27221-27224	the	_
174-9	27225-27231	online	_
174-10	27232-27239	version	_
174-11	27240-27242	of	_
174-12	27243-27247	this	_
174-13	27248-27253	paper	_
174-14	27254-27256	at	_
174-15	27257-27261	http	_
174-16	27261-27262	:	_
174-17	27262-27263	/	_
174-18	27263-27264	/	_
174-19	27264-27274	dx.doi.org	_
174-20	27275-27278	and	_
174-21	27279-27281	by	_
174-22	27282-27290	entering	_
174-23	27291-27294	doi	_
174-24	27294-27295	:	_
174-25	27295-27296	.	_
174-26	27296-27297	.	_
174-27	27297-27298	.	_

#Text=Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org and by entering doi:...
175-1	27299-27312	Supplementary	_
175-2	27313-27321	material	_
175-3	27322-27325	can	_
175-4	27326-27328	be	_
175-5	27329-27334	found	_
175-6	27335-27337	by	_
175-7	27338-27347	accessing	_
175-8	27348-27351	the	_
175-9	27352-27358	online	_
175-10	27359-27366	version	_
175-11	27367-27369	of	_
175-12	27370-27374	this	_
175-13	27375-27380	paper	_
175-14	27381-27383	at	_
175-15	27384-27388	http	_
175-16	27388-27389	:	_
175-17	27389-27390	/	_
175-18	27390-27391	/	_
175-19	27391-27401	dx.doi.org	_
175-20	27402-27405	and	_
175-21	27406-27408	by	_
175-22	27409-27417	entering	_
175-23	27418-27421	doi	_
175-24	27421-27422	:	_
175-25	27422-27423	.	_
175-26	27423-27424	.	_
175-27	27424-27425	.	_

#Text=Conflict of interest
#Text=The authors declared no conflicts of interest related to this research.
176-1	27437-27445	Conflict	_
176-2	27446-27448	of	_
176-3	27449-27457	interest	_
176-4	27467-27470	The	_
176-5	27471-27478	authors	_
176-6	27479-27487	declared	_
176-7	27488-27490	no	_
176-8	27491-27500	conflicts	_
176-9	27501-27503	of	_
176-10	27504-27512	interest	_
176-11	27513-27520	related	_
176-12	27521-27523	to	_
176-13	27524-27528	this	_
176-14	27529-27537	research	_
176-15	27537-27538	.	_

#Text=Contributors
#Text=Author YZ processed and analyzed the imaging and personality data, interpreted the results and wrote the manuscript.
177-1	27550-27562	Contributors	_
177-2	27572-27578	Author	_
177-3	27579-27581	YZ	_
177-4	27582-27591	processed	_
177-5	27592-27595	and	_
177-6	27596-27604	analyzed	_
177-7	27605-27608	the	_
177-8	27609-27616	imaging	_
177-9	27617-27620	and	_
177-10	27621-27632	personality	_
177-11	27633-27637	data	_
177-12	27637-27638	,	_
177-13	27639-27650	interpreted	_
177-14	27651-27654	the	_
177-15	27655-27662	results	_
177-16	27663-27666	and	_
177-17	27667-27672	wrote	_
177-18	27673-27676	the	_
177-19	27677-27687	manuscript	_
177-20	27687-27688	.	_

#Text=ZLZ interpreted results and wrote the manuscript.
178-1	27689-27692	ZLZ	_
178-2	27693-27704	interpreted	_
178-3	27705-27712	results	_
178-4	27713-27716	and	_
178-5	27717-27722	wrote	_
178-6	27723-27726	the	_
178-7	27727-27737	manuscript	_
178-8	27737-27738	.	_

#Text=FXC provided expertise in data interpretation and revised the manuscript.
179-1	27739-27742	FXC	_
179-2	27743-27751	provided	_
179-3	27752-27761	expertise	_
179-4	27762-27764	in	_
179-5	27765-27769	data	_
179-6	27770-27784	interpretation	_
179-7	27785-27788	and	_
179-8	27789-27796	revised	_
179-9	27797-27800	the	_
179-10	27801-27811	manuscript	_
179-11	27811-27812	.	_

#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
180-1	27813-27817	This	_
180-2	27818-27820	is	_
180-3	27821-27822	a	_
180-4	27823-27826	PDF	_
180-5	27827-27831	file	_
180-6	27832-27834	of	_
180-7	27835-27837	an	_
180-8	27838-27846	unedited	_
180-9	27847-27857	manuscript	_
180-10	27858-27862	that	_
180-11	27863-27866	has	_
180-12	27867-27871	been	_
180-13	27872-27880	accepted	_
180-14	27881-27884	for	_
180-15	27885-27896	publication	_
180-16	27896-27897	.	_

#Text=As a service to our customers we are providing this early version of the manuscript.
181-1	27898-27900	As	_
181-2	27901-27902	a	_
181-3	27903-27910	service	_
181-4	27911-27913	to	_
181-5	27914-27917	our	_
181-6	27918-27927	customers	_
181-7	27928-27930	we	_
181-8	27931-27934	are	_
181-9	27935-27944	providing	_
181-10	27945-27949	this	_
181-11	27950-27955	early	_
181-12	27956-27963	version	_
181-13	27964-27966	of	_
181-14	27967-27970	the	_
181-15	27971-27981	manuscript	_
181-16	27981-27982	.	_

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
182-1	27983-27986	The	_
182-2	27987-27997	manuscript	_
182-3	27998-28002	will	_
182-4	28003-28010	undergo	_
182-5	28011-28022	copyediting	_
182-6	28022-28023	,	_
182-7	28024-28035	typesetting	_
182-8	28035-28036	,	_
182-9	28037-28040	and	_
182-10	28041-28047	review	_
182-11	28048-28050	of	_
182-12	28051-28054	the	_
182-13	28055-28064	resulting	_
182-14	28065-28070	proof	_
182-15	28071-28077	before	_
182-16	28078-28080	it	_
182-17	28081-28083	is	_
182-18	28084-28093	published	_
182-19	28094-28096	in	_
182-20	28097-28100	its	_
182-21	28101-28106	final	_
182-22	28107-28114	citable	_
182-23	28115-28119	form	_
182-24	28119-28120	.	_

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
183-1	28121-28127	Please	_
183-2	28128-28132	note	_
183-3	28133-28137	that	_
183-4	28138-28144	during	_
183-5	28145-28148	the	_
183-6	28149-28159	production	_
183-7	28160-28167	process	_
183-8	28168-28174	errors	_
183-9	28175-28178	may	_
183-10	28179-28181	be	_
183-11	28182-28192	discovered	_
183-12	28193-28198	which	_
183-13	28199-28204	could	_
183-14	28205-28211	affect	_
183-15	28212-28215	the	_
183-16	28216-28223	content	_
183-17	28223-28224	,	_
183-18	28225-28228	and	_
183-19	28229-28232	all	_
183-20	28233-28238	legal	_
183-21	28239-28250	disclaimers	_
183-22	28251-28255	that	_
183-23	28256-28261	apply	_
183-24	28262-28264	to	_
183-25	28265-28268	the	_
183-26	28269-28276	journal	_
183-27	28277-28284	pertain	_
183-28	28284-28285	.	_

#Text=Personality is reflected in the brain's intrinsic functional architecture
#Text=Controlling the false discovery rate: a practical and powerful approach to multiple testing
#Text=Involvement of the spino-parabrachio-amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain
#Text=Neuronal correlates of the five factor model (FFM) of human personality: multimodal imaging in a large healthy sample
#Text=Alcohol and the human brain: a systematic review of different neuroimaging methods
#Text=Boosting for high-dimensional linear models
#Text=Identifying neurobiological phenotypes associated with alcohol use disorder severity
#Text=Childhood personality predicts alcohol abuse in young adults
#Text=Neuroticism influences brain activity during the experience of visceral pain
#Text=Emotional processing and brain activity in youth at high risk for alcoholism
#Text=An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
#Text=Testing predictions from personality neuroscience
#Text=Revisiting the role of the insula in addiction
#Text=Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence
#Text=Alcohol dependence as a chronic pain disorder
#Text=Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain
#Text=Automatically parcellating the human cerebral cortex
#Text=Personality
#Text=Personality and alcohol consumption: pooled analysis of 72,949 adults from eight cohort studies
#Text=Relationship between personality change and the onset and course of alcohol dependence in young adulthood
#Text=Neural activity of the anterior insula in emotional processing depends on the individuals' emotional susceptibility
#Text=Cortical thickness in adolescent marijuana and alcohol users: a three-year prospective study from adolescence to young adulthood
#Text=Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies
#Text=Medication treatment of different types of alcoholism
#Text=The five factors of personality and regional cortical variability in the Baltimore longitudinal study of aging
#Text=Neural correlates of personality: an integrative review
#Text=Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment
#Text=The Big Five of Personality and structural imaging revisited: a VBM - DARTEL study
#Text=Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
184-1	28286-28297	Personality	_
184-2	28298-28300	is	_
184-3	28301-28310	reflected	_
184-4	28311-28313	in	_
184-5	28314-28317	the	_
184-6	28318-28325	brain's	_
184-7	28326-28335	intrinsic	_
184-8	28336-28346	functional	_
184-9	28347-28359	architecture	_
184-10	28360-28371	Controlling	_
184-11	28372-28375	the	_
184-12	28376-28381	false	_
184-13	28382-28391	discovery	_
184-14	28392-28396	rate	_
184-15	28396-28397	:	_
184-16	28398-28399	a	_
184-17	28400-28409	practical	_
184-18	28410-28413	and	_
184-19	28414-28422	powerful	_
184-20	28423-28431	approach	_
184-21	28432-28434	to	_
184-22	28435-28443	multiple	_
184-23	28444-28451	testing	_
184-24	28452-28463	Involvement	_
184-25	28464-28466	of	_
184-26	28467-28470	the	_
184-27	28471-28499	spino-parabrachio-amygdaloid	_
184-28	28500-28503	and	_
184-29	28504-28505	-	_
184-30	28505-28517	hypothalamic	_
184-31	28518-28526	pathways	_
184-32	28527-28529	in	_
184-33	28530-28533	the	_
184-34	28534-28543	autonomic	_
184-35	28544-28547	and	_
184-36	28548-28557	affective	_
184-37	28558-28567	emotional	_
184-38	28568-28575	aspects	_
184-39	28576-28578	of	_
184-40	28579-28583	pain	_
184-41	28584-28592	Neuronal	_
184-42	28593-28603	correlates	_
184-43	28604-28606	of	_
184-44	28607-28610	the	_
184-45	28611-28615	five	_
184-46	28616-28622	factor	_
184-47	28623-28628	model	_
184-48	28629-28630	(	_
184-49	28630-28633	FFM	_
184-50	28633-28634	)	_
184-51	28635-28637	of	_
184-52	28638-28643	human	_
184-53	28644-28655	personality	_
184-54	28655-28656	:	_
184-55	28657-28667	multimodal	_
184-56	28668-28675	imaging	_
184-57	28676-28678	in	_
184-58	28679-28680	a	_
184-59	28681-28686	large	_
184-60	28687-28694	healthy	_
184-61	28695-28701	sample	_
184-62	28702-28709	Alcohol	_
184-63	28710-28713	and	_
184-64	28714-28717	the	_
184-65	28718-28723	human	_
184-66	28724-28729	brain	_
184-67	28729-28730	:	_
184-68	28731-28732	a	_
184-69	28733-28743	systematic	_
184-70	28744-28750	review	_
184-71	28751-28753	of	_
184-72	28754-28763	different	_
184-73	28764-28776	neuroimaging	_
184-74	28777-28784	methods	_
184-75	28785-28793	Boosting	_
184-76	28794-28797	for	_
184-77	28798-28814	high-dimensional	_
184-78	28815-28821	linear	_
184-79	28822-28828	models	_
184-80	28829-28840	Identifying	_
184-81	28841-28856	neurobiological	_
184-82	28857-28867	phenotypes	_
184-83	28868-28878	associated	_
184-84	28879-28883	with	_
184-85	28884-28891	alcohol	_
184-86	28892-28895	use	_
184-87	28896-28904	disorder	_
184-88	28905-28913	severity	_
184-89	28914-28923	Childhood	_
184-90	28924-28935	personality	_
184-91	28936-28944	predicts	_
184-92	28945-28952	alcohol	_
184-93	28953-28958	abuse	_
184-94	28959-28961	in	_
184-95	28962-28967	young	_
184-96	28968-28974	adults	_
184-97	28975-28986	Neuroticism	_
184-98	28987-28997	influences	_
184-99	28998-29003	brain	_
184-100	29004-29012	activity	_
184-101	29013-29019	during	_
184-102	29020-29023	the	_
184-103	29024-29034	experience	_
184-104	29035-29037	of	_
184-105	29038-29046	visceral	_
184-106	29047-29051	pain	_
184-107	29052-29061	Emotional	_
184-108	29062-29072	processing	_
184-109	29073-29076	and	_
184-110	29077-29082	brain	_
184-111	29083-29091	activity	_
184-112	29092-29094	in	_
184-113	29095-29100	youth	_
184-114	29101-29103	at	_
184-115	29104-29108	high	_
184-116	29109-29113	risk	_
184-117	29114-29117	for	_
184-118	29118-29128	alcoholism	_
184-119	29129-29131	An	_
184-120	29132-29141	automated	_
184-121	29142-29150	labeling	_
184-122	29151-29157	system	_
184-123	29158-29161	for	_
184-124	29162-29173	subdividing	_
184-125	29174-29177	the	_
184-126	29178-29183	human	_
184-127	29184-29192	cerebral	_
184-128	29193-29199	cortex	_
184-129	29200-29202	on	_
184-130	29203-29206	MRI	_
184-131	29207-29212	scans	_
184-132	29213-29217	into	_
184-133	29218-29223	gyral	_
184-134	29224-29229	based	_
184-135	29230-29237	regions	_
184-136	29238-29240	of	_
184-137	29241-29249	interest	_
184-138	29250-29257	Testing	_
184-139	29258-29269	predictions	_
184-140	29270-29274	from	_
184-141	29275-29286	personality	_
184-142	29287-29299	neuroscience	_
184-143	29300-29310	Revisiting	_
184-144	29311-29314	the	_
184-145	29315-29319	role	_
184-146	29320-29322	of	_
184-147	29323-29326	the	_
184-148	29327-29333	insula	_
184-149	29334-29336	in	_
184-150	29337-29346	addiction	_
184-151	29347-29355	Cortical	_
184-152	29356-29365	thickness	_
184-153	29365-29366	,	_
184-154	29367-29374	surface	_
184-155	29375-29379	area	_
184-156	29379-29380	,	_
184-157	29381-29384	and	_
184-158	29385-29391	volume	_
184-159	29392-29394	of	_
184-160	29395-29398	the	_
184-161	29399-29404	brain	_
184-162	29405-29411	reward	_
184-163	29412-29418	system	_
184-164	29419-29421	in	_
184-165	29422-29429	alcohol	_
184-166	29430-29440	dependence	_
184-167	29440-29441	:	_
184-168	29442-29455	relationships	_
184-169	29456-29458	to	_
184-170	29459-29466	relapse	_
184-171	29467-29470	and	_
184-172	29471-29479	extended	_
184-173	29480-29490	abstinence	_
184-174	29491-29498	Alcohol	_
184-175	29499-29509	dependence	_
184-176	29510-29512	as	_
184-177	29513-29514	a	_
184-178	29515-29522	chronic	_
184-179	29523-29527	pain	_
184-180	29528-29536	disorder	_
184-181	29537-29542	Whole	_
184-182	29543-29548	brain	_
184-183	29549-29561	segmentation	_
184-184	29561-29562	:	_
184-185	29563-29572	automated	_
184-186	29573-29581	labeling	_
184-187	29582-29584	of	_
184-188	29585-29600	neuroanatomical	_
184-189	29601-29611	structures	_
184-190	29612-29614	in	_
184-191	29615-29618	the	_
184-192	29619-29624	human	_
184-193	29625-29630	brain	_
184-194	29631-29644	Automatically	_
184-195	29645-29657	parcellating	_
184-196	29658-29661	the	_
184-197	29662-29667	human	_
184-198	29668-29676	cerebral	_
184-199	29677-29683	cortex	_
184-200	29684-29695	Personality	_
184-201	29696-29707	Personality	_
184-202	29708-29711	and	_
184-203	29712-29719	alcohol	_
184-204	29720-29731	consumption	_
184-205	29731-29732	:	_
184-206	29733-29739	pooled	_
184-207	29740-29748	analysis	_
184-208	29749-29751	of	_
184-209	29752-29758	72,949	_
184-210	29759-29765	adults	_
184-211	29766-29770	from	_
184-212	29771-29776	eight	_
184-213	29777-29783	cohort	_
184-214	29784-29791	studies	_
184-215	29792-29804	Relationship	_
184-216	29805-29812	between	_
184-217	29813-29824	personality	_
184-218	29825-29831	change	_
184-219	29832-29835	and	_
184-220	29836-29839	the	_
184-221	29840-29845	onset	_
184-222	29846-29849	and	_
184-223	29850-29856	course	_
184-224	29857-29859	of	_
184-225	29860-29867	alcohol	_
184-226	29868-29878	dependence	_
184-227	29879-29881	in	_
184-228	29882-29887	young	_
184-229	29888-29897	adulthood	_
184-230	29898-29904	Neural	_
184-231	29905-29913	activity	_
184-232	29914-29916	of	_
184-233	29917-29920	the	_
184-234	29921-29929	anterior	_
184-235	29930-29936	insula	_
184-236	29937-29939	in	_
184-237	29940-29949	emotional	_
184-238	29950-29960	processing	_
184-239	29961-29968	depends	_
184-240	29969-29971	on	_
184-241	29972-29975	the	_
184-242	29976-29987	individuals	_
184-243	29987-29988	'	_
184-244	29989-29998	emotional	_
184-245	29999-30013	susceptibility	_
184-246	30014-30022	Cortical	_
184-247	30023-30032	thickness	_
184-248	30033-30035	in	_
184-249	30036-30046	adolescent	_
184-250	30047-30056	marijuana	_
184-251	30057-30060	and	_
184-252	30061-30068	alcohol	_
184-253	30069-30074	users	_
184-254	30074-30075	:	_
184-255	30076-30077	a	_
184-256	30078-30088	three-year	_
184-257	30089-30100	prospective	_
184-258	30101-30106	study	_
184-259	30107-30111	from	_
184-260	30112-30123	adolescence	_
184-261	30124-30126	to	_
184-262	30127-30132	young	_
184-263	30133-30142	adulthood	_
184-264	30143-30150	Factors	_
184-265	30151-30161	modulating	_
184-266	30162-30168	neural	_
184-267	30169-30179	reactivity	_
184-268	30180-30182	to	_
184-269	30183-30187	drug	_
184-270	30188-30192	cues	_
184-271	30193-30195	in	_
184-272	30196-30205	addiction	_
184-273	30205-30206	:	_
184-274	30207-30208	a	_
184-275	30209-30215	survey	_
184-276	30216-30218	of	_
184-277	30219-30224	human	_
184-278	30225-30237	neuroimaging	_
184-279	30238-30245	studies	_
184-280	30246-30256	Medication	_
184-281	30257-30266	treatment	_
184-282	30267-30269	of	_
184-283	30270-30279	different	_
184-284	30280-30285	types	_
184-285	30286-30288	of	_
184-286	30289-30299	alcoholism	_
184-287	30300-30303	The	_
184-288	30304-30308	five	_
184-289	30309-30316	factors	_
184-290	30317-30319	of	_
184-291	30320-30331	personality	_
184-292	30332-30335	and	_
184-293	30336-30344	regional	_
184-294	30345-30353	cortical	_
184-295	30354-30365	variability	_
184-296	30366-30368	in	_
184-297	30369-30372	the	_
184-298	30373-30382	Baltimore	_
184-299	30383-30395	longitudinal	_
184-300	30396-30401	study	_
184-301	30402-30404	of	_
184-302	30405-30410	aging	_
184-303	30411-30417	Neural	_
184-304	30418-30428	correlates	_
184-305	30429-30431	of	_
184-306	30432-30443	personality	_
184-307	30443-30444	:	_
184-308	30445-30447	an	_
184-309	30448-30459	integrative	_
184-310	30460-30466	review	_
184-311	30467-30480	Heterogeneity	_
184-312	30481-30483	of	_
184-313	30484-30491	alcohol	_
184-314	30492-30495	use	_
184-315	30496-30504	disorder	_
184-316	30504-30505	:	_
184-317	30506-30519	understanding	_
184-318	30520-30530	mechanisms	_
184-319	30531-30533	to	_
184-320	30534-30541	advance	_
184-321	30542-30554	personalized	_
184-322	30555-30564	treatment	_
184-323	30565-30568	The	_
184-324	30569-30572	Big	_
184-325	30573-30577	Five	_
184-326	30578-30580	of	_
184-327	30581-30592	Personality	_
184-328	30593-30596	and	_
184-329	30597-30607	structural	_
184-330	30608-30615	imaging	_
184-331	30616-30625	revisited	_
184-332	30625-30626	:	_
184-333	30627-30628	a	_
184-334	30629-30632	VBM	_
184-335	30633-30634	-	_
184-336	30635-30641	DARTEL	_
184-337	30642-30647	study	_
184-338	30648-30656	Cortical	_
184-339	30657-30666	thickness	_
184-340	30667-30680	abnormalities	_
184-341	30681-30683	in	_
184-342	30684-30691	cocaine	_
184-343	30692-30701	addiction	_
184-344	30701-30702	-	_
184-345	30702-30703	-	_
184-346	30703-30704	a	_
184-347	30705-30715	reflection	_
184-348	30716-30718	of	_
184-349	30719-30723	both	_
184-350	30724-30728	drug	_
184-351	30729-30732	use	_
184-352	30733-30736	and	_
184-353	30737-30738	a	_
184-354	30739-30751	pre-existing	_
184-355	30752-30763	disposition	_
184-356	30764-30766	to	_
184-357	30767-30771	drug	_
184-358	30772-30777	abuse	_
184-359	30777-30778	?	_

#Text=Precuneus shares intrinsic functional architecture in humans and monkeys
#Text=Family history of alcoholism, alcohol use disorders and the five- factor model of personality
#Text=A contemplated revision of the NEO Five-Factor Inventory
#Text=Insular activity during passive viewing of aversive stimuli reflects individual differences in state negative affect
#Text=Personality traits and global self-esteem of alcohol addicts
#Text=White matter volume in alcohol use disorders: a meta-analysis
#Text=Dissecting the genetic architecture of human personality
#Text=The hidden island of addiction: the insula
#Text=Damage to the insula disrupts addiction to cigarette smoking
#Text=The NKI-Rockland sample: a model for accelerating the pace of discovery science in psychiatry
#Text=The biological and psychological basis of neuroticism: current status and future directions
#Text=Alcohol: effects on neurobehavioral functions and the brain
#Text=Representation of pain and somatic sensation in the human insula: a study of responses to direct electrical cortical stimulation
#Text=Brain substrates of craving to alcohol cues in subjects with alcohol use disorder
#Text=Analgesic effects of ethanol are influenced by family history of alcoholism and neuroticism
#Text=Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism
#Text=The Big Five default brain: functional evidence
#Text=Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review
#Text=How acute and chronic alcohol consumption affects brain networks: insights from multimodal neuroimaging
#Text=The dorsal posterior insula subserves a fundamental role in human pain
#Text=Neuroticism and the brain: a quantitative meta-analysis of neuroimaging studies investigating emotion processing
#Text=Anxiety positive subjects show altered processing in the anterior insula during anticipation of negative stimuli
#Text=Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals
#Text=The WU-Minn Human Connectome Project: an overview
#Text=Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism
#Text=Interhemispheric insular and inferior frontal connectivity are associated with substance abuse in a psychiatric population
#Text=Brain structure in adolescents and young adults with alcohol problems: systematic review of imaging studies
#Text=The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility
#Text=Neuroanatomical correlates of extraversion and neuroticism
#Text=Regional gray matter deficits in alcohol dependence: a meta-analysis of voxel-based morphometry studies
#Text=Clinical and pathological features of alcohol- related brain damage
#Text=Interrelations between pain and alcohol: an integrative review
#Text=Annual Research Review: Discovery science strategies in studies of the pathophysiology of child and adolescent psychiatric disorders - promises and limitations
#Text=Correlation of brain cortical thickness with neuroticism
#Text=(A) Left insula cortex thickness.
185-1	30779-30788	Precuneus	_
185-2	30789-30795	shares	_
185-3	30796-30805	intrinsic	_
185-4	30806-30816	functional	_
185-5	30817-30829	architecture	_
185-6	30830-30832	in	_
185-7	30833-30839	humans	_
185-8	30840-30843	and	_
185-9	30844-30851	monkeys	_
185-10	30852-30858	Family	_
185-11	30859-30866	history	_
185-12	30867-30869	of	_
185-13	30870-30880	alcoholism	_
185-14	30880-30881	,	_
185-15	30882-30889	alcohol	_
185-16	30890-30893	use	_
185-17	30894-30903	disorders	_
185-18	30904-30907	and	_
185-19	30908-30911	the	_
185-20	30912-30916	five	_
185-21	30916-30917	-	_
185-22	30918-30924	factor	_
185-23	30925-30930	model	_
185-24	30931-30933	of	_
185-25	30934-30945	personality	_
185-26	30946-30947	A	_
185-27	30948-30960	contemplated	_
185-28	30961-30969	revision	_
185-29	30970-30972	of	_
185-30	30973-30976	the	_
185-31	30977-30980	NEO	_
185-32	30981-30992	Five-Factor	_
185-33	30993-31002	Inventory	_
185-34	31003-31010	Insular	_
185-35	31011-31019	activity	_
185-36	31020-31026	during	_
185-37	31027-31034	passive	_
185-38	31035-31042	viewing	_
185-39	31043-31045	of	_
185-40	31046-31054	aversive	_
185-41	31055-31062	stimuli	_
185-42	31063-31071	reflects	_
185-43	31072-31082	individual	_
185-44	31083-31094	differences	_
185-45	31095-31097	in	_
185-46	31098-31103	state	_
185-47	31104-31112	negative	_
185-48	31113-31119	affect	_
185-49	31120-31131	Personality	_
185-50	31132-31138	traits	_
185-51	31139-31142	and	_
185-52	31143-31149	global	_
185-53	31150-31161	self-esteem	_
185-54	31162-31164	of	_
185-55	31165-31172	alcohol	_
185-56	31173-31180	addicts	_
185-57	31181-31186	White	_
185-58	31187-31193	matter	_
185-59	31194-31200	volume	_
185-60	31201-31203	in	_
185-61	31204-31211	alcohol	_
185-62	31212-31215	use	_
185-63	31216-31225	disorders	_
185-64	31225-31226	:	_
185-65	31227-31228	a	_
185-66	31229-31242	meta-analysis	_
185-67	31243-31253	Dissecting	_
185-68	31254-31257	the	_
185-69	31258-31265	genetic	_
185-70	31266-31278	architecture	_
185-71	31279-31281	of	_
185-72	31282-31287	human	_
185-73	31288-31299	personality	_
185-74	31300-31303	The	_
185-75	31304-31310	hidden	_
185-76	31311-31317	island	_
185-77	31318-31320	of	_
185-78	31321-31330	addiction	_
185-79	31330-31331	:	_
185-80	31332-31335	the	_
185-81	31336-31342	insula	_
185-82	31343-31349	Damage	_
185-83	31350-31352	to	_
185-84	31353-31356	the	_
185-85	31357-31363	insula	_
185-86	31364-31372	disrupts	_
185-87	31373-31382	addiction	_
185-88	31383-31385	to	_
185-89	31386-31395	cigarette	_
185-90	31396-31403	smoking	_
185-91	31404-31407	The	_
185-92	31408-31420	NKI-Rockland	_
185-93	31421-31427	sample	_
185-94	31427-31428	:	_
185-95	31429-31430	a	_
185-96	31431-31436	model	_
185-97	31437-31440	for	_
185-98	31441-31453	accelerating	_
185-99	31454-31457	the	_
185-100	31458-31462	pace	_
185-101	31463-31465	of	_
185-102	31466-31475	discovery	_
185-103	31476-31483	science	_
185-104	31484-31486	in	_
185-105	31487-31497	psychiatry	_
185-106	31498-31501	The	_
185-107	31502-31512	biological	_
185-108	31513-31516	and	_
185-109	31517-31530	psychological	_
185-110	31531-31536	basis	_
185-111	31537-31539	of	_
185-112	31540-31551	neuroticism	_
185-113	31551-31552	:	_
185-114	31553-31560	current	_
185-115	31561-31567	status	_
185-116	31568-31571	and	_
185-117	31572-31578	future	_
185-118	31579-31589	directions	_
185-119	31590-31597	Alcohol	_
185-120	31597-31598	:	_
185-121	31599-31606	effects	_
185-122	31607-31609	on	_
185-123	31610-31625	neurobehavioral	_
185-124	31626-31635	functions	_
185-125	31636-31639	and	_
185-126	31640-31643	the	_
185-127	31644-31649	brain	_
185-128	31650-31664	Representation	_
185-129	31665-31667	of	_
185-130	31668-31672	pain	_
185-131	31673-31676	and	_
185-132	31677-31684	somatic	_
185-133	31685-31694	sensation	_
185-134	31695-31697	in	_
185-135	31698-31701	the	_
185-136	31702-31707	human	_
185-137	31708-31714	insula	_
185-138	31714-31715	:	_
185-139	31716-31717	a	_
185-140	31718-31723	study	_
185-141	31724-31726	of	_
185-142	31727-31736	responses	_
185-143	31737-31739	to	_
185-144	31740-31746	direct	_
185-145	31747-31757	electrical	_
185-146	31758-31766	cortical	_
185-147	31767-31778	stimulation	_
185-148	31779-31784	Brain	_
185-149	31785-31795	substrates	_
185-150	31796-31798	of	_
185-151	31799-31806	craving	_
185-152	31807-31809	to	_
185-153	31810-31817	alcohol	_
185-154	31818-31822	cues	_
185-155	31823-31825	in	_
185-156	31826-31834	subjects	_
185-157	31835-31839	with	_
185-158	31840-31847	alcohol	_
185-159	31848-31851	use	_
185-160	31852-31860	disorder	_
185-161	31861-31870	Analgesic	_
185-162	31871-31878	effects	_
185-163	31879-31881	of	_
185-164	31882-31889	ethanol	_
185-165	31890-31893	are	_
185-166	31894-31904	influenced	_
185-167	31905-31907	by	_
185-168	31908-31914	family	_
185-169	31915-31922	history	_
185-170	31923-31925	of	_
185-171	31926-31936	alcoholism	_
185-172	31937-31940	and	_
185-173	31941-31952	neuroticism	_
185-174	31953-31965	Perspectives	_
185-175	31966-31968	on	_
185-176	31969-31972	the	_
185-177	31973-31985	neuroscience	_
185-178	31986-31988	of	_
185-179	31989-31996	alcohol	_
185-180	31997-32001	from	_
185-181	32002-32005	the	_
185-182	32006-32014	National	_
185-183	32015-32024	Institute	_
185-184	32025-32027	on	_
185-185	32028-32035	Alcohol	_
185-186	32036-32041	Abuse	_
185-187	32042-32045	and	_
185-188	32046-32056	Alcoholism	_
185-189	32057-32060	The	_
185-190	32061-32064	Big	_
185-191	32065-32069	Five	_
185-192	32070-32077	default	_
185-193	32078-32083	brain	_
185-194	32083-32084	:	_
185-195	32085-32095	functional	_
185-196	32096-32104	evidence	_
185-197	32105-32115	Functional	_
185-198	32116-32128	neuroimaging	_
185-199	32129-32136	studies	_
185-200	32137-32139	of	_
185-201	32140-32147	alcohol	_
185-202	32148-32151	cue	_
185-203	32152-32162	reactivity	_
185-204	32162-32163	:	_
185-205	32164-32165	a	_
185-206	32166-32178	quantitative	_
185-207	32179-32192	meta-analysis	_
185-208	32193-32196	and	_
185-209	32197-32207	systematic	_
185-210	32208-32214	review	_
185-211	32215-32218	How	_
185-212	32219-32224	acute	_
185-213	32225-32228	and	_
185-214	32229-32236	chronic	_
185-215	32237-32244	alcohol	_
185-216	32245-32256	consumption	_
185-217	32257-32264	affects	_
185-218	32265-32270	brain	_
185-219	32271-32279	networks	_
185-220	32279-32280	:	_
185-221	32281-32289	insights	_
185-222	32290-32294	from	_
185-223	32295-32305	multimodal	_
185-224	32306-32318	neuroimaging	_
185-225	32319-32322	The	_
185-226	32323-32329	dorsal	_
185-227	32330-32339	posterior	_
185-228	32340-32346	insula	_
185-229	32347-32356	subserves	_
185-230	32357-32358	a	_
185-231	32359-32370	fundamental	_
185-232	32371-32375	role	_
185-233	32376-32378	in	_
185-234	32379-32384	human	_
185-235	32385-32389	pain	_
185-236	32390-32401	Neuroticism	_
185-237	32402-32405	and	_
185-238	32406-32409	the	_
185-239	32410-32415	brain	_
185-240	32415-32416	:	_
185-241	32417-32418	a	_
185-242	32419-32431	quantitative	_
185-243	32432-32445	meta-analysis	_
185-244	32446-32448	of	_
185-245	32449-32461	neuroimaging	_
185-246	32462-32469	studies	_
185-247	32470-32483	investigating	_
185-248	32484-32491	emotion	_
185-249	32492-32502	processing	_
185-250	32503-32510	Anxiety	_
185-251	32511-32519	positive	_
185-252	32520-32528	subjects	_
185-253	32529-32533	show	_
185-254	32534-32541	altered	_
185-255	32542-32552	processing	_
185-256	32553-32555	in	_
185-257	32556-32559	the	_
185-258	32560-32568	anterior	_
185-259	32569-32575	insula	_
185-260	32576-32582	during	_
185-261	32583-32595	anticipation	_
185-262	32596-32598	of	_
185-263	32599-32607	negative	_
185-264	32608-32615	stimuli	_
185-265	32616-32624	Striatum	_
185-266	32625-32628	and	_
185-267	32629-32635	insula	_
185-268	32636-32647	dysfunction	_
185-269	32648-32654	during	_
185-270	32655-32668	reinforcement	_
185-271	32669-32677	learning	_
185-272	32678-32692	differentiates	_
185-273	32693-32702	abstinent	_
185-274	32703-32706	and	_
185-275	32707-32715	relapsed	_
185-276	32716-32741	methamphetamine-dependent	_
185-277	32742-32753	individuals	_
185-278	32754-32757	The	_
185-279	32758-32765	WU-Minn	_
185-280	32766-32771	Human	_
185-281	32772-32782	Connectome	_
185-282	32783-32790	Project	_
185-283	32790-32791	:	_
185-284	32792-32794	an	_
185-285	32795-32803	overview	_
185-286	32804-32817	Impulsiveness	_
185-287	32818-32821	and	_
185-288	32822-32828	insula	_
185-289	32829-32839	activation	_
185-290	32840-32846	during	_
185-291	32847-32853	reward	_
185-292	32854-32866	anticipation	_
185-293	32867-32870	are	_
185-294	32871-32881	associated	_
185-295	32882-32886	with	_
185-296	32887-32894	genetic	_
185-297	32895-32903	variants	_
185-298	32904-32906	in	_
185-299	32907-32913	GABRA2	_
185-300	32914-32916	in	_
185-301	32917-32918	a	_
185-302	32919-32925	family	_
185-303	32926-32932	sample	_
185-304	32933-32941	enriched	_
185-305	32942-32945	for	_
185-306	32946-32956	alcoholism	_
185-307	32957-32973	Interhemispheric	_
185-308	32974-32981	insular	_
185-309	32982-32985	and	_
185-310	32986-32994	inferior	_
185-311	32995-33002	frontal	_
185-312	33003-33015	connectivity	_
185-313	33016-33019	are	_
185-314	33020-33030	associated	_
185-315	33031-33035	with	_
185-316	33036-33045	substance	_
185-317	33046-33051	abuse	_
185-318	33052-33054	in	_
185-319	33055-33056	a	_
185-320	33057-33068	psychiatric	_
185-321	33069-33079	population	_
185-322	33080-33085	Brain	_
185-323	33086-33095	structure	_
185-324	33096-33098	in	_
185-325	33099-33110	adolescents	_
185-326	33111-33114	and	_
185-327	33115-33120	young	_
185-328	33121-33127	adults	_
185-329	33128-33132	with	_
185-330	33133-33140	alcohol	_
185-331	33141-33149	problems	_
185-332	33149-33150	:	_
185-333	33151-33161	systematic	_
185-334	33162-33168	review	_
185-335	33169-33171	of	_
185-336	33172-33179	imaging	_
185-337	33180-33187	studies	_
185-338	33188-33191	The	_
185-339	33192-33199	Alcohol	_
185-340	33199-33200	,	_
185-341	33201-33208	Smoking	_
185-342	33209-33212	and	_
185-343	33213-33222	Substance	_
185-344	33223-33234	Involvement	_
185-345	33235-33244	Screening	_
185-346	33245-33249	Test	_
185-347	33250-33251	(	_
185-348	33251-33257	ASSIST	_
185-349	33257-33258	)	_
185-350	33258-33259	:	_
185-351	33260-33271	development	_
185-352	33271-33272	,	_
185-353	33273-33284	reliability	_
185-354	33285-33288	and	_
185-355	33289-33300	feasibility	_
185-356	33301-33316	Neuroanatomical	_
185-357	33317-33327	correlates	_
185-358	33328-33330	of	_
185-359	33331-33343	extraversion	_
185-360	33344-33347	and	_
185-361	33348-33359	neuroticism	_
185-362	33360-33368	Regional	_
185-363	33369-33373	gray	_
185-364	33374-33380	matter	_
185-365	33381-33389	deficits	_
185-366	33390-33392	in	_
185-367	33393-33400	alcohol	_
185-368	33401-33411	dependence	_
185-369	33411-33412	:	_
185-370	33413-33414	a	_
185-371	33415-33428	meta-analysis	_
185-372	33429-33431	of	_
185-373	33432-33443	voxel-based	_
185-374	33444-33455	morphometry	_
185-375	33456-33463	studies	_
185-376	33464-33472	Clinical	_
185-377	33473-33476	and	_
185-378	33477-33489	pathological	_
185-379	33490-33498	features	_
185-380	33499-33501	of	_
185-381	33502-33509	alcohol	_
185-382	33509-33510	-	_
185-383	33511-33518	related	_
185-384	33519-33524	brain	_
185-385	33525-33531	damage	_
185-386	33532-33546	Interrelations	_
185-387	33547-33554	between	_
185-388	33555-33559	pain	_
185-389	33560-33563	and	_
185-390	33564-33571	alcohol	_
185-391	33571-33572	:	_
185-392	33573-33575	an	_
185-393	33576-33587	integrative	_
185-394	33588-33594	review	_
185-395	33595-33601	Annual	_
185-396	33602-33610	Research	_
185-397	33611-33617	Review	_
185-398	33617-33618	:	_
185-399	33619-33628	Discovery	_
185-400	33629-33636	science	_
185-401	33637-33647	strategies	_
185-402	33648-33650	in	_
185-403	33651-33658	studies	_
185-404	33659-33661	of	_
185-405	33662-33665	the	_
185-406	33666-33681	pathophysiology	_
185-407	33682-33684	of	_
185-408	33685-33690	child	_
185-409	33691-33694	and	_
185-410	33695-33705	adolescent	_
185-411	33706-33717	psychiatric	_
185-412	33718-33727	disorders	_
185-413	33728-33729	-	_
185-414	33730-33738	promises	_
185-415	33739-33742	and	_
185-416	33743-33754	limitations	_
185-417	33755-33766	Correlation	_
185-418	33767-33769	of	_
185-419	33770-33775	brain	_
185-420	33776-33784	cortical	_
185-421	33785-33794	thickness	_
185-422	33795-33799	with	_
185-423	33800-33811	neuroticism	_
185-424	33812-33813	(	_
185-425	33813-33814	A	_
185-426	33814-33815	)	_
185-427	33816-33820	Left	_
185-428	33821-33827	insula	_
185-429	33828-33834	cortex	_
185-430	33835-33844	thickness	_
185-431	33844-33845	.	_

#Text=(B) Right fusiform cortex thickness.
186-1	33846-33847	(	_
186-2	33847-33848	B	_
186-3	33848-33849	)	_
186-4	33850-33855	Right	_
186-5	33856-33864	fusiform	_
186-6	33865-33871	cortex	_
186-7	33872-33881	thickness	_
186-8	33881-33882	.	_

#Text=HC, healthy comparisons; AUD, alcohol use disorders.
187-1	33883-33885	HC	_
187-2	33885-33886	,	_
187-3	33887-33894	healthy	_
187-4	33895-33906	comparisons	_
187-5	33906-33907	;	_
187-6	33908-33911	AUD	_
187-7	33911-33912	,	_
187-8	33913-33920	alcohol	_
187-9	33921-33924	use	_
187-10	33925-33934	disorders	_
187-11	33934-33935	.	_

#Text=P-values for the correlations in HC and AUD are both shown.
188-1	33936-33944	P-values	_
188-2	33945-33948	for	_
188-3	33949-33952	the	_
188-4	33953-33965	correlations	_
188-5	33966-33968	in	_
188-6	33969-33971	HC	_
188-7	33972-33975	and	_
188-8	33976-33979	AUD	_
188-9	33980-33983	are	_
188-10	33984-33988	both	_
188-11	33989-33994	shown	_
188-12	33994-33995	.	_

#Text=Validation result using the Human Connectome Project data set
#Text=(A) Correlation of neuroticism with AUD.
189-1	33996-34006	Validation	_
189-2	34007-34013	result	_
189-3	34014-34019	using	_
189-4	34020-34023	the	_
189-5	34024-34029	Human	_
189-6	34030-34040	Connectome	_
189-7	34041-34048	Project	_
189-8	34049-34053	data	_
189-9	34054-34057	set	_
189-10	34058-34059	(	_
189-11	34059-34060	A	_
189-12	34060-34061	)	_
189-13	34062-34073	Correlation	_
189-14	34074-34076	of	_
189-15	34077-34088	neuroticism	_
189-16	34089-34093	with	_
189-17	34094-34097	AUD	_
189-18	34097-34098	.	_

#Text=The dot in AUD group indicates an extreme neuroticism score.
190-1	34099-34102	The	_
190-2	34103-34106	dot	_
190-3	34107-34109	in	_
190-4	34110-34113	AUD	_
190-5	34114-34119	group	_
190-6	34120-34129	indicates	_
190-7	34130-34132	an	_
190-8	34133-34140	extreme	_
190-9	34141-34152	neuroticism	_
190-10	34153-34158	score	_
190-11	34158-34159	.	_

#Text=(B) Correlation of the left insula cortex thickness with neuroticism score.
191-1	34160-34161	(	_
191-2	34161-34162	B	_
191-3	34162-34163	)	_
191-4	34164-34175	Correlation	_
191-5	34176-34178	of	_
191-6	34179-34182	the	_
191-7	34183-34187	left	_
191-8	34188-34194	insula	_
191-9	34195-34201	cortex	_
191-10	34202-34211	thickness	_
191-11	34212-34216	with	_
191-12	34217-34228	neuroticism	_
191-13	34229-34234	score	_
191-14	34234-34235	.	_

#Text=P-values for the correlations in HC and AUDS are both shown.
192-1	34236-34244	P-values	_
192-2	34245-34248	for	_
192-3	34249-34252	the	_
192-4	34253-34265	correlations	_
192-5	34266-34268	in	_
192-6	34269-34271	HC	_
192-7	34272-34275	and	_
192-8	34276-34280	AUDS	_
192-9	34281-34284	are	_
192-10	34285-34289	both	_
192-11	34290-34295	shown	_
192-12	34295-34296	.	_

#Text=HC, healthy comparisons; AUD, alcohol use disorders.
193-1	34297-34299	HC	_
193-2	34299-34300	,	_
193-3	34301-34308	healthy	_
193-4	34309-34320	comparisons	_
193-5	34320-34321	;	_
193-6	34322-34325	AUD	_
193-7	34325-34326	,	_
193-8	34327-34334	alcohol	_
193-9	34335-34338	use	_
193-10	34339-34348	disorders	_
193-11	34348-34349	.	_

#Text=Vertex-based analysis of the brain cortical regions
#Text=(A) Left insula.
194-1	34350-34362	Vertex-based	_
194-2	34363-34371	analysis	_
194-3	34372-34374	of	_
194-4	34375-34378	the	_
194-5	34379-34384	brain	_
194-6	34385-34393	cortical	_
194-7	34394-34401	regions	_
194-8	34402-34403	(	_
194-9	34403-34404	A	_
194-10	34404-34405	)	_
194-11	34406-34410	Left	_
194-12	34411-34417	insula	_
194-13	34417-34418	.	_

#Text=(B) Right fusiform.
195-1	34419-34420	(	_
195-2	34420-34421	B	_
195-3	34421-34422	)	_
195-4	34423-34428	Right	_
195-5	34429-34437	fusiform	_
195-6	34437-34438	.	_

#Text=Vertices in red represent the region with P-value less than 0.05.
196-1	34439-34447	Vertices	_
196-2	34448-34450	in	_
196-3	34451-34454	red	_
196-4	34455-34464	represent	_
196-5	34465-34468	the	_
196-6	34469-34475	region	_
196-7	34476-34480	with	_
196-8	34481-34488	P-value	_
196-9	34489-34493	less	_
196-10	34494-34498	than	_
196-11	34499-34503	0.05	_
196-12	34503-34504	.	_

#Text=Summary of the AUD subjects and health controls used in this study.
197-1	34505-34512	Summary	_
197-2	34513-34515	of	_
197-3	34516-34519	the	_
197-4	34520-34523	AUD	_
197-5	34524-34532	subjects	_
197-6	34533-34536	and	_
197-7	34537-34543	health	_
197-8	34544-34552	controls	_
197-9	34553-34557	used	_
197-10	34558-34560	in	_
197-11	34561-34565	this	_
197-12	34566-34571	study	_
197-13	34571-34572	.	_

#Text=Variables\tHC (n=65)\tAUD (n=65)\t \tDemographics\t \tAge\t44.2 (18.6)\t45.6 (17.6)\t \tSex (Female)\t37 (56.9%)\t33 (50.8%)\t \tRace (White)\t50 (76.9%)\t49 (75.4%)\t \tIQ\t101.6 (11.9)\t101.4 (12.9)\t \tSocioeconomic status\t44.0 (14.4)\t44.8 (10.6)\t \tHandedness\t75.3 (28.5)\t71.2 (37.4)\t \tTraumatic events*\t34 (52.3%)\t51 (78.5%)\t \tAge at drinking onset\t17.5 (4.0)\t16.8 (2.6)\t \tTobacco use status*\t \tNever used tobacco\t35 (53.9%)\t13 (20.0%)\t \tPast tobacco user\t19 (29.2%)\t29 (44.6%)\t \tCurrent tobacco user\t11 (16.9%)\t23 (35.4%)\t \tMarijuana use status*\t \tNever used marijuana\t34 (52.3%)\t12 (18.5%)\t \tPast marijuana user\t24 (36.9%)\t34 (52.3%)\t \tCurrent marijuana user\t7 (10.8%)\t19 (29.2%)\t \tPsychiatric comorbidity\t \tNumber of Comorbidities\t \t0\t\t31 (47.7%)\t \t1\t\t17 (26.2%)\t \t2\t\t7 (10.8%)\t \t3\t\t6 (9.2%)\t \t>3\t\t4 (6.1%)\t \tTop 3 comorbidities\t \tCannabis abuse/dependence\t\t15 (23.1%)\t \tMajor depressive disorder\t\t14 (21.5%)\t \tCocaine abuse/dependence\t\t8 (12.3%)\t \tGlobal brain measurement\t \tICV (cm3)\t1479.5 (128.8)\t1491.3 (149.9)\t \tlh_Thickness (mm)\t2.49 (0.11)\t2.48 (0.10)\t \trh_Thickness (mm)\t2.48 (0.12)\t2.47 (0.10)\t \t
#Text=Notes: HC, healthy comparisons; AUD, alcohol use disorders.
198-1	34573-34582	Variables	_
198-2	34583-34585	HC	_
198-3	34586-34587	(	_
198-4	34587-34588	n	_
198-5	34588-34589	=	_
198-6	34589-34591	65	_
198-7	34591-34592	)	_
198-8	34593-34596	AUD	_
198-9	34597-34598	(	_
198-10	34598-34599	n	_
198-11	34599-34600	=	_
198-12	34600-34602	65	_
198-13	34602-34603	)	_
198-14	34606-34618	Demographics	_
198-15	34621-34624	Age	_
198-16	34625-34629	44.2	_
198-17	34630-34631	(	_
198-18	34631-34635	18.6	_
198-19	34635-34636	)	_
198-20	34637-34641	45.6	_
198-21	34642-34643	(	_
198-22	34643-34647	17.6	_
198-23	34647-34648	)	_
198-24	34651-34654	Sex	_
198-25	34655-34656	(	_
198-26	34656-34662	Female	_
198-27	34662-34663	)	_
198-28	34664-34666	37	_
198-29	34667-34668	(	_
198-30	34668-34673	56.9%	_
198-31	34673-34674	)	_
198-32	34675-34677	33	_
198-33	34678-34679	(	_
198-34	34679-34684	50.8%	_
198-35	34684-34685	)	_
198-36	34688-34692	Race	_
198-37	34693-34694	(	_
198-38	34694-34699	White	_
198-39	34699-34700	)	_
198-40	34701-34703	50	_
198-41	34704-34705	(	_
198-42	34705-34710	76.9%	_
198-43	34710-34711	)	_
198-44	34712-34714	49	_
198-45	34715-34716	(	_
198-46	34716-34721	75.4%	_
198-47	34721-34722	)	_
198-48	34725-34727	IQ	_
198-49	34728-34733	101.6	_
198-50	34734-34735	(	_
198-51	34735-34739	11.9	_
198-52	34739-34740	)	_
198-53	34741-34746	101.4	_
198-54	34747-34748	(	_
198-55	34748-34752	12.9	_
198-56	34752-34753	)	_
198-57	34756-34769	Socioeconomic	_
198-58	34770-34776	status	_
198-59	34777-34781	44.0	_
198-60	34782-34783	(	_
198-61	34783-34787	14.4	_
198-62	34787-34788	)	_
198-63	34789-34793	44.8	_
198-64	34794-34795	(	_
198-65	34795-34799	10.6	_
198-66	34799-34800	)	_
198-67	34803-34813	Handedness	_
198-68	34814-34818	75.3	_
198-69	34819-34820	(	_
198-70	34820-34824	28.5	_
198-71	34824-34825	)	_
198-72	34826-34830	71.2	_
198-73	34831-34832	(	_
198-74	34832-34836	37.4	_
198-75	34836-34837	)	_
198-76	34840-34849	Traumatic	_
198-77	34850-34856	events	_
198-78	34856-34857	*	_
198-79	34858-34860	34	_
198-80	34861-34862	(	_
198-81	34862-34867	52.3%	_
198-82	34867-34868	)	_
198-83	34869-34871	51	_
198-84	34872-34873	(	_
198-85	34873-34878	78.5%	_
198-86	34878-34879	)	_
198-87	34882-34885	Age	_
198-88	34886-34888	at	_
198-89	34889-34897	drinking	_
198-90	34898-34903	onset	_
198-91	34904-34908	17.5	_
198-92	34909-34910	(	_
198-93	34910-34913	4.0	_
198-94	34913-34914	)	_
198-95	34915-34919	16.8	_
198-96	34920-34921	(	_
198-97	34921-34924	2.6	_
198-98	34924-34925	)	_
198-99	34928-34935	Tobacco	_
198-100	34936-34939	use	_
198-101	34940-34946	status	_
198-102	34946-34947	*	_
198-103	34950-34955	Never	_
198-104	34956-34960	used	_
198-105	34961-34968	tobacco	_
198-106	34969-34971	35	_
198-107	34972-34973	(	_
198-108	34973-34978	53.9%	_
198-109	34978-34979	)	_
198-110	34980-34982	13	_
198-111	34983-34984	(	_
198-112	34984-34989	20.0%	_
198-113	34989-34990	)	_
198-114	34993-34997	Past	_
198-115	34998-35005	tobacco	_
198-116	35006-35010	user	_
198-117	35011-35013	19	_
198-118	35014-35015	(	_
198-119	35015-35020	29.2%	_
198-120	35020-35021	)	_
198-121	35022-35024	29	_
198-122	35025-35026	(	_
198-123	35026-35031	44.6%	_
198-124	35031-35032	)	_
198-125	35035-35042	Current	_
198-126	35043-35050	tobacco	_
198-127	35051-35055	user	_
198-128	35056-35058	11	_
198-129	35059-35060	(	_
198-130	35060-35065	16.9%	_
198-131	35065-35066	)	_
198-132	35067-35069	23	_
198-133	35070-35071	(	_
198-134	35071-35076	35.4%	_
198-135	35076-35077	)	_
198-136	35080-35089	Marijuana	_
198-137	35090-35093	use	_
198-138	35094-35100	status	_
198-139	35100-35101	*	_
198-140	35104-35109	Never	_
198-141	35110-35114	used	_
198-142	35115-35124	marijuana	_
198-143	35125-35127	34	_
198-144	35128-35129	(	_
198-145	35129-35134	52.3%	_
198-146	35134-35135	)	_
198-147	35136-35138	12	_
198-148	35139-35140	(	_
198-149	35140-35145	18.5%	_
198-150	35145-35146	)	_
198-151	35149-35153	Past	_
198-152	35154-35163	marijuana	_
198-153	35164-35168	user	_
198-154	35169-35171	24	_
198-155	35172-35173	(	_
198-156	35173-35178	36.9%	_
198-157	35178-35179	)	_
198-158	35180-35182	34	_
198-159	35183-35184	(	_
198-160	35184-35189	52.3%	_
198-161	35189-35190	)	_
198-162	35193-35200	Current	_
198-163	35201-35210	marijuana	_
198-164	35211-35215	user	_
198-165	35216-35217	7	_
198-166	35218-35219	(	_
198-167	35219-35224	10.8%	_
198-168	35224-35225	)	_
198-169	35226-35228	19	_
198-170	35229-35230	(	_
198-171	35230-35235	29.2%	_
198-172	35235-35236	)	_
198-173	35239-35250	Psychiatric	_
198-174	35251-35262	comorbidity	_
198-175	35265-35271	Number	_
198-176	35272-35274	of	_
198-177	35275-35288	Comorbidities	_
198-178	35291-35292	0	_
198-179	35294-35296	31	_
198-180	35297-35298	(	_
198-181	35298-35303	47.7%	_
198-182	35303-35304	)	_
198-183	35307-35308	1	_
198-184	35310-35312	17	_
198-185	35313-35314	(	_
198-186	35314-35319	26.2%	_
198-187	35319-35320	)	_
198-188	35323-35324	2	_
198-189	35326-35327	7	_
198-190	35328-35329	(	_
198-191	35329-35334	10.8%	_
198-192	35334-35335	)	_
198-193	35338-35339	3	_
198-194	35341-35342	6	_
198-195	35343-35344	(	_
198-196	35344-35348	9.2%	_
198-197	35348-35349	)	_
198-198	35352-35353	>	_
198-199	35353-35354	3	_
198-200	35356-35357	4	_
198-201	35358-35359	(	_
198-202	35359-35363	6.1%	_
198-203	35363-35364	)	_
198-204	35367-35370	Top	_
198-205	35371-35372	3	_
198-206	35373-35386	comorbidities	_
198-207	35389-35397	Cannabis	_
198-208	35398-35403	abuse	_
198-209	35403-35404	/	_
198-210	35404-35414	dependence	_
198-211	35416-35418	15	_
198-212	35419-35420	(	_
198-213	35420-35425	23.1%	_
198-214	35425-35426	)	_
198-215	35429-35434	Major	_
198-216	35435-35445	depressive	_
198-217	35446-35454	disorder	_
198-218	35456-35458	14	_
198-219	35459-35460	(	_
198-220	35460-35465	21.5%	_
198-221	35465-35466	)	_
198-222	35469-35476	Cocaine	_
198-223	35477-35482	abuse	_
198-224	35482-35483	/	_
198-225	35483-35493	dependence	_
198-226	35495-35496	8	_
198-227	35497-35498	(	_
198-228	35498-35503	12.3%	_
198-229	35503-35504	)	_
198-230	35507-35513	Global	_
198-231	35514-35519	brain	_
198-232	35520-35531	measurement	_
198-233	35534-35537	ICV	_
198-234	35538-35539	(	_
198-235	35539-35542	cm3	_
198-236	35542-35543	)	_
198-237	35544-35550	1479.5	_
198-238	35551-35552	(	_
198-239	35552-35557	128.8	_
198-240	35557-35558	)	_
198-241	35559-35565	1491.3	_
198-242	35566-35567	(	_
198-243	35567-35572	149.9	_
198-244	35572-35573	)	_
198-245	35576-35588	lh_Thickness	_
198-246	35589-35590	(	_
198-247	35590-35592	mm	_
198-248	35592-35593	)	_
198-249	35594-35598	2.49	_
198-250	35599-35600	(	_
198-251	35600-35604	0.11	_
198-252	35604-35605	)	_
198-253	35606-35610	2.48	_
198-254	35611-35612	(	_
198-255	35612-35616	0.10	_
198-256	35616-35617	)	_
198-257	35620-35632	rh_Thickness	_
198-258	35633-35634	(	_
198-259	35634-35636	mm	_
198-260	35636-35637	)	_
198-261	35638-35642	2.48	_
198-262	35643-35644	(	_
198-263	35644-35648	0.12	_
198-264	35648-35649	)	_
198-265	35650-35654	2.47	_
198-266	35655-35656	(	_
198-267	35656-35660	0.10	_
198-268	35660-35661	)	_
198-269	35665-35670	Notes	_
198-270	35670-35671	:	_
198-271	35672-35674	HC	_
198-272	35674-35675	,	_
198-273	35676-35683	healthy	_
198-274	35684-35695	comparisons	_
198-275	35695-35696	;	_
198-276	35697-35700	AUD	_
198-277	35700-35701	,	_
198-278	35702-35709	alcohol	_
198-279	35710-35713	use	_
198-280	35714-35723	disorders	_
198-281	35723-35724	.	_

#Text=ICV, intracranial volume. lh, left hemisphere. rh, right hemisphere.
#Text=indicates P < 0.05.
199-1	35725-35728	ICV	_
199-2	35728-35729	,	_
199-3	35730-35742	intracranial	_
199-4	35743-35749	volume	_
199-5	35749-35750	.	_
199-6	35751-35753	lh	_
199-7	35753-35754	,	_
199-8	35755-35759	left	_
199-9	35760-35770	hemisphere	_
199-10	35770-35771	.	_
199-11	35772-35774	rh	_
199-12	35774-35775	,	_
199-13	35776-35781	right	_
199-14	35782-35792	hemisphere	_
199-15	35792-35793	.	_
199-16	35794-35803	indicates	_
199-17	35804-35805	P	_
199-18	35806-35807	<	_
199-19	35808-35812	0.05	_
199-20	35812-35813	.	_

#Text=Group differences among the five personality traits.
200-1	35814-35819	Group	_
200-2	35820-35831	differences	_
200-3	35832-35837	among	_
200-4	35838-35841	the	_
200-5	35842-35846	five	_
200-6	35847-35858	personality	_
200-7	35859-35865	traits	_
200-8	35865-35866	.	_

#Text=Personality\tDescriptive statistics mean (sd)\t \t\tModel-based group difference\t \t\t \tHC\tAUD\tHC-AUD\tFDR P value\t \tNeuroticism\t15.6 (5.7)\t19.0 (7.8)\t−3.5\t0.043\t \tExtraversion\t31.8 (5.1)\t29.7 (5.7)\t2.0\t0.196\t \tOpenness\t31.5 (5.1)\t32.7 (5.4)\t−0.7\t0.978\t \tAgreeableness\t34.7 (5.8)\t35.1 (5.9)\t−1.8\t0.092\t \tConscientiousness\t35.2 (6.4)\t34.2 (8.8)\t0.6\t0.978\t \t
#Text=Notes: HC, healthy comparisons; AUD, alcohol use disorders.
201-1	35867-35878	Personality	_
201-2	35879-35890	Descriptive	_
201-3	35891-35901	statistics	_
201-4	35902-35906	mean	_
201-5	35907-35908	(	_
201-6	35908-35910	sd	_
201-7	35910-35911	)	_
201-8	35915-35926	Model-based	_
201-9	35927-35932	group	_
201-10	35933-35943	difference	_
201-11	35949-35951	HC	_
201-12	35952-35955	AUD	_
201-13	35956-35962	HC-AUD	_
201-14	35963-35966	FDR	_
201-15	35967-35968	P	_
201-16	35969-35974	value	_
201-17	35977-35988	Neuroticism	_
201-18	35989-35993	15.6	_
201-19	35994-35995	(	_
201-20	35995-35998	5.7	_
201-21	35998-35999	)	_
201-22	36000-36004	19.0	_
201-23	36005-36006	(	_
201-24	36006-36009	7.8	_
201-25	36009-36010	)	_
201-26	36011-36012	−	_
201-27	36012-36015	3.5	_
201-28	36016-36021	0.043	_
201-29	36024-36036	Extraversion	_
201-30	36037-36041	31.8	_
201-31	36042-36043	(	_
201-32	36043-36046	5.1	_
201-33	36046-36047	)	_
201-34	36048-36052	29.7	_
201-35	36053-36054	(	_
201-36	36054-36057	5.7	_
201-37	36057-36058	)	_
201-38	36059-36062	2.0	_
201-39	36063-36068	0.196	_
201-40	36071-36079	Openness	_
201-41	36080-36084	31.5	_
201-42	36085-36086	(	_
201-43	36086-36089	5.1	_
201-44	36089-36090	)	_
201-45	36091-36095	32.7	_
201-46	36096-36097	(	_
201-47	36097-36100	5.4	_
201-48	36100-36101	)	_
201-49	36102-36103	−	_
201-50	36103-36106	0.7	_
201-51	36107-36112	0.978	_
201-52	36115-36128	Agreeableness	_
201-53	36129-36133	34.7	_
201-54	36134-36135	(	_
201-55	36135-36138	5.8	_
201-56	36138-36139	)	_
201-57	36140-36144	35.1	_
201-58	36145-36146	(	_
201-59	36146-36149	5.9	_
201-60	36149-36150	)	_
201-61	36151-36152	−	_
201-62	36152-36155	1.8	_
201-63	36156-36161	0.092	_
201-64	36164-36181	Conscientiousness	_
201-65	36182-36186	35.2	_
201-66	36187-36188	(	_
201-67	36188-36191	6.4	_
201-68	36191-36192	)	_
201-69	36193-36197	34.2	_
201-70	36198-36199	(	_
201-71	36199-36202	8.8	_
201-72	36202-36203	)	_
201-73	36204-36207	0.6	_
201-74	36208-36213	0.978	_
201-75	36217-36222	Notes	_
201-76	36222-36223	:	_
201-77	36224-36226	HC	_
201-78	36226-36227	,	_
201-79	36228-36235	healthy	_
201-80	36236-36247	comparisons	_
201-81	36247-36248	;	_
201-82	36249-36252	AUD	_
201-83	36252-36253	,	_
201-84	36254-36261	alcohol	_
201-85	36262-36265	use	_
201-86	36266-36275	disorders	_
201-87	36275-36276	.	_

#Text=Highlights
#Text=Subjects with AUD diagnosis history had higher neuroticism scores than HCs.
202-1	36277-36287	Highlights	_
202-2	36288-36296	Subjects	_
202-3	36297-36301	with	_
202-4	36302-36305	AUD	_
202-5	36306-36315	diagnosis	_
202-6	36316-36323	history	_
202-7	36324-36327	had	_
202-8	36328-36334	higher	_
202-9	36335-36346	neuroticism	_
202-10	36347-36353	scores	_
202-11	36354-36358	than	_
202-12	36359-36362	HCs	_
202-13	36362-36363	.	_

#Text=Neuroticism was correlated with cortical thickness of insula and fusiform in AUDs.
203-1	36364-36375	Neuroticism	_
203-2	36376-36379	was	_
203-3	36380-36390	correlated	_
203-4	36391-36395	with	_
203-5	36396-36404	cortical	_
203-6	36405-36414	thickness	_
203-7	36415-36417	of	_
203-8	36418-36424	insula	_
203-9	36425-36428	and	_
203-10	36429-36437	fusiform	_
203-11	36438-36440	in	_
203-12	36441-36445	AUDs	_
203-13	36445-36446	.	_

#Text=The AUD-impacted insula cortical thickness-neuroticism correlation was replicated.
204-1	36447-36450	The	_
204-2	36451-36463	AUD-impacted	_
204-3	36464-36470	insula	_
204-4	36471-36479	cortical	_
204-5	36480-36501	thickness-neuroticism	_
204-6	36502-36513	correlation	_
204-7	36514-36517	was	_
204-8	36518-36528	replicated	_
204-9	36528-36529	.	_
